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 Summary and objectives 
Summary and objectives 
The current Doctoral Thesis, named “Smart dressings based on nanostructured fibers 
containing natural origin antimicrobial and anti-inflammatory compounds” has been developed 
at the Department of Chemical Engineering and Environmental Technology (University of 
Zaragoza, Spain) in the group of Nanostructured Films and Particles (NFP), which is a member 
of the Aragon Institute of Nanoscience (INA). This research has been developed in this institute 
and also in the Biomedical Research Center of Aragon (CIBA). A predoctoral stay of 6 months 
was performed at the Methodist Hospital Research Institute in Houston (Texas, US) supervised 
by Professor Ennio Tasciotti. This research was supported by a FPI predoctoral fellowship, 
funded by the Spanish Ministry of Economy and Competitiveness (CTQ2014-52384-R). The 
short stay was also funded by the Network of Biomedical Research Center in the field of 
Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN). 
Due to the development of bacterial resistances, the search of new compounds to treat 
infections is in the spotlight of researchers. In this scenario, this thesis is focused on the design 
of a bioactive dressing based on electrospun polycaprolactone (PCL) nanofibers loading natural 
compounds obtained from essential oils (EOs) acting as anti-inflammatory and antimicrobial 
compounds for wound healing treatment. For this aim, a deep research in bactericidal and anti-
inflammatory EOs compounds properties was carried out. 
The first purpose of the thesis was to tackle wound infection with plant-derived natural 
compounds. For this goal, the bactericidal properties and mechanisms of different free EOs in 
planktonic bacteria cultures using a Gram-positive strain, Staphylococcus aureus (ATCC 
25923) and a Gram-negative strain, Escherichia coli S17 were studied. In addition, since biofilm 
formation is a challenge in wound infections, the effect of natural compounds was studied in S. 
aureus biofilm. The high volatility character of EOs and the fact that they can be oxidized in 
contact with air or ultraviolet light, make difficult their application. Encapsulation of EOs is a 
good technique to protect their properties. Thus, thymol (THY), the compound that 
demonstrated the best antimicrobial activity against planktonic bacteria and biofilm, was 
encapsulated into PCL nanofibers. Nanofibers synthesis and THY encapsulation were carried 
out using the electrospinning technique. This method allows the fabrication of patches with high 
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using a cGFP-expressing S. aureus strain through quantitative assays and confocal microscopy. 
In order to use these natural compounds for wound healing applications, free-compound 
cytotoxicity assays were carried out in three different cell types: fibroblast, keratinocytes and 
macrophages. Moreover, a co-culture model using J774 macrophages and cGFP-expressing S. 
aureus was developed to study and to monitor the effect of THY loaded PCL patches in 
intracellular bacteria. 
The second goal in the thesis was to find an anti-inflammatory natural compound effective 
for wound treatment. For these assays, an in vitro inflammatory model was optimized in 
lipopolysaccharide (LPS) -activated J774 macrophages. These experiments were developed in 
the Methodist Hospital Research Institute in Houston (Texas, US). The study of the increase or 
reduction levels of inflammatory cytokines allowed us to determine the best anti-inflammatory 
natural compounds evaluated in our studies. Among them, PCL-THY patches demonstrated to 
be the patches that better reduced inflammation in an in vitro inflammatory model. 
After concluding that THY had antimicrobial and anti-inflammatory properties when 
loaded in PCL nanofibers, an in vivo experiment to determine the effectiveness of the designed 
patches in an infected skin wound model was developed. SKH1 hairless mice were used to 
analyze the in vivo bactericidal and anti-inflammatory properties of PCL-THY patches for their 
potential clinical application. 
The document is structured in different chapters that address each of the goals of this 
doctoral thesis: 
o Chapter I corresponds with the introductory part where general concepts are exposed. 
The chapter includes a description of wound healing processes, pointing the factors 
affecting the procedure such as infection and inflammation. Different types of wound 
healing treatments as antibiotics are described, highlighting antibiotic resistance as the 
reason to choose plant-derived compounds as wound healing treatment. Electrospinning 
technique is explained to understand the synthesis of PCL nanofibers and the 
encapsulation of the active principle.   
 
o Chapter II focuses on antimicrobial activity of free EOs to tackle wound infection. 
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(MBC) were measured for different plant-derived natural compounds in S. aureus (ATCC 
25923) and E. coli S17 strains. In addition, a biofilm S. aureus model was optimized to 
determine the effect of EOs in these bacterial formations. The mechanism of action of 
EOs in bacteria was studied by scanning electron microscopy (SEM) and flow cytometry. 
Cytotoxicity of EOs treatment was also evaluated in skin-related cell types such as 
fibroblasts, keratinocytes and macrophages. Carvacrol (CAR), cinnamaldehyde (CIN) and 
THY exhibit the highest in vitro antimicrobial activities against E. coli and S. aureus by 
disrupting bacteria membrane. These results are included in the published article entitled 
“Evaluation of the antimicrobial activity and cytotoxicity of different components of 
natural origin present in essential oils”. García-Salinas, S.; Elizondo-Castillo, H.; 
Arruebo, M.; Mendoza, G.; Irusta, S. Molecules 2018, 23 (6), 1–18. 
https://doi.org/10.3390/molecules23061399. 
 
o Chapter III considering the results obtained in Chapter II, THY was chosen as the 
compound to be loaded into electrospun PCL nanofibers due to its antimicrobial activity 
and low cytotoxicity compared with the other EOs tested. PCL-THY patches were 
synthetized, and bactericidal properties were measured against both, planktonic culture 
and biofilm of cGFP-expressing S. aureus. A co-culture model using cGFP-expressing S. 
aureus and J774 macrophages was developed to study the effect of PCL-THY patches in 
infected cells. Compared to non-loaded dressings, PCL-THY dressings were able to 
eliminate the pathogenic bacteria in coculture models using infected murine macrophages. 
In addition, it was corroborated the successful ability of the patch in preventing biofilm 
formation. These results are included in the recently submitted article entitled 
“Antimicrobial Wound Dressings Against Fluorescent and Methicillin-Sensitive 
Intracellular Pathogenic Bacteria” Garcia-Salinas, S.; Gamez-Herrera, E.; Landa, G.; 
Arruebo, M.; Irusta, S.; Mendoza, G. ACS Applied Materials & Interfaces Manuscript ID: 
am-2020-05668q. 
 
o Chapter IV describes the anti-inflammatory activity of EOs with the aim of reducing and 
controlling the inflammatory process during wound healing. Excessive inflammation can 
cause the activation of unnecessary cells or cytokines, generating deleterious effects, 
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activated with LPS was carried out. Different free natural compounds reported as anti-
inflammatory were assessed. Thus, infected macrophages were treated and analyzed at the 
genetic level, measuring Il (interleukin) 1b, iNos (inducible Nitric oxide synthase) and 
Il10 cytokines by RT-PCR (Real Time-Polymerase Chain Reaction). PCL patches loaded 
with EOs were tested using the same in vitro model, confirming previous results. In 
addition, it was assessed cell morphology and average cell area comparing treated cells 
with positive (LPS-activated cells without treatment) and negative (non LPS-activated 
cells) controls. This experiment demonstrated the similarity among treated cells and non-
activated cells, confirming the anti-inflammatory effect of THY loaded PCL patches. 
These results are included in the published article entitled “Electrospun Anti-
Inflammatory Patch Loaded with Essential Oils for Wound Healing”. García-Salinas, S.; 
Evangelopoulos, M.; Gámez-Herrera, E.; Arruebo, M.; Irusta, S.; Taraballi, F.; Mendoza, 
G.; Tasciotti, E. Int. J. Pharm. 2020, 577 (January), 119067. 
https://doi.org/10.1016/j.ijpharm.2020.119067. 
 
o Chapter V joins all the research performed during the thesis in an S. aureus (ATCC 
25923) infected wound in vivo model in SHK1 hairless mice. Thus, it was analyzed the in 
vivo bactericidal and inflammatory properties of the designed dressing. In addition, 
controls of free EO and a clinical compound (chlorhexidine) were added to assess the 
advantages of our patch against other treatments. Starting by infection, quantitative and 
qualitative measurements of bacteria present in the wound were collected at different dpi 
(days post infection). Moreover, the histological analysis of skin wounds was carried out 
to evaluate inflammatory reaction and new vessels formation. Studies demonstrated that 
PCL-THY can prevent infection, promote wound healing and prompt regeneration. These 
results are included in the recently accepted article entitled “Efficiency of Antimicrobial 
Electrospun Thymol-Loaded Polycaprolactone Mats in vivo”  Garcia-Salinas, S.; Gamez-
Herrera, E.; Asin, J.; de Miguel, R.; Andreu, V.; Sancho-Albero, M.; Mendoza, G.; Irusta, 
S.; Arruebo, M. ACS Applied Biomaterials. Manuscript ID: mt-2020-002706. 
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o Appendix I describes the main characterization techniques and biological methods in 
order to evaluate the antimicrobial and anti-inflammatory ability of free and loaded 
compounds. 
 
o Appendix II indicates the references used to write this work. 
 
o Appendix III points the published scientific papers and participation in conferences 
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Resumen y objetivos 
La presente tesis doctoral denominada “Apósitos inteligentes basados en la encapsulación 
de compuestos antimicrobianos y anti-inflamatorios de origen natural en fibras 
nanoestructuradas” ha sido desarrollada en el Departamento de Ingeniería Química y 
Tecnologías del Medioambiente (Universidad de Zaragoza, España) en el Grupo de Películas y 
Partículas Nanoestructuradas (NFP), miembro del Instituto de Nanociencia de Aragón (INA). 
Parte de la investigación ha sido desarrollada en el Centro de Investigación Biomédica de 
Aragón (CIBA). Durante este periodo, se ha realizado una estancia de 6 meses en el Methodist 
Hospital Research Institute en Houston (Texas, US), supervisada por el Profesor Ennio 
Tasciotti. La tesis ha sido financiada por el Programa de Formación de Personal Investigador 
(FPI) proporcionado por el Ministerio de Economía y Competitividad de España (CTQ2014-
52384-R). La estancia fue co-financiada por el Centro de Investigación Biomédica en Red en el 
campo de la Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN). 
Debido al desarrollo de resistencias bacterianas, el interés en la búsqueda de nuevos 
compuestos para abordar infecciones ha crecido exponencialmente para los investigadores. Por 
este motivo, esta tesis doctoral está enfocada en el diseño de un apósito basado en nanofibras de 
policaprolactona (PCL) sintetizadas mediante electrospinning, que encapsulen compuestos 
naturales que actúen como anti-inflamatorios y antimicrobianos para el tratamiento de heridas. 
Con este objetivo, se ha llevado a cabo un profundo estudio de los aceites esenciales con 
propiedades bactericidas y anti-inflamatorias.    
El primer objetivo de la tesis doctoral fue abordar la infección de heridas con compuestos 
naturales derivados de plantas. Para esto, se estudiaron las propiedades y los mecanismos de 
acción de diferentes compuestos en bacterias planctónicas utilizando dos modelos bacterianos, 
uno Gram-positivo, como S. aureus (ATCC 25923) y otro Gram-negativo, como E. coli-S17. 
Teniendo en cuenta que la formación de biofilm es un problema en las infecciones de heridas, 
se estudió el efecto de los compuestos naturales en un modelo de biofilm de S. aureus. El 
carácter volátil de los EOs y la posibilidad de oxidarse cuando están en contacto con luz 
ultravioleta o el aire, hacen difícil su aplicación. La encapsulación de estos compuestos ayuda a 
proteger sus propiedades y facilitar así su aplicación final. Así, el timol (THY) demostró ser el 
compuesto con mejor actividad antimicrobiana en ambos modelos bacterianos, de modo que fue 
encapsulado en nanofibras de PCL. La síntesis de nanofibras y la encapsulación del THY se 
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llevaron a cabo mediante la técnica de electrospinning. Este método permite la fabricación de 
nanofibras con encapsulación de compuestos volátiles, como el THY, gracias a la rápida 
formación de las fibras. Las propiedades bactericidas de los apósitos de PCL cargado con THY 
se estudiaron utilizando un modelo de S. aureus que expresaba GFP y así poder realizar ensayos 
cuantitativos y mediante microscopía confocal.  
El segundo objetivo de la tesis ha sido encontrar un compuesto natural anti-inflamatorio 
para el tratamiento de heridas. Para ello, se ha optimizado un modelo inflamatorio in vitro en 
macrófagos J774 activados con lipopolisacárido (LPS). Estos experimentos se llevaron a cabo 
en el Methodist Hospital Research Institute en Houston (Texas, US), donde se determinaron los 
niveles de citoquinas inflamatorias lo que nos permitió determinar entre los testados los mejores 
compuestos naturales anti-inflamatorios. Además, las membranas de PCL-THY demostraron 
ser los mejores apósitos reduciendo la inflamación, entre los distintos tratamientos de estudio. 
Tras concluir que el THY encapsulado en nanofibras de PCL mantiene las propiedades 
antimicrobianas y anti-inflamatorias, se desarrolló un modelo in vivo para determinar la 
efectividad de los apósitos en heridas de piel infectadas. Para ello, se utilizaron ratones sin pelo 
SKH1 para analizar las propiedades bactericidas e inflamatorias para su potencial aplicación 
clínica.  
El documento está estructurado en diferentes capítulos que abordan cada uno de los 
objetivos de la tesis doctoral:  
o El Capítulo I corresponde con la parte introductoria, donde se explican los conceptos 
generales. El capítulo incluye una descripción del proceso de curación de una herida, 
resaltando factores que afectan al mismo, como por ejemplo la infección e inflamación. 
Se explican también los diferentes tipos de tratamientos que existen, como los antibióticos, 
poniendo especial atención en el desarrollo de resistencias bacterianas a los mismos, como 
la razón principal de elección de compuestos naturales para el tratamiento de heridas. La 
técnica de electrospinning se detalla para entender la síntesis de fibras de PCL y la 
encapsulación de los principios activos.  
 
o El Capítulo II se centra en la actividad antimicrobiana de los compuestos libres para 
abordar la infección de heridas. Se calculó la Concentración Mínima Inhibitoria (MIC) y 
la Concentración Mínima Bactericida (MBC) de diferentes compuestos derivados de 
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plantas en una cepa de S. aureus (ATCC 25923) y otra de E. coli-S17.  Además, se 
desarrolló un modelo de biofilm en S. aureus para determinar el efecto de los compuestos 
libres en estas estructuras bacterianas. El mecanismo de acción de los aceites esenciales 
en las bacterias fue estudiado mediante microscopía electrónica de barrido (SEM) y 
citometría de flujo. Por último, se estudió la citotoxicidad de los compuestos en tres tipos 
celulares relacionados con la piel: fibroblastos, queratinocitos y macrófagos. Carvacrol 
(CAR), cinamaldehido (CIN) y THY demostraron tener la mayor actividad antimicrobiana 
en un modelo in vitro de S. aureus y E. coli. a través de la disrupción de la membrana 
bacteriana. Estos resultados están incluidos en el artículo publicado titulado “Evaluation 
of the antimicrobial activity and cytotoxicity of different components of natural origin 
present in essential oils”. García-Salinas, S.; Elizondo-Castillo, H.; Arruebo, M.; 
Mendoza, G.; Irusta, S. Molecules 2018, 23 (6), 1–18. 
https://doi.org/10.3390/molecules23061399. 
 
o Capítulo III: Teniendo en cuenta los resultados obtenidos en el Capítulo II, el THY fue 
elegido para ser encapsulado en nanofibras de PCL, dada su capacidad antimicrobiana y 
su baja citotoxicidad comparada con el resto de los compuestos. Se midió el efecto del 
PCL-THY en contacto con cGFP-expressing S. aureus en suspensión y en forma de 
biofilm. Por último, se diseñó un modelo de co-cultivo con cGFP-expressing S. aureus y 
macrófagos J774 para estudiar el efecto del PCL-THY en células infectadas. Los apósitos 
de PCL-THY eliminaron el crecimiento bacteriano en un modelo de infección de 
macrófagos J774. Además, los estudios corroboraron la inhibición de la formación de 
biofilm. Los resultados están incluidos en el artículo titulado “Antimicrobial Wound 
Dressings Against Fluorescent and Methicillin-Sensitive Intracellular Pathogenic 
Bacteria” Garcia-Salinas, S.; Gamez-Herrera, E.; Landa, G.; Arruebo, M.; Irusta, S.; 
Mendoza, G. enviado para su publicación a ACS Applied Materials & Interfaces. 
Manuscript ID: am-2020-05668q. 
 
o El Capítulo IV describe la actividad anti-inflamatoria de los aceites esenciales con el 
objetivo de reducir y controlar el proceso inflamatorio en la curación de heridas. La 
abundante inflamación puede causar la activación de células o citoquinas innecesarias que 
generan efectos deletéreos y retrasan el proceso de curación. Por esta razón, se optimizó 
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un modelo inflamatorio con macrófagos J774 activados con LPS y se estudió el efecto de 
diferentes compuestos naturales reportados como anti-inflamatorios. Los macrófagos 
infectados se trataron y se analizaron a nivel genético, midiendo los niveles de expresión 
de Il (Interleucina) 1b, iNos (óxido nítrico sintasa inducible) e Il10 por RT-PCR (Real 
Time-Polymerase Chain Reaction). Los aceites esenciales con mejor resultado se 
encapsularon en nanofibras de PCL y se estudió el efecto de los mismos, confirmando los 
resultados previamente obtenidos. Además, se realizaron experimentos en los que se 
evaluó la morfología celular, comparando las células tratadas con controles positivos 
(células activadas con LPS sin tratamiento) y negativos (células no activadas con LPS). 
Este experimento demostró la similitud entre las células tratadas y las no activadas, 
confirmando los efectos anti-inflamatorios del tratamiento. Los resultados están incluidos 
en el artículo publicado titulado “Electrospun Anti-Inflammatory Patch Loaded with 
Essential Oils for Wound Healing”. García-Salinas, S.; Evangelopoulos, M.; Gámez-
Herrera, E.; Arruebo, M.; Irusta, S.; Taraballi, F.; Mendoza, G.; Tasciotti, E. Int. J. Pharm. 
2020, 577 (January), 119067. https://doi.org/10.1016/j.ijpharm.2020.119067 
 
o El Capítulo V unifica toda la investigación realizada durante la tesis en un modelo in vivo 
de infección de heridas con S. aureus (ATCC 25923) en ratones sin pelo SKH1. Se 
analizaron las propiedades bactericidas y antiinflamatorias de los apósitos diseñados. 
Además, se realizaron controles del compuesto libre y de clorhexidina (compuesto 
utilizado en la clínica) para conocer las ventajas de nuestros apósitos frente a otros 
tratamientos. En cuanto al control de la infección, se realizaron medidas cuantitativas y 
cualitativas de las bacterias presentes en la herida a diferentes tiempos post-infección. En 
cuanto al control de la inflamación, se realizaron análisis histológicos de las heridas 
evaluando la reacción de células inflamatorias y la formación de nuevos vasos sanguíneos. 
Los estudios demostraron que los apósitos de PCL-THY pueden prevenir la infección, 
además de promover la regeneración en heridas. Los resultados están incluidos en el 
artículo titulado “Efficiency of Antimicrobial Electrospun Thymol-Loaded 
Polycaprolactone Mats in vivo” Garcia-Salinas, S.; Gamez-Herrera, E.; Asin, J.; de 
Miguel, R.; Andreu, V.; Sancho-Albero, M.; Mendoza, G.; Irusta, S.; Arruebo, M.: 
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o El Capítulo VI resume las principales conclusiones obtenidas en este trabajo. 
 
o El Apéndice I describe las técnicas de caracterización y métodos biológicos utilizados 
para evaluar la actividad antimicrobiana y anti-inflamatoria de los compuestos libres y 
encapsulados.  
 
o El Apéndice II indica las referencias utilizadas en este trabajo 
 
o El Apéndice III señala los artículos publicados y la participación en congresos que se han 

































This chapter provides a brief review of the literature and the state of the art about wound healing 
process and potential treatments. The chapter includes a description of factors that delay the 
procedure, such as infection and inflammation, and describes the emerging problem of antibiotic 
resistances. Abording the novel technology of nanoscience, electrospinning technique allows 
nanofibers synthesis encapsulating bioactive molecules. EOs demonstrated low levels of 
induction of antimicrobial resistance that make them interesting for bactericidal applications. 
This chapter describes electrospinning mechanism and the advantages that provides to 
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I.1. Wound healing process 
A cutaneous wound is defined as the disruption of the normal structure and function of 
the skin, in which many cell types collaborate to restore the tissue in a physiological process 
called wound healing.1,2 A wound can range from a superficial damage in the epithelial integrity 
to the disruption of deeper subcutaneous tissues such as muscles and vessels.3 There are different 
types of wounds:  
a. Acute wounds: These wounds imply both functional and anatomical restoration in 5-10 
days or within 30 days. They can be acquired by traumatic loss of tissue or by a surgical 
procedure.1  
b. Chronic wounds: This type includes wounds that do not progress orderly and total healing 
may be delayed, incomplete and disturbed by many factors which prolong one or more 
physiological stages. These factors involve infection, hypoxia, necrosis, production of 
exudates and increased levels of cytokines or immune cells that perpetuate a non-healing 
state. These wounds can be caused by pressure, burns, vasculitis, etc.1,4 
c. Complicated wounds: These wounds are those that combine a cutaneous infection and a 
tissue defect. Bacteria colonization depends on the virulence, number and type of 
microorganism present and may perpetuate a non-healing state. In this type of wound, it 
becomes very relevant the tissue defect, including its traumatic or post-infectious 
aetiology.4  
Wound healing is a complex and dynamic progression which involves four different steps 
represented in Figure I.1: 1) arrest the bleeding by blood coagulation and hemostasis; 2) 
initiation of an acute inflammatory response to the initial injury; 3) cell proliferation, migration 
and regeneration; 4) remodeling of connective tissue in which the aim is to restore the skin 
integrity and strength to culminate the repair of the tissue.5 These events can occur together or 
independently depending on the cell type compromised by the injury.6    
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Figure I.1: Wound healing evolution and cell expression in each phase of the process. Adapted 
from Plastic and Reconstructive Surgery, 117/7, G. Broughton, J.E. Janis, C.E. Attinger, The 
basic science of wound healing, 12S-34S.   
I.1.1. Coagulation and hemostasis phase 
Coagulation and hemostasis take place immediately after injury with two main goals; in a 
short term, to arrest bleeding. In a long-term, it provides an extracellular matrix needed during 
the wound healing process (monocytes, neutrophils, fibroblasts and endothelial cells) avoiding 
the colonization of external agents. Immediately upon injury, damaged blood vessels 
vasoconstrict and the coagulation cascade is initiated. The process results in a fibrin clot 
formation, which consists of an aggregation of collagen, platelets, thrombin, fibrinogen and 
fibronectin in a fibrin network, which stops bleeding and releases cytokines and growth factors 
that help to initiate the inflammatory response.7,8 This phase needs special attention for 
infection. Microbes have free entrance to deeper tissues and thus, the possibility to colonize and 
contaminate them.  
I.1.2. Inflammatory phase 
Inflammation is a localized and protective response to a tissue injury which can be 
aggravated under the presence of infection. Inflammatory cells play a key role in wound healing 
contributing to the clean-up of cell debris, as well as to the protection of the wound from 





a.  Early inflammatory phase: The fibrin clot and damaged cells release intracellular contents 
such as danger-associated molecular patterns (DAMPs), which activate cytokines such as 
interleukin 1 (IL-1), tumor necrosis factor α (TNFα), transforming growth factor β (TGFβ) 
or IL-18, among others. When they accumulate, the inflammatory phase is initiated.8,10 In 
addition, pathogen-associated molecular patterns (PAMPs) join to their ligands in toll-like 
receptors (TLRs) leading the production of more growth factors and cytokines.11 As 
response, prostaglandins manage the blood vessels vasodilation to allow the effective 
circulation of inflammatory cells.12,13 As Figure I.1 shows, neutrophils take relevance in 
this phase by the expression of pro-inflammatory cytokines and the clearing of bacteria and 
debris by the release of proteolytic enzymes that will digest bacteria and damaged tissue.14 
This cell type is responsible for the transmigration through the endothelial layer to allow 
the expression of adhesion molecules, attracting more inflammatory cells. 
 
b. Late inflammatory phase: As part of the late inflammatory phase, more neutrophils and 
other immune and repairing cell types are attracted to the injury (Figure  I.1).2 For example, 
monocytes in the nearby tissue and blood are attracted to the injured area and transformed 
into macrophages, which are able to present antigens, call other inflammatory cells to the 
wound area, phagocyte the dead neutrophils, kill bacteria by phagocytosis and generate 
nitric monoxide (NO).2,15,16  Two types of macrophages can be differentiated; i) classically 
activated M1 pro-inflammatory macrophages, present in a first stage of wound healing and 
ii) alternatively activated M2 anti-inflammatory and pro-angiogenic macrophages.17  
This well-coordinated procedure is possible due to the production of arrest signals as 
checkpoint controllers of inflammation.18    
I.1.3. Proliferative phase: Epithelization, angiogenesis and provisional matrix formation 
The closure of the injured tissue takes place during the proliferative phase, when 
angiogenesis, fibroplasia and re-epithelialization occur.19 Macrophages are the link between the 
inflammatory and proliferative phases. M2 macrophages manage the transition into the 
proliferative phase acting as angiogenesis and fibroplasia mediators by the release of different 
factors such as the vascular endothelial growth factor (VEGF), TNFα, TGFβ, epidermal growth 
factor (EGF), platelet-derived growth factor (PDGF) and IL-1. It has been reported that animals 
showing macrophage depletion have a delayed epithelization.14,20  
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Chemotaxis is the ability of cells to move along a chemical gradient.21 In response to EGF 
and TGFα, epithelial cells in the edge of the wound start proliferating and moving by chemotaxis 
to form a barrier against microorganisms and fluid losses.22 Fibroblasts and endothelial cells are 
the most predominant cellular groups in this phase (Fig. I.1). Endothelial cells secrete VEGF, 
PDGF, TNFα, and TGFβ to promote vasodilation, neovascularization and vessel repair. In 
addition, NO released by endothelial cells in response to hypoxia, stimulates more VEGF 
production.15,16 This chemotactic activity is necessary for angiogenesis, in order to supply 
nutrients and oxygen to tissues, and to promote immune cells migration.23–25 
Fibroblasts migrate into the wound and secrete keratinocyte growth factor (KGF)-1 and 
IL-6 to stimulate keratinocytes migration, proliferation and differentiation to the injured 
area.15,16 In addition, fibroblasts release PDGF and start synthesizing collagen to provide 
integrity and strength, and transform into myofibroblasts, which are important for wound 
contraction. Medrado et al.9 demonstrated that myofibroblasts accumulated on the edges of the 
wound promote contractive activities, closing the wound’s borders toward the center. 
Fibroblasts are also responsible for synthesizing a provisional matrix formed of collagen, 
glycosaminoclycans, hyaluronan and fibronectin. Abundant extracellular matrix (ECM) 
accumulates and promotes cell migration for tissue regeneration.26,27  
I.1.4. Remodeling phase  
Remodeling phase is characterized for forming new epithelium achieving the maximum 
tensile strength through degradation, reorganization and synthesis of ECM, to restructure normal 
tissue.6 Three of the most remarkable processes during this phase are: a) maturing of the 
elements in tissue, b) resolution of the inflammation and c) changes in the composition of the 
ECM.28 For example, the initial and disorganized  matrix composed of fibrin and fibronectin is 
replaced;8 collagen type III starts to degrade and hyaluronic and fibronectin acid levels are 
reduced, meanwhile the synthesis of type I collagen increases.29 In the final step of wound 
healing, collagen fibers start to be thicker and to align in parallel in order to increase the tissue 
strength.30 Depending on the injured area and healing duration, approximately 80% of collagen 
fibers recover the original strength, although it depends on the localization and duration of the 
repair. Nevertheless, the original strength can never be recovered.1,4  
With the aim to form a scar with a reduced number of cells, inflammatory cells and 





and transform into myofibroblasts with contraction properties to achieve an efficient tissue 
closure.9,31 All the process is controlled by different growth factors such as PDGF, TFG-β and 
FGF (Fibroblast Growth Factor).32,33  
I.2. Factors affecting wound healing 
Wound healing is a complex process in which many factors can affect physiologic 
responses and cellular function. For example, hypoxia or decreased glucose levels can slow 
down the healing process due to the high requirement of an adequate supply of energy. 
Particularly, the proliferative phase is characterized by an enhanced metabolism that needs a 
rich blood supply to provide glucose and oxygen,34,35 which may be impaired under hypoxic or 
hypoglycemic conditions. On the other hand, ischemia can be associated with edema or elevated 
tissue pressures, which compromises the inflammatory phase by affecting wound perfusion and 
thus, delaying the wound healing process.36 Illnesses as diabetes mellitus or hypothyroidism can 
affect the proliferative and remodeling phases by decreasing collagen production and 
maturation. As consequence, wound tensile strength is reduced and wound healing delayed.37,38 
Some factors, such as age, hypothermia, nutrition, smoking or corticosteroids, can prolong the 
wound healing process at different phases.36 For example, experimental studies have 
demonstrated a decreased healing in older animals in which inflammatory and proliferative 
phases are affected.39 Hypothermia or nicotine induce vasoconstriction, reducing cellular 
response and, as consequence, the efficiency of healing.40,41  
One important factor affecting healing is wound infection. Invasion and dissemination of 
microorganisms may affect the host natural immune system and delay wound healing.42,43 The 
clinical significance of load infection in delaying wound healing was described back in 1964 by 
Bendy et al.44 and until now, there have been multiple studies about effects, causes and 
treatments for wound infection. 
I.2.1 Importance of infection  
When skin is damaged, bacteria can penetrate into the tissue causing infections.45 In 
addition, the accumulation of cellular debris can promote bacterial colonization and infection, 
highlighting the importance of clearing the wound of microorganisms, dead tissue and foreign 
bodies.1,42 The origin of wound contaminants are mainly three: a) the environment, b) the 
surrounding skin and c) endogenous sources involving mucosal membranes.46 Aerobic or 
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facultative pathogens receive importance for being the main causes of delayed wound healing 
and infection. For example, the Center for Disease and Prevention guideline has recognized 
Staphylococcus aureus, Escherichia coli, Pseudomonas aeruginosa and coagulase-negative 
staphylococci, as the most frequent pathogens in surgical wound infections.47 S. aureus takes 
relevance in cutaneous wounds, being the most common pathogen isolated from surgical site 
infections and cutaneous abscesses.48 The most common wound infections depending on the 
origin are the following: 
a. Surgical site infection (SSI) has been described as the most typical type of hospital-acquired 
infection. SSI is defined as a postoperative infection that takes place within 30 days of a 
surgical practice.49,50 Clean surgery implies 1-5% risk of post-operative infection, 
meanwhile the percentage rises to 27% in non-sterile procedures. SSI causes an increase in 
clinical and economical expenses not only due to prolonged hospitalization, diagnostic tests 
or additional treatments (direct costs), but also related to the patient´s physical and mental 
health (indirect costs).51,52 It has been reported that patients with SSI generate an 
economical burden double that patients who do not develop an infection.53 In 2015, the 
Spanish healthcare costs related to SSI reached $1.084.639, meanwhile when indirect costs 
were included, this number increased.54      
b. Soft tissue infections are defined as infections of any of the layers in the soft tissue (dermis, 
subcutaneous tissue, superficial or deep fascia and muscle). It has been demonstrated that 
S. aureus is the pathogen that infects 25-30% of this type of wounds, although infection can 
also have a polymicrobial origin.42,55 
c. Bite wound infections: Bacterial population of an animal bite depends on the oral flora of 
the animal and is often polymicrobial having a mixture of aerobic and anaerobic organisms. 
Most common bites are from dogs and cats.56  
d. Burn wound infections: Burns are a type of trauma related with thermal injury. The skin is 
a barrier to microbial invasion; when these wounds are moderate or severe, they need 
immediate specialized care to minimize morbidity and mortality. According to the National 
Center for Injury Prevention and Control in the United States, approximately 500,000 burn 
cases needed medical treatment in 2016 and about 5,000 patients died from burn related 
complications such as infections. S. aureus is the most common pathogen that colonize 





e. Leg, foot and decubitus (pressure) ulcers are produced for the prolonged immobilization, 
causing skin breakdown due to pressure over a bony prominence. Bacterial infection is the 
most common complication associated with this trauma, specifically, with soft tissues and 
bones, resulting in both morbidity and mortality and increased costs for healthcare 
facilities.59,60 There exist 4 different pressure injuries according to the severity and level of 
tissue damaged. Stage I corresponds with an erythema; Stages II and III are deep tissue 
injuries, and stage IV corresponds to a full thickness tissue loss. 
Wounds heal quickly if the conditions in the injured site are optimal, in terms of 
maintaining blood perfusion to deliver oxygen, nutrients and immune cells and thus, providing 
a minimal chance for pathogenic microorganisms to colonize and proliferate.61 However, there 
are predisposing factors for infection, including diseases, poor hygiene or low host immunity.62 
An infected wound progression includes a range of microbial and host factors such as type, size, 
site and depth of the wound, microbial load and level of virulence, the immune status of the host 
and level of blood perfusion.42 Non-healing wounds are characterized by a prolonged 
inflammation, failure in re-epithelialization and remodeling. Signs of persistent infection can be 
pain, erythema, edema, heat and purulence, or in a more advanced wound, serous exudate, 
discoloration of granulation tissue and wound breakdown.63   
I.2.2 Biofilm formation 
The existence of bacteria, particularly in chronic colonization, is not usually as a free-
living planktonic state, but in clusters called biofilms. Biofilms are populations of bacteria 
aggregated and embedded in a self-secreted extracellular polymeric substance (EPS) which 
provides a protective environment to exogenous threats. Biofilm thickness can range from 
microns to millimeters and can be constituted of a single type of bacteria or polymicrobial. This 
matrix includes a complex structure of water channels to allow transfer of nutrients and waste 
products.64  
Infected wounds can lead to severe conditions when biofilms are formed. It has been 
reported that biofilms can be many times more resistant than planktonic bacteria to antibiotic 
treatment.43. Within biofilm, intercellular signaling molecules produced by bacteria are present; 
in response to factors secreted by other bacteria in the community, they can coordinate bacterial 
activities, control the biofilm growth pattern or change the phenotype and thus, its virulence 
factors. This phenomenon is called quorum sensing (cell-cell communication). In this regard, 
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two different groups of signaling molecules are released: Gram-negative bacteria release fatty 
acid derivatives, meanwhile Gram-positive bacteria use peptide derivatives for intercellular 
communication.65,66 
Biofilm can grow in nature (plants, rocks, soil), medical devices (catheters, valves) and in 
the human body, in which biofilm helps bacteria to protect themselves of external agents, 
increasing the resistance to different therapies and host defenses. It has been reported that 
antibiotic concentration against biofilm should be many times higher than the dose used against 
planktonic bacteria.67 As Figure I.2 shows, a biofilm cluster can detach from the original surface 
and move onto surrounding areas causing infection dissemination.64 
Figure I.2: Representation of biofilm formation. (A) Attachment: Bacteria in wounds can be 
cleared by antibodies and immune cells. (B) Proliferation: Bacteria can attach to the wound and 
start forming biofilm. (C) Maturing: Biofilm growths attracting more immune cells, which 
release phagocytic enzymes. (D) Bacteria can be released from biofilm and disseminate. 
Phagocytic enzymes can damage tissue in the edges of the wound. Adapted from Science, 
284/5418, J. Costerton, P. Stewart, E. Greenberg, Bacterial biofilms: A common cause of 
persistent infections, 1318-1322.   
Biofilm formation would allow bacteria to increase host inflammation, which alters the 
normal transition from inflammatory to proliferative phases and thus, delays wound healing 
process. Bacteria within biofilm can alter many inflammatory mediators such as cytokines and 
blood components, and change oxygen concentration and pH in the wound, affecting not only 
the inflammatory cellular response, but also the repair phase.68 For example, prolonged presence 





inflammatory factors. Also, keratinocytes migration is inhibited by the presence of these cells.69 
Due to the expression of neutrophils and macrophages, pro-inflammatory cytokines secretion is 
increased, resulting in an impaired wound healing.70  
I.2.3 Bacteria resistance to antibiotics 
How an infected wound should be treated is a widespread discussion that remarks the 
importance of clinical observations and microbiological care in wound healing. Advanced 
cutaneous infections or deep tissue affections are recommended to be treated with systemic 
antibiotics. However, if the infection is localized in an injured area, the treatment should be 
initiated with topical agents. Topical antimicrobial compounds include antiseptics and 
antibiotics. If these first topical treatments fail, an alternative topical therapy can be considered, 
unless clinical signs of infection are progressing. In that case, systemic antibiotic therapy should 
be prescribed with the narrowest spectrum of antimicrobial activity. With no signs of infection, 
systemic antibiotics should not be used.42    
Antibiotics are substances that kill or inhibit the growth of bacteria in or on the body.71 
Although antibiotics have been one of the most important advances in research and medicine, 
the excessive use of these compounds, not only in human health, but also in agriculture and 
livestock, has helped bacteria to develop antibiotic resistance strategies, bringing today a global 
concern for human health. Antimicrobial resistance (AMR) development has been rated among 
one of the 10 urgent threats by the World Health Organization in 2019.72 Antibiotic resistance 
is a mechanism of adaptation to antibiotic exposure in which microbes develop resistance 
against most used antibiotics.73,74 The most common drug-resistant microorganisms are 
Enterococcus faecium, S. aureus, Klebsiella pneumoniae, Acinetobacteri baumannii P. 
aeruginosa, Enterobacter spp., and E. coli pathogens, all of them belong to a group called 
ESKAPEE.75 Some of them are considered as critical by the WHO.76 Since 200077, only 30 new 
antibiotics have been approved for clinical use, and around 40 are in different developmental 
phases.78 AMR cause 50.000 deaths every year across the US and Europe, although it is expected 
to rise up to 10 million deaths in 2050.79   
It is reported that changes that allow resistance to appear, are produced at the genetic level 
(Figure I.3). In particular, one of the mechanisms to develop AMR is that bacteria are capable 
to mutate or introduce new genetic information without disturbing their target function.80,81 
Another mechanism is that bacteria may block the target access by modifying membrane 
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permeability. In that case, Gram negative bacteria are less permeable than Gram positive 
bacteria due to the presence of outer membrane and thus, this type of bacteria have a higher 
possibility to develop AMR.82,83 In addition, porins of the membrane (channels for diffusion of 
hydrophilic antibiotics) can mutate, reducing the diffusion of antibiotics inside the cell.84 
Another mechanism is through the use of active efflux pumps (EPs), which have the ability to 
reduce antibiotics concentration inside the bacterial cell by flushing them out.74 Apart of all 
these mechanisms, bacteria have the ability to modify drug molecules inactivating the site of 














Figure I.3: Molecular mechanisms in bacteria to develop antimicrobial resistance. Reprinted 
from Fitoterapia, 140, Z. Yu, J. Tang, T. Khare et al., The alarming antimicrobial resistance in 
ESKAPEE pathogens: Can essential oils come to the rescue? pages 104433., Copyright (2020), 
with permission from Elsevier.    
Biofilm formation has an important role helping bacteria to develop antibiotic 
resistances.86 It was thought that EPS matrix in biofilm did not allow antibiotics to penetrate 





and, as a consequence, the acquired resistance may be associated to intrinsic features of bacteria. 
It is known that antibiotic targets are related to bacterial metabolism. However, since bacteria 
within the biofilm are dormant, antibiotics have not an active effect on them. Related to the 
resistance acquisition, it has also been reported that oxidative stress, bacterial density and 
nutrition supply are factors that can help to develop mutation and specific gene expression.87,88 
I.2.4 Antiseptics 
Apart from antibiotics, there exist a wide range of antiseptics that have been used to 
control infections in wound healing. Antiseptics are chemical agents that are toxic to a wide 
range of microorganisms that inhibit their growth and development, in contrast to antibiotics, 
which selectively kill and inhibit the growth and development of bacteria.71,89 Historically, the  
antiseptics most used have been hydrogen peroxide, iodine-based preparations, Dakin’s solution 
(dilute hypochlorite), chlorhexidine and silver-releasing compounds. It has been reported that 
hydrogen peroxide, chlorhexidine and iodine-based preparations are toxic to tissues when they 
are applied chronically to wounds.89–91 Silver ions have demonstrated efficacy against Gram-
negative and antibiotic resistant microorganisms. Their mechanism of action consists on a 
sequence of events such as the disruption of bacterial cell walls, penetration into the cell and 
action at the target side, damaging intracellular and nuclear structures.92,93 Silver ions should be 
used as a solution to produce bactericidal activity, being its effect not complete in a dry wound.  
In addition, this product can cause irritation and be toxic to keratinocytes and fibroblasts.89,94 
Other products described as antiseptics are natural compounds, which have been widely reported 
due to their antimicrobial activity.  
I.3. Essential oils  
As previously commented, AMR is expected to cause 10 million deaths by 2050.79  Since 
the development of resistance to antibiotics is increasing, there is a need for innovative 
approaches of new antimicrobials with reduced ability to generate resistances.73 Even though 
essential oils (EOs) have been set aside by the antibiotic era, they possess different properties 
that make them potential compounds for clinical strategies in wound management.95    
EOs are concentrated natural products formed by aromatic plants, among others, as 
secondary metabolites. In nature, these compounds are crucial in the protection of plants being 
antibacterial, antivirals, anti-fungal and insecticides. In addition, they play a key role reducing 
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the appetite of herbivores for such plants and attracting insects for pollen and seed dispersion. 
Historically, these compounds have been used in embalmment, preservation of foods and for 
medical applications.95 These compounds are volatile, rarely colored and soluble in lipids and 
in organic solvents, which are present, among others, in different plant organs such as buds, 
flowers, leaves, seed, fruits, roots, etc. There have been reported approximately 3,000 EOs, 300 
of which are important for pharmaceutical, agronomic, food, sanitary, cosmetic and perfume 
industries due to their antioxidant, antibacterial, food preservation, anti-inflammatory and local 
anesthetic properties.95–97 Each EO is a mixture of about 20 to 60 different components in 
different concentrations. Only 2 or 3 of these components are at high concentrations and 
determine the biological and chemical properties of the essential oil.98 Next, most common used 
plant-derived natural compounds in medical applications are going to be here briefly described:  
a. Carvacrol: It is a volatile phenolic monoterpene present as active principle in essential oils 
in plants such as Lamiaceae (Origanum genera) and Verbenaceae (Lippia genera). This 
compound possesses different properties as antimicrobial, antioxidant, antifungal and anti-
inflammatory.99–101  
b. Thymol: It is a phenolic monoterpene found in essential oils extracted from plants which 
belong to the Lamiaceae family, included in Thymis, Lippia and Origanum genera, among 
others. Different properties of this compound have been reported, as antimicrobial, 
antioxidant, antiseptic and anti-inflammatory.102–104   
c. Cinnamaldehyde: It is a phenylpropanoid present in Cinnamomum cassia (Cinnamomum 
genera), giving cinnamon its characteristic odor. It shows diverse pharmacological 
activities like antimicrobial, antioxidant and anti/pro-inflammatory.100,105,106 
d. Eugenol: Eugenol is the major component of clove, flower buds of the tree in the family 
Mytraceae. This compound is an aromatic phenol that possesses antimicrobial, antioxidant, 
anti-inflamatory and cytotoxic properties.107 
e. β-caryophyllene: This compound is a bicyclic sesquiterpene derived from many plants such 
as basil (Ocimum spp.), black pepper (Piper nigrum L.), cinnamomum (Cinnamomum spp.) 
or oregano (Origanum vulgare L.). Its biological effects are antimicrobial, antioxidant, anti-
inflammatory and analgesic.108 
f. Rosmarinic acid: It is a phenolic acid present in several plants of the Lamiaceae family, 
including rosemary (Rosmarinus officinalis). The main properties of this compound are 





g. Squalene: It is a triterpene compound present in a large amount of plants and other sources 
as shark liver oil. One species with high squalene content is Polygonum chinense L. The 
main properties of this compound are antioxidant, anti-inflammatory, antibacterial and 
antifungal.111,112   
h. Tyrosol: Tyrosol is a polyphenolic compound extract from Olea europaea that acts as 
antioxidant, anti-inflammatory and antimicrobial.113,114  
i. Curcumin: This compound is a polyphenolic present in the rhizome of turmeric of Curcuma 
longa. It possesses a wide range of biological actions as antiapoptotic, anti-inflammatory, 
antioxidant, anti-carcinogenic, among others.115,116  
I.3.1. Activity of essential oils against bacteria  
To better understand the mechanisms of action of EOs against bacteria, it is necessary to 
know the different structures of the cell walls of Gram-positive and Gram-negative bacteria. 
Gram-positive bacteria wall consists of a 90-95% of peptidoglycans linked to other molecules 
and proteins. However, Gram-negative bacteria structure is more complicated due to the 
presence of an outer membrane (OM) that lies outside the inner peptidoglycan-based layer. Both 
layers are linked by Broun’s lipoproteins, covalently connected to peptidoglycans and 
embedded in the OM. This layer allows hydrophilic solutes transport but it is almost 
impermeable to hydrophobic molecules.117  
The activity of EOs against bacteria depends on their chemical composition and it is based 
on multiple mechanisms of action. 118,119 Commonly, EOs inhibit the growth of bacteria and the 
synthesis of toxic bacterial metabolites. For example, cell membrane is the first target of EOs. 
The integrity of this structure is crucial for bacteria survival because it is responsible for 
metabolites and ions transport, which are essential for all the activities occurring in the microbial 
cell. Also, the membrane represents an effective barrier from the external environment.120 The 
hydrophobicity of EOs disrupts bacterial structures, resulting in an alteration of membrane 
permeability and thus, leading to the leakage of cell content, cytoplasm coagulation or proteins 
denaturation.119 
The antimicrobial activity of terpenoids, such as thymol and carvacrol, is related to the 
hydroxyl group and the presence of delocalized electrons in their chemical structure.121 It has 
been demonstrated that it is not as important the hydroxyl position as its presence.118,122 Thymol 
can interact with the polar head-groups of lipids, damaging the outer and inner membranes. It 
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affects membrane permeability and thus, allows the release of K+ ions and Adenosine 
Triphosphate (ATP).121,123,124 Carvacrol, an isomer of thymol, causes structural and functional 
damage to membranes, increasing fluidity and permeability and thus, releasing bacterial 
lipopolysaccharides (LPS). Moreover, carvacrol can alter ions transport, introducing H+ into the 
cytoplasm and exporting K+ outside the cell.122,123 Regarding phenylpropenes molecules, such 
as eugenol and cinnamaldehyde, they can exhibit antimicrobial activity due to the methyl group 
and the presence of a double bond in the α, β positions of the side chain. Depending on the 
concentration, cinnamaldehyde can: a) inhibit enzymes involved in cytokine interactions at sub-
lethal concentrations; b) inhibit ATPase at higher doses and c) modify membrane permeability, 
similar to thymol and carvacrol at lethal concentrations.125 About eugenol, apart from affecting 
ATP transport, it can change the membrane fatty acid profile and target different enzymes as 
ATPase, histidine carboxylase, amylase and protease, affecting the membrane fluidity and thus 
acting as antimicrobial compound.125,126   
To sum up, plant-derived natural compounds have not specific cellular targets but multiple 
ones. Owing their hydrophobicity, they can pass through the cell wall and the cytoplasmic 
membrane altering the cellular permeability, causing cellular destabilization by different 
mechanisms, what is known as “essential oils versatility”.119 Only a few articles have described 
some bacterial mechanisms to counteract EOs damage, as for example, the effect on the fatty 
acids. Thus, bacteria would adapt the membrane to the damage trying to survive. When EOs 
modify membrane components and compromise fluidity, bacteria can increase the amount of 
unsaturated fatty acids, responsible for the fluidity of the membrane.127 In spite of this 
mechanism, and due to the fact that EOs can act at different levels, there has not been described 
the development of EOs resistance.128   
I.3.2. Anti-inflammatory activity of EOs  
Inflammation is a protective mechanism in response to injury or infection.9 During this 
process, there is an influx of inflammatory cells to the damaged area, increased activity of 
different enzymes, expression of cellular adhesion molecules such as the intercellular adhesion 
molecule (ICAM), and release of cytokines.129 With the aim to reduce excessive and prolonged 
inflammation, the anti-inflammatory activity of EOs has been studied. This EOs activity is 
attributed to their antioxidant properties and the interaction with signaling cascades related with 





a. Effects on the arachidonic metabolism: Arachidonic acid is a polyunsaturated fatty acid 
present in cell membranes that can be released to the external medium when inflammation 
is activated. It is metabolized by two main pathways, the cyclooxygenase (COX) and 
lipoxygenase (LOX) pathways, in different eicosanoids such as prostaglandins and 
leukotrienes.129 Both are responsible of amplifying and mediating inflammatory response, 
enhancing vascular permeability; in addition, leukotrienes mediate the contraction of 
muscle fibers in blood vessels.130 It has been reported that some active principles of EOs, 
such as thymol and eugenol, can inhibit lipoxygenase effects and thus, acting as anti-
inflammatory compounds.131  
b. Effects on cytokines production: The production of cytokines may be enhanced by the 
release of LPS and lipoteichoic acid (LTA). The first one is present in Gram-negative 
bacteria, meanwhile LTA is a molecule present in the cytoplasmic membrane of Gram-
positive bacteria. Il-1β and TNF-α are two of the main cytokines which levels are increased 
in the inflammatory process. The major sources of Il-1β release are macrophages, 
neutrophils and T lymphocytes, whereas TNF-α is produced by macrophages, fibroblasts 
and endothelial cells.132 It is known that active principles in EOs can reduce or even inhibit 
the production of these cytokines. For example, cinnamaldehyde can inhibit the secretion 
of Il-1β and TNF-α in J774 macrophages stimulated with LPS or LTA.133 Furthermore, 
thymol reduces pro-inflammatory cytokines (Il-1β and iNOS) in J774 macrophages 
activated with LPS134 and D-limonene suppresses Il-1β, Il6 and TNF-α in LPS-stimulated 
RAW 264.7 macrophages in a dose-dependent manner.135   
c. Modulation of pro-inflammatory genes expression: Nuclear factor- ĸB (NF-ĸB) and 
mitogen-activated protein kinases (MAPK) are two of the most important signaling 
pathways activated during inflammation.136 NF-ĸB is a transcriptional regulator linked to 
the inhibiting ĸB molecule (IĸB) in the cytoplasm of cells and thus, it is inactivated under 
homeostatic conditions. When an inflammatory signal arrives, IĸB is degraded via 
proteasome, allowing NF-ĸB-p65 to translocate into the nucleus and bind to DNA, 
promoting the transcription of pro-inflammatory genes such as Il-1β and TNF-α, and 
enzymes such as inducible Nitric Oxide Synthase (iNOS) and COX-2.137 
Apart from these signaling pathways, another molecule that plays an important role in 
inflammation is NO, which is catalyzed by NOS (Nitric Oxide Synthase) in different isoforms, 
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being iNOS the most important during inflammation. Inflammatory mediators, such as Il-1β, 
TNF-α and LPS, stimulate iNOS expression and thus, NO level increases and subsequently the 
inflammatory response. It has been demonstrated that some plant derived natural compounds 
can arrest signaling pathways and reduce the inflammatory response by inhibiting pro-
inflammatory cytokines, and iNOS. Figure I.4 shows the NF-ĸB pathway interrupted at different 
levels by EOs. Thymol inhibits NO production and arrest NF-ĸB pathway at different levels via 
LPS-induced inflammation.132,138 Furthermore, thymol, curcumin and squalene reduce 
phosphorylation of IĸB decreasing NF-ĸB translocation.139,140 Also, curcumin reduces NF-ĸB 
activation by inhibiting p65 translocation to the nucleous.140 Cinnamaldehyde inhibits the TLR 
oligomerization, reducing NF-ĸB activation.141 Eugenol blocks the release of TNF-α and Il-1β 
and suppresses their mRNA expression in LPS-stimulated human macrophages.142    
 





I.3.3. Biomedical applications of EOs  
Some clinical trials have been developed in order to study the effectivity of EOs in 
different medical applications, especially, nasal and oral infections. For example, the 
accumulation and maturation of oral biofilm is common to be treated with chlorhexidine as oral 
antiseptic. However, secondary effects are well-known, increasing the interest for other 
alternative antiplaque agents such as thymol, menthol or eucalyptol. In this clinical trial, no 
significant differences were found between the 0.2% chlorhexidine and the essential oils 
(Listerine®) at reducing the bacterial vitality. However, chlorhexidine was more efficient 
reducing biofilm thickness.143 Other application  has been in vulvovaginal fungal infections.144 
In this clinical trial cumin seed extract cream was used to treat infections though no results have 
been published.  
Despite EOs have been tested for infections, no clinical trials have been found related with 
wound healing process. Due to the demonstrated effectivity of EOs and the increasing problem 
with antibiotic resistances, EOs have been proposed as possible wound treatment in order to 
avoid or reduce infections and control inflammatory phase.  
I.4. Wound dressings  
Traditionally, wet-to-dry dressings were used for wounds having debridement. It was in 
the late 20th century when occlusive dressings began to be produced to protect and provide an 
effective moist environment to wounds. Due to the hypoxia created by the dressing, processes 
such as angiogenesis, collagen synthesis and re-epithelialization were promoted.145,146 In the 
mid 1980’s a dressing which supplied moisture and absorbed fluids was produced, but it was in 
the mid 1990’s when synthetic wound dressings such as hydrogels, alginates, tissue adhesives, 
etc. were designed to improve wound healing conditions.147 
Nowadays, traditional wound dressings are used in the management of clean and dry 
wounds with mild exudate levels or applied as secondary dressings (used to keep the primary 
dressing securely in place). They consist on sterile gauzes that absorb exudates in an open 
wound. A frequent change of the dressing is necessary to avoid its adherence to the wound.148 
These dressings only cover the wound and reduce the possibility of infections. Because of this, 
the use of advanced dressings that promote healing and keep the wound hydration is necessary 
for complicated wounds.149,150  
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I.4.1. Advanced wound dressings 
These dressings are usually based on synthetic polymers and are focused on healing 
promotion. There are different subtypes:  
a. Semi-permeable films: They are based on transparent and adherent polyurethane which 
allows the water vapor, O2 and CO2 transmission and provides a surface impermeable to 
bacteria. e.g.: Opsite™, Tegaderm™, Bioclusive™.147   
b. Semi-permeable foams: They consist of two parts, one hydrophilic foam, in contact with 
the wound, and another hydrophobic foam, exposed to the outdoor. The exposed surface 
protects the wound of liquid and the outside but allows gaseous and water vapor exchange. 
e.g.: Lyofoam™, Allevyn™ and Tielle™.151,152   
c. Hydrogels: They are based on insoluble hydrophilic polymers such as poly (methacrylates) 
and polyvinyl pyrrolidine. The high-water content promotes granulation and ephitelization 
keeping an appropriate moist environment. e.g. Intrasite™, Nu-gel™, Aquaform™ 
polymers.152,153   
d. Hydrocolloids: They involve two different layers, an inner colloidal layer and a water-
impermeable surface. The hydrocolloid is permeable to water vapor and impermeable to 
bacteria. When the dressing is in contact with the wound, it absorbs the exudate and creates 
a gel that provides moist environment that protects granulation tissue. e.g. Granuflex™, 
Comfeel™, Tegasorb™.148 
e. Alginate: They contain sodium and calcium salts with absorbent properties that allow 
wound exudates. Sorbsan™, Kaltostat™, Algisite™.148,154   
I.4.2. Bioactive wound dressings 
Advanced dressings can be improved by entrapping bioactive molecules to the wound 
bed. Sometimes they can encapsulate antimicrobials to avoid bacterial colonization and growth 
factors or bioactive particles to promote wound healing (proliferation, migration and 
vascularization of endothelial progenitor cells).147,155 Bioactive molecules include natural 
molecules such as proteins, cytokines or lipids or other compounds that may modify signaling 
pathways or contribute to tissue repair. Bioactive molecules are usually cell-permeable and non-
immunogenic and can modify intracellular processes in a reversible way.156 
They are composed of biomaterials and widely recognized for their biocompatibility, 





polymers such as chitosan, collagen, polycaprolactone (PCL) or poly lactic-co-glycolic acid 
(PLGA), among others.147,155,157,158   
I.5. Electrospun nanofibers 
As it was mentioned before, in addition to other processes, the hydrophobicity of EOs can 
disrupt bacterial structures, leading to the membrane alteration and reduction of its viability.119 
However, this non-polar character and their high volatility character make difficult their 
application. In addition, some EOs can be oxidized in contact with air or ultraviolet light.159 It 
becomes necessary to incorporate an emulsifier or appropriate solvent to guarantee their 
solubility in aqueous media when they are studied as free compounds. The agents most 
commonly used are Tween 80 (poly-sorbate 80), Tween 20 (polyoxyethylene (2) sorbitan mono-
laurate) and dimethyl sulfoxide (DMSO). The use of these agents is reported to cause low 
stability and physicochemical changes in EOs, and thus, the active properties may be reduced. 
For this reason, numerous researchers have focused their studies on increasing EOs stability and 
bioactive function.160,161   
Encapsulation of EOs is a good technique to protect their properties and to ensure an 
appropriate contact between natural compounds and their target.162 There exist different 
methods to incorporate EOs to dressings. For example, immersing a gauze in an extract or 
mixing EOs with an alginate solution, letting the mixture dry until dressing formation.163,164 
However, the electrospinning method makes the encapsulation process easier for volatile 
materials due to the fast fibers’ formation.165,166  
I.5.1. History of electrospinning  
This technique was first patented in 1902 by John Cooley and William.167 In 1934 and 
1944, Anton Formhals published two patents with improvements in the equipment that allowed 
its commercialization as a method for the processing of polymers producing materials with 
controlled size, porosity and morphology.168,169 In the last years, researchers made 
electrospinning one of the most versatile methods to obtain materials with large surface area-to-
volume ratio, high porosity and flexibility. Electrospinning is an adaptable technology used to 
produce ultrafine polymeric fibers on both nanometer and micrometer scales by applying an 
electrostatic field to the polymer solution, driven by the supply of a high voltage between a 
needle tip and a collector.168,170,171 It is a versatile and viable method for the production of fibers 
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to target a large range of applications as for example, the use as wound dressing material, 
described by a patent filed in 1977.172  
I.5.2. Principle of electrospinning  
Electrospinning is an electrohydrodynamic process in which a liquid drop is electrified to 
produce a jet that can be stretched and elongated to form fibers. During the process, the polymer 
solution is extruded through the spinneret to generate a liquid drop as a result of surface tension. 
Under the electric field, the drop becomes charged, generating an electrostatic repulsion among 
the surface and deforming the drop to a Taylor cone, from which a charged jet is ejected. The 
jet is then extended into a line and due to the electrostatic instabilities (also known as whipping 
instability), it is subjected to movements and the jet is split into thinner fibers. The small 
diameter allows solvent evaporation and the fibers to solidify quickly, leading to the deposition 
on the conductive collector.173–175 The equipment consists of four main parts represented in 
Figure I.5: 
- Syringe pump: The main function is to drive the polymer solution to the needle. 
- Spinneret: It is usually a hypodermic needle with blunt tip connected to a positive pole. 
The polymer solution passes through the needle. 
- High-voltage power supply: It handles the electric field between conductive collector 
and spinneret.  














I.5.2.1. Formation of Taylor Cone 
In the presence of an electrical potential difference between the collector and the needle, 
the surface of the drop becomes positively charged. With the gradual increase of voltage, more 
charges are accumulated in the surface and higher is the repulsion. Meanwhile the surface 
tension of the drop favors a spherical shape to minimize the total surface free energy, the 
electrostatic repulsion tends to deform the drop increasing the surface to reduce the repulsion.176 
This phenomenon is exemplified in Figure I.6. When the electric forces overcome the surface 
tension, the Taylor cone is formed. 
Figure I.6: Schematic figure of Taylor cone and jet formation varying the applied voltage. 
Adapted from Chemical Reviews, 119/8, Xue J. Wu T. Dai Y. Xia Y., Electrospinning and 
electrospun nanofibers: methods, materials, and applications, 5298-5415.   
I.5.2.2. Thinning of the Jet 
Due to the repulsion between charges, an electrically charged jet is ejected and accelerated 
in the way of the electric field to the conductive collector.177 The acceleration may be influenced 
by the surface tension and the viscoelastic force in the jet and thus progressively attenuated. The 
diameter decreases gradually with the distance between the needle and the collector. And thus, 
the jet is continuously stretched. If the acceleration is zero or constant, any small perturbation 
such as electrostatic repulsion among the surface charges, may destroy the straight 
movement.178–180 There exist three types of instabilities:176  
a. Rayleigh instability is an axisymmetric instability and may promote the breakup of the jet 
into droplets, dominated by surface tension. It can be avoided with a strong electric field.  
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b. The second one is also an axisymmetric instability and it happens at a stronger electric field 
than the previous one.  
c. The whipping or bending instability is non-axisymmetric. Due to the electrostatic repulsion 
among surface in a strong electric field, there are aerodynamic instabilities and “lateral 
electrostatic force” in a radial direction relative to the jet.  
These instabilities depend on the interaction between the charges in the jet and the external 
electric field and appear at different rates controlled by physicochemical properties of the liquid 
and electrospinning parameters. For example, to obtain ultrathin nanofibers, it is necessary to 
get rapid growth of whipping instability to stretch the jet.178   
I.5.2.3. Solidification of the jet 
When the jet is elongated, the evaporation of solvent promotes the solidification into 
fibers. A thinner diameter of fibers causes a high evaporation rate. After solidification, the 
instabilities cease but charges may be trapped on the surface of the dry fibers due to the low 
conductivity of most materials.179 Fibers morphology will depend on the instabilities that take 
part in the process. Figure I.7 represents the pathway followed by the jet.  
 






The jet path from the needle to the collector can be divided in two parts; (a) An ohmic 
flux in which there is a slow acceleration characterized by surface tension and charges repulsion, 
and (b) a connective flux characterized by a fast acceleration where takes place the solidification 
of the jet. In the first phase, the jet follows a straight direction until an instability occurs. Then 
the jet enters in the second phase, where the jet is gradually thinner until total solidification.181  
I.5.3. Materials for electrospinning  
Electrospinning technique has been used for the synthesis of nanofibers from different 
types of materials, for example, organic polymers including natural and synthetic and they have 
been used for multiple applications. For example, synthetic materials as polystyrene and poly 
(vinyl chloride) are used for environmental protection applications.176 On the other hand, 
different materials have been described for their use in biomedical applications. Due to their 
biodegradability and biocompatibility, the most common polymers used are poly (α-hydroxy 
acids), specifically, lactic and glycolic acids and their copolymers with ε-caprolactone for their 
biodegradable character.165 It is well reported that these materials hydrolyze and thus, degrade 
in nontoxic products in weeks or months depending on their molecular structure.182 It is possible 
to electrospun into nanofibers other kind of materials as natural biopolymers (DNA, dextran, 
chitosan, collagen, etc.) and conductive polymers (polyaniline, polypyrrole).176    
Different kinds of materials have been reported for EOs loading. For example, a composite 
of PVA-CHI-GT (polyvinyl alcohol-chitosan-gelatin) was electrospun with Zataria multiflora 
for wound healing applications183 and polyethylene oxide nanofibers containing Tea tree oil has 
been used for antibacterial packaging.184 Other  materials such as cellulose acetate185, polyvinyl 
pyrrolidine, polylactide acid, polyurethane, polycaprolactone or silk fibroin have been loaded 
with EOs for biomedical applications.186    
There are two conditions for a successful solution electrospinning: (a) enough high 
molecular weight for the polymer and (b) the polymer should be dissolved in appropriate 
solvents. Especially, polymers with low melting points, as for example PCL, have good stability 
in the electrospinning process. PCL is a synthetic bioresorbable material widely chosen for 
biomedical applications due to its biocompatibility and biodegradation rate. Besides, it degrades 
into not toxic fractions under physiological environment.187 As it was mentioned before, the 
solvent used to dissolve PCL is very important. Most common solvents are chloroform, 
dichloromethane, dimethylformamide, methanol or a combination of them. It has been deeply 
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studied the electrospinning of PCL and it has been demonstrated that in medical applications, it 
is important to imitate the natural extracellular morphology to promote optimal cell growth. For 
this, it is essential that nanofibers synthesis may not produce beads.171,188 Due to these 
properties, electrospun-PCL nanofibers have been widely used to encapsulate plant-derived 
natural compounds for medical applications. For example, Bui. et al.189 synthetized curcumin-
loaded PCL nanofibers, Tampau et al.190 developed PCL nanofibers encapsulating carvacrol, 
and Martinez-Abad et al.191  loaded cinammaldehyde and isothiocyanate in PCL films, all of 
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This chapter studies the antimicrobial properties of different molecules present in EOs against 
planktonic and biofilm-forming Gram-positive (Staphylococcus aureus) and Gram-negative 
(Escherichia coli) bacteria. In addition, it was analyzed the bactericidal mechanisms of the 
different molecules and their cytocompatibility. Carvacrol, cinnamaldehyde, and thymol exhibit 
the highest in vitro antimicrobial activities against E. coli and S. aureus, with membrane 
disruption as bactericidal mechanism identified, fact that also hampers S. aureus biofilm 
formation and partially eliminates preformed biofilms. These three compounds also showed 
lower cell toxicity than the conventional widely used chlorhexidine. 
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II.1. Introduction 
As it was mentioned in Chapter I the use and misuse of antibiotics has led to the emergence 
of antibiotic resistance in human and animal pathogens, which is recognized as a serious and 
global concern.192 The continued evolution of antimicrobial resistance (AMR) in hospitals is a 
growing concern because of its potential to endanger the future of antimicrobial drug therapy.193 
Even the new generation of antibiotics is becoming virtually ineffective, and it is predicted that 
AMR will cause more deaths than cancer-associated diseases by the middle of the century.194 
Sub-inhibitory antibiotic doses help stepwise selection of resistance, and the resulting resistant 
clones like methicillin-resistant S. aureus, E. coli, and Klebsiella are rapidly disseminated.195 
Multiple antimicrobial resistance determinants have been found in E. coli on the same plasmid, 
further facilitating their propagation and co-selection. For instance, the multidrug resistance 
plasmid IncA/C found in E. coli, often encodes for resistance to common antimicrobial agents 
such as tetracycline, chloramphenicol/florfenicol, streptomycin/spectinomycin, sulfonamides, 
and extended spectrum β-lactamases, and its spread to pathogenic bacteria may limit 
antibacterial means to fight infections caused by these bacteria.193 
Because of the emergence of AMR, the Center for Disease Control (CDC) has endorsed 
the need for the research of new substances with the potential to combat resistant strains. In 
2011, academics and industry collaborated on a priority list for approaches to resolve the 
“antimicrobial-resistance crisis.” Amongst the potential strategies suggested, the development 
of alternatives to antibiotics were proposed.196 Compounds from natural sources such as 
animals, plants, and microorganisms have been highlighted as renewed potential antimicrobial 
alternatives.197 Famous seafarers (e.g., Marco Polo) established routes for spice trade, and 
different compounds of natural origin present in spices are still being used today to prevent 
foodborne pathogens showing low levels of antimicrobial resistance.198 Essential oils (EOs) are 
oily aromatic substances extracted from plants with antibacterial, antifungal, insecticidal, and 
antiviral properties. EOs have been distilled for more than 2,000 years, and there is now renewed 
interest in the antimicrobial properties of phytochemicals and EOs in particular. The 
demonstrated low levels of induction of antimicrobial resistance toward EOs could be related to 
the fact that these substances do not attack a single specific target but have multiple modes of 
antibacterial action.199 Antibiotics, and antiseptics like chlorhexidine, have been shown to be 
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able to generate resistance in Staphylococcus by mechanisms (mutations in qacA/B gene) that 
may be common to other microorganisms.200  
EOs are complex blends of a variety of molecules such as terpenoids, phenol-derived 
aromatic components, and aliphatic components. Their compositions depend on factors such as 
seasonal variation, climate, plant organ, age, subspecies, and even the oil extraction method. 
Consequently, the extracted product can fluctuate in quality, quantity, and composition.201 
Generally, EOs contain about 20–60 components, up to more than 100 single substances, at 
quite different concentrations; two or three are major components at fairly high concentrations 
(20–70%) compared to other components that are present only in trace amounts. Because of 
this, in order to have a systematic evaluation of EOs’ antibacterial activity, it is necessary to 
focus on the study of their main components. 
Different extracted components from EOs such as carvacrol, thymol, eugenol, 
perillaldehyde, and cinnamaldehyde have been reported as antibacterial agents.202 However, the 
reported values for their minimum inhibitory (MICs) and bactericidal (MBCs) concentrations 
are extremely divergent. For example, the MIC of carvacrol toward S. aureus found in the 
literature ranges from approximately 0.15 mg/mL203 to 15 mg/mL.204 In some cases, the 
different MICs reported could be attributed to the bacteria strain used. Wang et al.205 reported 
an MIC value for carvacrol of 0.31 mg/mL for S. aureus (ATCC 43300), while using S. aureus 
(ATCC 6538), Silva da Luz et al.206 reported a MIC of 2.45 mg/mL for the same component. 
Even for the same bacteria strain (ATCC 6538), MIC values for carvacrol of 0.4 mg/mL207 and 
0.015% v/v (approximately 0.147 mg/mL)203 can be found in the literature. 
Beside the well-documented antibacterial action of EO components, there is some 
evidence corroborating the enhancement in the antimicrobial action of EO components used in 
combination with other antimicrobial agents, both synthetic and natural.208 Thymol and 
carvacrol were found to have additive antibacterial effect against S. aureus, E. coli, Salmonella, 
and Bacillus cereus. Ye et al.209 tested the synergy between cinnamaldehyde and carvacrol in S. 
aureus and E. coli among other bacteria and concluded that cinnamaldehyde and carvacrol 
exhibit high antibacterial activities and have synergistic antimicrobial action against these 
bacteria. Thymol and carvacrol were found to give an additive effect when tested against S. 
aureus and Pseudomonas aeruginosa.121 
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One interesting application of EO components with antimicrobial activity would be their 
incorporation into wound dressings since they can prevent or treat wound-associated infections 
and aid tissue regeneration.210 Bacterial components have been highlighted as harmful factors 
during wound healing due to their interference with cell-matrix interactions and due a reduced 
inflammatory response they produce. In this regard, S. aureus colonize from 30% to 50% of 
healthy adults and is able to rapidly infect skin lesions with a consequential inflammatory 
process.211 E. coli is also among the main bacterial species that commonly colonize skin wounds, 
and from this initial colonization, severe problems can occur such as topical infections or even 
sepsis.212 Within the clinical settings, biofilm formation is a pressing challenge that leads to 
chronic infections. Biofilms are communities of microorganisms living at an interphase attached 
to each other through the extracellular polymeric substance, composed of extracellular DNA, 
proteins, and polysaccharides. Due to the protection of this matrix, bacteria show up to 1,000 
times greater tolerance to antibiotics and biocides than their planktonic counterparts.213 
Prevention of biofilm formation is considered preferable to its removal, since the latter is a very 
difficult and demanding task, which can cause recontamination problems due to the uncontrolled 
release of bacterial cells and toxins after their disruption. One of the outstanding antimicrobial 
properties of many EOs is that they can also be effective even against microbial biofilms.214 
II.2. Objective 
The aim of this work was to shed light on the evaluation of the bactericidal activity and 
mechanisms of action of EO-present molecules against S. aureus and E. coli in planktonic 
growth. The antibiofilm efficiency and the possibility of synergy between carvacrol (CAR), 
cinnamaldehyde (CIN) and thymol (THY) were also analyzed. The potential toxicity of those 
components was also investigated in different cell types, including human dermal fibroblasts, 
keratinocytes, and macrophages. The main goal of this work is to deepen our understanding of 
the effects and mechanisms of these purified molecules on bacteria, avoiding the intrinsic 
variability of their extraction from plants, and focusing on their own ability to hamper bacteria 
growth and colonization.215 
II.3. Experimental 
 First of all, a deep research in literature was done to know which EOs are reported as 
antimicrobial, and thus, some compounds were chosen to work with. The antimicrobial activity 
of these free EOs was studied following the broth microdilution method216  in two different 
 
 
 Chapter II 
46 
bacteria, a Gram-positive model, S. aureus (ATCC 25923) and a Gram-negative model, E. coli 
S17. In addition, three techniques were performed to analyze the mechanism of action of 
selected compounds; Scanning Electron Microscopy (SEM), flow cytometry and 
Live/Dead®BacLight™ bacterial viability kit to be observed under confocal microscopy, that 
stains live and dead areas in bacteria membrane. Antimicrobial ability of free EOs was also 
studied in two different models of biofilm: effect of the compounds to eradicate preformed 
biofilms, and to prevent the formation of these structures. Moreover, a synergic study was 
carried out to know the effect of EOs when they interact. Finally, a metabolism cytotoxicity 
assay was done to study the effect of EOs treatment in three different cell lines related with skin: 
fibroblasts, keratinocytes and macrophages. The Blue Cell Viability assay was used for this 
goal.  
The characterization techniques and different evaluation methods are described in detail 
in Appendix I.  
II.4. Results and discussion  
II.4.1. Bactericidal activity against planktonic bacteria  
II.4.1.1. MIC and MBC values 
The antibacterial effect of several components present in different EOs reported as 
bactericidal, such as carvacrol,217 thymol,215 cinnamaldehyde,218 eugenol,219 β-caryophyllene,220  
rosmarinic acid,221 and squalene222 were studied. Table 1 shows the MIC and MBC results of 
these components against E. coli and S. aureus. The most active compounds were THY, CAR, 
CIN, showing the lowest concentrations to inhibit or hamper planktonic bacteria growth. EOs 
have been pointed out as a suitable strategy due to their bactericidal properties together with 
their inability to generate antimicrobial resistances.223–225 According to our results, previous 
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Table II.1: Chemical structure, MIC and MBC values of different essential oils. Average of 12 
replicas per compound.  
 
II.4.1.2. Bactericidal mechanism  
E. coli and S. aureus exposed during 24 h to CAR, CIN, and THY at MIC and MBC 
concentrations were morphologically examined by scanning electron microscopy (SEM) 
(Figures II.1 and II.2). The morphology and microstructure of S. aureus before being exposed 
to any compound can be observed in Figure II.1.A, having a normal and spherical shape and a 
well-preserved cell membrane. However, after exposition to CAR, CIN and THY at MICs for 
24 h (Figure II.1.B, D and F), the morphology of S. aureus was distorted. Part of the cell 
peptidoglycan structure appeared depressed, indicating an initial damage. Same pattern is 
Active compound Structure 
MIC (mg/mL) MBC (mg/mL) 
E. coli S. aureus E. coli S. aureus 
Carvacrol 
 
0.2 0.2 0.4 0.3 
Cinnamaldehyde 
 
0.2 0.4 0.3 0.5 
Thymol 
 
0.2 0.2 0.3 0.3 
Eugenol 
 
0.4 1.3 0.5 1.5 
β-caryophyllene 
 
>4.0 >4.0 >4.0 >4.0 
Rosmarinic acid 
 
>4.0 2.5 >4.0 4.0 
Squalene 
 
>4.0 >4.0 >4.0 >4.0 
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followed when S. aureus is exposed to MBC for 24 h (Figure II.1.C, E and G). Bacteria became 
deformed and wrinkled, indicating that the intracellular content had leaked out. There was a 
reduced number of bacteria in the samples, probably due to the severe damage to the bacterial 
peptidoglycan layer and cell membrane and subsequently cell death. The reduction in cell size, 
length, and diameter observed for S. aureus in response to the treatment with EOs could be 













































Figure II.1: SEM images of S. aureus: A) Untreated (control sample); Treatment with MIC of 
B) CAR; D) CIN; F) THY; and treatment with MBC of C) CAR; E) CIN; G) THY.  
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E. coli untreated cells were rod shaped, regular and kept intact morphology (Figure II.2.A) 
in contrast to MIC-treated cells (Figure II.2.B, D and F), which showed morphological 
alterations and lyses of the outer membrane integrity in cells. At MBC, a complete lysis or 
























Figure II.2: SEM images of S. aureus: A) Untreated (control sample); Treatment with MIC of 
B) CAR; D) CIN; F) THY; and treatment with MBC of C) CAR; E) CIN; G) THY.  
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In order to confirm the bactericidal mechanism of the active compounds present in EOs, 
flow cytometry and confocal microscopy studies were developed. Flow cytometry histograms 
(Figure II.3) displayed peaks in the range of the negative control (damaged membrane caused 
by chlorhexidine226) when S. aureus and E. coli were treated with the tested compounds at MBC, 
which is consistent with cell membrane disruption as previously reported.227 Only CIN-treated 
cells show peaks slightly displaced toward the positive control (undamaged membrane) for both 
microorganisms, suggesting that the involvement of cell membrane disruption in bacteria death 
was not as clear as the SEM images showed.  
Figure II.3: Flow cytometry histograms at MBC of CAR (A, D), CIN (B, E) and THY (C, F) 
on S. aureus (A, B and C) and E. coli (D, E and F).  
Confocal microscopy images (Figure II. 4) clearly confirmed membrane damage exerted 
by the compounds tested when bacteria were incubated with the MICs of the molecules, showing 
red staining related to membrane integrity compromise. Furthermore, for E. coli, the damaged 
membrane areas can be clearly distinguished (Figure II.4 D, E and F). All these results point out 
to the bacteria membrane disruption as the bactericidal mechanism exerted by the compounds 
present in the EOs. 
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Figure II.4: Confocal microscopy images of S. aureus (A-C) and E. coli (D-F) treated with 
MIC of CAR (A, D), CIN (B, E) and THY (C, F), stained with the Live/Dead®BacLight™ 
bacterial viability kit. Red staining displays membrane damage. 
Our work focuses on the bactericidal effects and the mechanisms of action of purified EOs 
(CAR, CIN, THY) against Gram positive (S. aureus ATCC 25923) and Gram negative (E. 
coliS17) bacteria in order to elucidate their own ability to kill bacteria. MIC and MBC studies 
(Table II.1) pointed to THY, CAR and CIN as the most effective studied molecules against E. 
coli and S. aureus showing the lowest concentrations to inhibit or hamper planktonic bacteria 
growth. The bactericidal mechanism of the most effective EOs (CAR, THY, CIN) was assessed 
by SEM, flow cytometry and confocal microscopy after treatment of E. coli and S. aureus 
planktonic cultures at MIC and MBC concentrations for 24 h (Figures II 1-4). These 
methodologies pointed to membrane disruption as the bactericidal mechanism exerted by these 
molecules. It is known that phenols, terpenes and aldehydes antibacterial effect is due to their 
action against the cell cytoplasmic membrane.125 It has been reported that CAR and THY disturb 
the membrane integrity, increasing the membrane permeability and causing a leakage of protons 
and potassium finally leading to the loss of membrane potential.228 Nazzaro et al.125 suggested 
that the presence of the hydroxyl group in CAR and THY is related to the inactivation of the 
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microbial enzymes. This group would interact with the cell membrane causing leakage of 
cellular components, a change in fatty acids and phospholipids, and an impairment of the energy 
metabolism influencing genetic material synthesis. However, some authors have pointed out to 
different bactericidal mechanisms of action for both compounds due to the different location of 
the hydroxyl group in their structure affecting cell membrane permeability229, while others agree 
with our results, showing similar effects for both compounds on bacterial membrane 
structure.230  
According to the literature, the antibacterial mechanism of CIN is not clear. On the one 
hand, its antimicrobial action was attributed to the inhibition of the amino acid decarboxylase 
activity to bind proteins and no disintegration of the membrane was observed.209 However, 
Nazzaro et al.125 sustained that like CAR, CIN inhibits the generation of adenosine triphosphate 
from dextrose and disrupts the cell membrane. In addition, the hydrophobicity of EOs enables 
their accumulation in cell membranes disturbing their structures and causing an increase in the 
permeability allowing intracellular constituents leakage.228 Our studies would indicate similar 
trends in MIC and MBC values for CAR, THY, and CIN, as well as the disruption of the 
bacterial surface as target for their activity by three different experimental techniques analyzed. 
II.4.1.3. Synergism 
Synergistic interactions between EO active compounds may increase their efficacy as 
antibacterial agents. In our studies, the Fractional Inhibitory Concentration Index (FICI) values 
obtained against S. aureus (Table II.2) indicate that only the CAR-THY combination has an 
additive effect, while CIN has no interaction with the other compounds tested. These results 
may be related to their chemical structure as CAR and THY have almost the same molecular 
structure (Table II.1). It is worth noting that all the FICI values are smaller than 4.0 indicating 
that there is no antagonism between the tested active compounds. 
 
Table II.2: Fractional Inhibitory Concentration (FIC) and Fractional Inhibitory Concentration 
Index (FICI) values for EOs combination.  



















1 NI: No interaction; 2 ADD: Additive 
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On the other hand, it is reported that synergism between EOs is more efficient as 
bactericidal agents. For instance, polyethylene films containing a mixture of CAR and THY 
entrapped within halloysite nanotubes exhibited superior antimicrobial activity against E. coli 
than films containing the individual compounds alone.229 The combination of CIN and CAR 
showed better bactericidal effect compared with the components alone against food-borne 
bacteria.209 Zhou et al.231 reported that CIN had a synergistic effect when combined with THY 
or CAR against Salmonella typhimurium. However, in our case, FICI data obtained against S. 
aureus (Table II.2) pointed to CAR-THY as the most efficient combination displaying an 
additive effect, while CIN did not exert any synergism. The synergistic mechanism between 
CIN with CAR or THY was proposed to be caused by the increase in the membrane permeability 
that enables CIN to be transported into the cell.209 But according to the treated bacteria SEM 
micrographs (Figures II.1 and II.2), flow cytometry histograms (Figure II.3) and confocal 
microscopy images (Figure II. 4), the effect of the three compounds against E. coli is mainly 
outer membrane disintegration and the morphology of treated S. aureus was similar for the three 
active compounds. THY and CAR were previously found to give an additive antimicrobial 
effect on S. aureus121, which is in accordance with its similar chemical structure (Table I.1). 
II.4.2. Antibiofilm activity  
S. aureus biofilm formation was observed by calcofluor white staining and by SEM 
analysis after incubation for 16 h (Figure II.5 A, B, respectively). The quantification (colony 
forming units per milliliter = CFU/mL) of bacteria has been carried out following two methods, 
disrupting a preformed biofilm (Figure II.5.C) and interfering in biofilm formation (Figure 
II.5.D) with the antimicrobial compounds. The treatment with different concentrations (0.25-1 
mg/mL) of EOs has shown a statistically significant decrease in bacteria growth compared to 
the untreated biofilms (Figure II.5.C). At 0.5 mg/mL of EOs, preformed biofilms showed a 
reduction in bacteria growth around 2 logs when biofilm was treated with CIN, while CAR and 
THY exerted a superior decrease (3 logs). The highest tested concentration (1 mg/mL) showed 
a reduction in CFU/mL higher than 5 logs. As expected, concentrations of the active molecules 
higher than MIC and even MBC values obtained for planktonic bacteria are needed for biofilm 
elimination. The addition of these compounds to the bacteria suspension before biofilm 
formation hindered this process since there was a significant decrease in the bacterial growth 
(Figure II.5.D). THY and CAR produced higher reductions of about 5 and 6 logs, respectively. 
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Again, the concentrations needed to retard biofilm growth and development were higher than 
the MIC values retrieved for planktonic bacteria (Table I.1). 
Figure II.5: Biofilm formation and eradication. A) calcofluor staining and B) SEM image of S. 
aureus biofilm formed after 16 h. Images C and D correspond with the effect of EOs at different 
concentrations (0.25-1 mg/mL) on S. aureus biofilm. C) Elimination of preformed biofilm and 
D) inhibition of biofilm formation. CAR: biofilm treated with carvacrol; CIN: biofilm treated 
with cinnamaldehyde; THY: biofilm treated with thymol; CTRL: not treated biofilm.  
S. aureus is involved in a wide range of infections that are difficult to treat and it often 
resides within biofilms at the infection site.230 Due to biofilm protection, bacteria show up more 
resistant to external threatens than their planktonic counterparts.213 Because of this, it is 
important to find compounds that interfere with the early steps of biofilm formation and slow 
down its formation rate. As expected, concentrations of the active molecules higher than MIC 
and even MBC values obtained for planktonic bacteria are needed for biofilm elimination. This 
study shows that concentrations higher than 1 mg/mL of any of the compounds tested would be 
necessary for the total elimination of preformed S. aureus (ATCC 25923) biofilms. Again, the 
concentrations needed to retard biofilm growth and development were higher than the MIC 
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values retrieved for planktonic bacteria (Table II.1), but they were in the same range than those 
reported in the literature.215 
II.4.3. Cytotoxicity 
Cytocompatibility and not cytotoxicity is required for a wound-healing product since it 
would be in contact with the infected wound tissue and its neighboring eukaryotic cells. The 
cytotoxicity activities of these antimicrobial compounds were investigated using fibroblasts, 
macrophages, and keratinocytes cell lines (Figure II.6). Inflammatory cells such as macrophages 
are generated during wound healing,232 whereas keratinocytes and fibroblasts are part of the 
epidermis and dermis, respectively. Due to the insolubility of those compounds in aqueous 
media, those were dissolved in Tween® 80 as described in the materials and methods section.  
Figure II.6: Cell viability after treatment with carvacrol, cinnamaldehyde, thymol and 
chlorhexidine for 24 h on: A) human dermal fibroblasts; B) macrophages and C) keratinocytes. 
Samples are graphed considering untreated cells as 100% viability. *p < 0.05; **p < 0.01; ***p 
< 0.001; ****p < 0.0001. Error bars represent mean ± SD of three replicas. 
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CIN was the most cytotoxic chemical of the tested molecules; a dose of 0.03 mg/mL of 
this compound was enough to reduce the viability of the three cell types below 70% (lowest 
value established by the ISO 10993-5 233 to consider a material as non-cytotoxic). THY and 
CAR can be considered toxic to fibroblasts at concentrations equal or higher than 0.09 mg/mL, 
and the calculated subcytotoxic doses for keratinocytes were 0.06 mg/mL. There is also a 
difference between the effect of THY and CAR on macrophages, since subcytotoxic 
concentrations were 0.06 and 0.09 mg/mL, respectively. Chlorhexidine, a typical disinfectant 
and antiseptic drug used in skin disinfection, was tested for comparison. For the studied 
concentrations (0.004–0.125 mg/mL), chlorhexidine reduces the viability of the three cellular 
types to 70% or below. Only fibroblasts show viability higher than 70% in presence of 
chlorohexidine at 0.004 mg/mL. For keratinocytes and macrophages, the subcytotoxic 
concentration was lower than 0.004 mg/mL. 
These subcytotoxic values of the tested compounds were lower than the MICs and MBCs 
retrieved for bacteria but higher than those obtained with chlorhexidine. In order to reduce 
bacterial burden in wounds, topical antiseptic agents, among them chlorohexidine gluconate, 
are usually applied as 2 and 4 v/v % topical solutions, concentrations five orders of magnitude 
higher than the subcytotoxic doses. Therefore, in this study, the presence of antibacterial 
compounds of natural origin in a wound dressing material at MBC concentrations would be only 
three orders of magnitude higher than the subcytotoxic dose in the worst case scenario 
demonstrating that those natural origin compounds are less harmful against eukaryotic cells than 
conventional antiseptics. 
Previous studies have also evaluated the toxicity of different plant-derived natural 
compounds on different human cell types, such as fibroblasts234, intestinal cells235 or different 
tumor cell lines236,237. Their results show subcytotoxic concentrations for CAR and THY in the 
same range as ours (~500 µM)235 or higher (50% viability at ~5 µg/mL)234 and also very similar 
for CIN (~10 µg/mL)237 pointing to apoptosis and membrane damage as key cytotoxic 
mechanisms. Even though the studied molecules showed cytotoxic activity at doses above 0.06–
0.09 mg/mL, it is important to point out that during the regenerative process in an infected 
wound the antimicrobial compound at those doses would eradicate both bacteria and eukaryotic 
cells, but while bacteria are removed from the injury, eukaryotic cells are continuously arriving 
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to the wound to participate in the regenerative process.210 Hence, only a small fraction of 
eukaryotic cells would be damaged. 
II.5. Conclusions 
Compounds present in EOs including CAR, CIN, and THY exhibit the highest in vitro 
antimicrobial activities against E. coli and S. aureus of all the antimicrobials tested. THY 
showed the lowest MBC values (0.3 mg/mL) among all of the compounds tested and was the 
most effective bactericide against the Gram-negative and Gram-positive strains evaluated. 
According to SEM images, flow cytometry and confocal microscopy bacteria membrane 
disruption is the bactericidal mechanism attributable to studied compounds. There was no 
antagonism between the tested active compounds, but no synergism was found either; only the 
CAR-THY combination showed an additive effect. The presence of those compounds at 
concentrations above 0.5 mg/mL hinders S. aureus biofilm formation and also partially 
eliminates preformed biofilms. Subcytotoxic values of the tested EOs (0.015–0.090 mg/mL) are 
much higher than chlorhexidine doses (0.004 mg/mL). All these studied properties make EOs 
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This chapter studies the antimicrobial action of thymol (THY) loaded in polycaprolactone (PCL) 
based electrospun dressings by measuring antibiofilm activity and the ability to eradicate 
intracellular and extracellular pathogenic bacteria. We have used Staphylococcus aureus 
Newman strain (methicillin-sensitive strain, MSSA) expressing the coral green fluorescent 
protein (cGFP) as a traceable model of pathogenic bacteria commonly infecting skin and soft 
tissue. Compared to non-loaded dressings, THY-loaded PCL was able to eliminate the 
pathogenic bacteria in a J774 macrophage coculture model. In addition, by using confocal 
microscopy and the conventional microdilution plating method, we corroborated the successful 
ability of THY in preventing also biofilm formation.  
 
 
 The content of this chapter has been adapted from the following submitted work:  
Garcia-Salinas, S.; Gamez-Herrera, E.; Landa, G.; Arruebo, M.; Irusta, S.; Mendoza, G. 
Antimicrobial Wound Dressings Against Fluorescent and Methicillin-Sensitive 
Intracellular Pathogenic Bacteria. 






Table of contents 
 
III.1. Introduction          61 
III.2. Objective           63 
III.3. Experimental          63 
III.4. Results and discussion         64 
 III.4.1. Physico-chemical characterization of the electrospun nanofibers  64 
 III.4.2. Bactericidal activity        66 
 III.4.3. Antibiofilm activity        68 
 III.4.4. Cytotoxicity assessment of the PCL-THY patches    70 
 III.4.5. In vitro model of infection of J774 macrophages    72 










 Thymol wound dressing against pathogenic bacteria 
61 
III.1. Introduction 
The expansion of resistance to antibiotics is thwarting the search of new molecules due to 
the high investment that it implies for the pharmaceutical industry.196 In addition, despite all the 
global efforts to control and reduce the use and misuse of antibiotics, the antibiotic use in 76 
countries studied over 16 years (2000-2015) increased 65% (expressed as prescribed daily 
doses), and the antibiotic consumption rate increased 39%.238 Thus, new alternatives have been 
developed to treat bacterial infections. As Chapter II shows, natural compounds have 
antimicrobial activity by damaging cell membrane, proposing this type of compounds as 
antibiotic substitutes. The probability to develop bacterial resistance towards essential oils 
(EOs) is low. This fact may fall on the multicomponent nature and varied composition of EOs 
and in their ability to target multiple bacterial pathways, meanwhile antibiotics normally focus 
on one single target.224 However, it has been reported that bacteria can adapt its membrane 
composition and structure in response to subinhibitory concentrations of some antimicrobials 
present in EOs such as thymol (THY).128 Therefore, sustained concentrations above minimal 
inhibitory concentrations should be maintained at all times to prevent resistances. THY, a 
monoterpenoid phenol compound present in different EOs as that obtained from Thymus 
vulgaris, have demonstrated its antimicrobial activity in different bacterial strains such as 
Staphylococcus aureus, a major human pathogen which causes substantial morbidity and 
mortality in skin and soft tissue associated infections as well as in implant-associated 
infections.239–241 
To overcome EOs solubility limitations and provide with sustained release systems, new 
pharmaceutical formulations have been proposed.242 Nanotechnology has contributed to the 
progress in different areas of medicine including diagnosis, therapy and in their combination 
(i.e., theragnostics).243 Within the nanotechnology field, due to their large area per volume ratio, 
nanofibers outstand as ideal building blocks in different biomedical materials applied in drug 
delivery,244 biomedical devices,245 biosensing246 or as dressings for wound healing.247 
Regarding this last application, the synthesis of polymeric electrospun nanofibers loading 
antimicrobial and anti-inflammatory drugs (including EOs), has been explored in the 
development of antimicrobial wound dressings.248 Compared to conventional fibers, 
nanofibrous patches contain fibers ranging from nanometers to micrometers showing the great 
advantages of high porosity, narrow diameter distribution and high-specific surface area prone 
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for the release of loaded antimicrobial compounds. Some electrospun dressings are made of 
biomaterials recognized for their biocompatibility, biodegradability and lack of toxicity, such 
as natural or synthetic polymers (chitosan, collagen, polycaprolactone (PCL) or poly lactic-co-
glycolic acid (PLGA)).249 PCL is a biocompatible polymer approved by the FDA in many 
devices due to its high biocompatibility and controlled hydrolytic biodegradation.250 Loaded 
with antimicrobial drugs, PCL nanofibers have demonstrated high efficiency not only 
preventing infection development, but also avoiding biofilm formation.251–253  
As it was aforementioned, biofilms are populations of microorganisms aggregated and 
embedded in a polymeric matrix (EPS) which provides bacteria with a protector environment to 
medical treatments. It is well known that the existence of bacteria, particularly in chronic 
colonization, is commonly not as free-living planktonic state, but as organized clusters called 
biofilms.64 Within the biofilm there are intercellular signaling molecules produced by bacteria 
that respond to cell population density by gene regulation. In response to factors secreted by 
other bacteria in the community, bacteria can coordinate their activities, control the biofilm 
growth pattern or change their phenotype and thus, their virulence factors.65 Antibiotics can 
penetrate the extracellular surface of planktonic bacteria, but bacteria within the biofilm can be 
protected and the antibiotic diffusion impaired.254 Against this fact, EOs have been studied for 
their biofilm disruption potential. It has been reported the ability of some EOs to inhibit biofilm 
formation or disrupt already formed biofilms, suggesting their potential use in food preservation 
and in antimicrobial therapies.255,256 Their antibiofilm activity may be attributed to different 
mechanisms: inhibition of bacterial adhesion to surfaces at an initial stage, or  inhibition of 
Quorum Sensing (cell to cell communication).256 THY has been shown as an effective 
compound to inhibit biofilm formation, not only in monomicrobial cultures of S. aureus, but 
also with polymicrobial cultures of different bacteria (e.g., S. aureus, Listeria 
monocytogenes).240,255 This effect may be attributed to the disruption of bacteria membranes 
permeability and thus, hindering surface adhesion.257 Therefore, THY reduces bacterial growth, 
interferes with biofilm formation and promotes biofilm eradication.258 
Exposed subcutaneous tissues have been shown as critical scenarios for potential infection 
development having the favorable microenvironment for bacteria colonization and 
contamination.46 The risk of infection represents a general concern in skin and soft tissue open 
wounds, where each phase of wound healing is challenged by the possibility of microbial 
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infection.259,260 Following postsurgical wound analysis, it has been demonstrated that the 
average hospitalization period rises from 14 to 24 days when wounds became infected.261 
Infected wounds are characterized by a failure in inflammation, re-epithelialization and 
remodeling phases. Signs of infection may be pain, erythema, edema, heat and purulence, 
exudate, discoloration or wound breakdown.63 
For a complete tissue regeneration, the wound healing process requires the complete 
removal of any microbial exogenous contamination. Macrophages play an essential role in 
wound healing, not only eliminating pathogens or dead cells, but also releasing cytokines, 
growth and angiogenic factors that take part in the wound healing process.262 In this regard, 
tissue-resident macrophages recognize pathogen-associated patterns, such as the presence of 
bacterial endotoxin lipopolysachharide (LPS) during infections, causing the enrollment of other 
cells which help to fight a potential infection.263 S. aureus is a pathogen described to survive 
within phagocytic cells, such as macrophages, persisting in parts of their life-cycle 
intracellularly during infections.241,264,265 Co-culture models of S. aureus infected macrophages 
have been developed to study the behavior of bacteria under the presence of different 
antimicrobial treatments.265–267  
III.2. Objective 
This chapter develops the synthesis of electrospun THY-loaded PCL nanofibers and it is 
studied the effect of thisdrug-eluting wound dressing against cGFP-expressing antibiotic 
sensitive S. aureus (MSSA) growth. Three different infection models have been developed: (a) 
planktonic bacteria, (b) biofilm formation and (c) a co-culture model of J774 macrophages 
infected with cGFP-expressing S. aureus. Besides the development of quantitative methods, 
confocal microscopy was used to observe both biofilm formation and the co-culture model after 
the treatment with dressings based on THY-loaded PCL nanofibers.  
II.3. Experimental  
 Electrospun THY-loaded nanofibers were synthetized and characterized regarding 
morphology, drug loading and drug release after 24 h. Morphology was studied by Scanning 
Electron Microscopy (SEM), whereas drug loading and release were determined by GC-MS and 
UPLC liquid chromatography, respectively. Antimicrobial activity of free THY and PCL-THY 
patches was studied in a cGFP-expressing S. aureus strain following the broth microdilution 
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method216  and agar broth (ASTME-2180-18) standard test268, respectively. The ability of PCL-
THY patches to inhibit biofilm formation was measured quantitatively following the broth 
microdilution method and qualitatively by confocal microscopy. A co-culture model of J774 
macrophages infected with cGFP-expressing S. aureus was developed to study the infective 
action of the pathogen in eukaryotic cells. These assays were analyzed by confocal microscopy.  
The characterization techniques and different evaluation methods are described in 
Appendix I.  
III.4. Results and discussion 
III.4.1. Physico-chemical characterization of the electrospun nanofibers 
Figure III.1 shows the SEM micrographs of PCL and PCL-THY nanofibers. Both fibrous 
patches were homogeneous in their fiber diameter distribution having a bead-free surface. PCL 
patches showed mean diameter in their fibers of 779 ± 86 nm, meanwhile THY-loaded PCL 
nanofibers mean diameter was 794 ± 96 nm. Sadeghianmaryan et al.269 also obtained PCL 
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Figure III.1: Patches synthesis and characterization. A) Scheme depicting the PCL nanofibers 
synthesis by electrospinning. B) Table shows nanofiber diameters and PCL-THY drug loading 
(w/w %) and encapsulation efficiency (%). Mean ± SD (N=100). C) PCL morphological 
characterization by SEM. D) PCL-THY morphological characterization by SEM. E) THY 
release and Peppas and Sahlin equation parameters. 
The morphology and dimensions of the electrospun fibers depend on processing and 
polymer solution parameters.270 Syntheses parameters were the same for PCL or PCL-THY 
patches, using a polymer flow rate of 1 mL/h and a distance from tip to collector of 18 cm. The 
presence of THY in the synthesis solution did not change the ionic conductivity (22.2 µS for 
PCL and 20.8 µS for PCL-THY) and, despite of the increase in the solution viscosity (from 1.4 
to 1.6 cP for PCL and for PCL-THY, respectively), it did not affect the resulting fibers 
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morphology.270. Alfaro De Prá et al.271 also demonstrated that PCL fibers with average diameters 
of 663 ± 334 nm can be obtained using a rotatory drum collector.  
THY loading in prepared fibers was 8.2 ± 0.9 wt.% which renders an encapsulation 
efficiency of 40.8 ± 4.6 wt.%. This low EE achieved could be related to the use of a rotating 
collector, since for carvacrol (isomer of THY) loaded polyvinyl acetate fibers prepared using 
this collection system, the EE was also low (43-55 %) attributed to the evaporation of the 
monoterpenoid phenol derivative.272 The study of release kinetics demonstrated a fast burst 
THY release from the PCL-THY patches. Figure III.1.E shows that 28% of the encapsulated 
THY was released in the first hour. Peppas and Sahlin release kinetics model was the best 
mathematical fit for THY release with a R2 correlation coefficient of 0.993; results are shown 
in Figure III.1.E. This model explains a drug release occurring through the coupling of Fickian 
diffusion and polymer chains relaxation phenomena273. In our case the K1>>K2 implies that the 
Fickian diffusion is the predominant mechanism in the THY release.  
III.4.2. Bactericidal activity 
Figure III.2 shows the antibacterial activity of free and THY encapsulated in PCL 
determined in cultures of cGFP-expressing S. aureus. A concentration of 0.05 mg/mL of free 
THY were enough to significantly inhibit bacteria growth (MIC), showing a reduction from 109 
to 107 CFU/mL. When bacteria were treated with 0.15 mg/mL of free THY, no growth was 
found, meaning that MBC was reached. However, when bacteria were treated with PCL-THY, 
it was observed that 10 mg of PCL-THY reached the MIC inhibiting bacteria growth from 109 
to 106 CFU/mL, whereas 12 mg of PCL-THY were enough to avoid cGFP-expressing S. aureus 
growth (MBC) in an agar culture of 3 mL of volume having 105 CFU of inoculum. Considering 
THY loading and release kinetics from the patches, a mat of 10 mg would provide with a THY 
concentration released of 0.08 mg/mL in the time analyzed, meanwhile 12 mg of PCL-THY 
would release THY to the medium reaching a THY concentration of 0.1 mg/mL in the same 
time. The slight MIC and MBC differences observed between free THY and THY released from 
the PCL-THY patches can be associated with the experimental method followed, since free 
THY is challenged against bacteria in a liquid culture medium (TSB), whereas THY-loaded 
patches are studied using solid agar (TSA).   
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Figure III.2: Effect of THY treatment in cGFP-expressing S. aureus growth (CFU/mL) in 
contact during 24h. A) Free THY (0.01-0.15 mg/mL) and B) PCL-THY (10-12 mg). All samples 
are statistically compared with the positive control sample (non-treated bacteria). *p<0.05; 
****p<0.0001. Mean ± SD of three replicas are represented.  
Wound healing may be impaired by wound infection mediated by different bacteria. The 
microorganisms closely related to the colonization of skin and soft tissue wounds are from the 
Staphylococci family (in particular, S. epidermidis and S. aureus).64 As Chapter II demonstrates, 
THY is one of the best compounds inhibiting bactericidal growth of S. aureus strains, showing 
a MIC of 0.2 mg/mL and a MBC of 0.3 mg/mL against S. aureus (ATCC 25923).240 In the 
treatment with THY, Badawy et al.274 reported a MIC for S. aureus (ATCC 6538) of 0.13 
mg/mL, meanwhile Rua et al.275 identified a MIC in the range of 0.46-0.51 mg/mL for different 
S. aureus strains. These previous studies point out to the higher sensitivity of the cGFP-
expressing S. aureus strain used in this work since a concentration of 0.05 mg/mL of free THY 
was enough to inhibit the bacteria growth (MIC), whereas the complete elimination of the 
bacteria was reached when free THY concentration was 0.15 mg/mL.  
Superior sensitivity of this strain was also found for THY loaded PCL fibers. The 
comparison of these results with our previous studies247 showed the same pattern. In the current 
study, 12 mg of THY-loaded PCL patches (corresponding with 0.1 mg/mL of THY released in 
24h) were enough to achieve the MBC when working with cGFP-expressing S. aureus, 
meanwhile 30 mg of PCL-THY (0.38 mg/mL of THY released in 24 h) were needed to 
completely eradicate bacteria using a S. aureus (ATCC 25923) strain.247 These differences in 
THY susceptibility may be attributed to phenotype differences among S. aureus strains as 
explained above.   
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III.4.3. Antibiofilm activity 
cGFP-expressing S. aureus biofilm formation was monitored by confocal microscopy by 
using the Calcofluor White stain (Figure III.3). As mentioned in the experimental section 
(Appendix I), two approaches were followed based on the incubation times and the amount of 
THY-loaded PCL patches used. 
As it can be observed in Figure III.3, THY-free PCL patches (7 and 12 mg; left images) 
let the bacteria (stained in green) grow all over the well, forming a homogeneous layer of 
biofilm, which was clearly stained with Calcofluor White (in blue) on top of the bacteria settled 
underneath (green layer), as depicted in the bottom panels of both images. These results suggest 
that bacteria released the EPS typical of biofilm on the wells. However, PCL-THY patches 
clearly decreased the number of bacteria present in the wells being their numbers lower when 
the patch´s weight was increased. The images on the right show that the presence of bacteria 
was almost totally reduced when the THY concentration was increased. In this case, although 
all treated samples were stained with Calcofluor White, none of them showed a top coating 
labelled in blue which would be characteristic of biofilm formation, demonstrating the lack of 
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Figure III.3: Confocal laser scanning microscopy was performed to evaluate the effect of 
different THY-loaded patches having different weights (5-7 mg and 10-12 mg) and different 
incubation times (1 and 24h) compared with PCL control samples. For each incubation time, 
the three upper images correspond to cGFP-expressing S. aureus attached to the bottom of the 
well. Bottom images show the Calcofluor stain of biofilm formed. Bacteria is depicted in green 
whereas biofilm stains in blue.  
These qualitative results were confirmed with a quantitative method. Attached bacteria 
were collected from the bottom of the wells and cultured in agar plates. Figure III.4 shows the 
bacteria growth quantification after treatment following both methodologies. Positive controls 
(7 and 12 mg of PCL patches) reached 109 CFU/mL of bacterial growth in 24h whereas the 
treatment with 5-7 mg of PCL-THY for 24h (Figure III.4.A) or with 10-12 mg of PCL-THY for 
1h (Figure III.4.B) displayed a significant decrease in bacterial growth in the range of 105-106 
CFU/mL, confirming the qualitative results showed in Figure III.3.  
Considering the release kinetics results, 5 and 7 mg of PCL-THY patches would release 
in 24h 0.06 and 0.09 mg/mL of THY, respectively. These concentrations in which we obtained 
MIC values, correlate with the inhibitory concentrations when using free THY in planktonic 
bacteria. Those results highlight the potential of these patches to provide with prophylaxis 
against biofilm formation and to reduce already formed biofilms. 
Figure III.4: Quantification of cGFP-expressing S. aureus to evaluate biofilm formation against 
different treatments with PCL-THY: A) 5-7 mg for 24h; B) 10-12 mg for 1h. Results derived 
from PCL-THY are statistically compared to those obtained from the PCL patches used as 
control. **p<0.01; ***p<0.001; ****p<0.0001. Mean ± SD of three replicas are represented.  
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A recent study states that 78% of non-healing chronic wounds contain biofilms.259 The 
elimination of bacterial bioburden is essential to promote wound healing in chronic wounds.276 
Sharifi et al. demonstrated that sub-MIC concentrations (MIC/2 to MIC/16) of different EOs 
obtained from Thymus daenensis and Satureja hortensis in contact with S. aureus for 24h, 
significantly prevented biofilm formation.257 Moreover, Cabarkapa et al.258 treated bacteria 
(Salmonella Enteriditis) with sub-MIC (MIC/2-MIC/4) concentrations of Origanum and 
Thymus essential oils as well as their active components carvacrol and THY, and results showed 
that biofilm formation was inhibited. These studies corroborate our results, not only 7 mg of 
PCL-THY eliminate already formed biofilms, but also we demonstrate that the exposition to 5 
mg PCL-THY for 24h, reduces bacterial attachment to the well. The obtained results may 
evidence that cell wall damage can negatively affect bacterial attachment as we previously 
described240, which, according to Kerekes et al.255 represents the first step in biofilm formation, 
followed by formation of microcolonies, maturation and cell dispersal.256,275 The effect of THY 
against bacterial adhesion has also been demonstrated by Yuan et al.278 when they analyzed PIA 
(Polysaccharide Intracellular Adhesion), a component involved in adhesion and aggregation. 
This component was reduced under the presence of THY and thus, bacteria could adhere to 
materials at the initial stage, but they were unable to form biofilms due to a reduced cell-to-cell 
adhesion.278,279 Therefore, THY reduces bacterial growth, interferes with biofilm formation and 
promotes biofilm eradication.258   
III.4.4. Cytotoxicity assessment of PCL-THY patches 
Cytotoxicity of PCL-THY was studied in J774 macrophages at cell metabolism level using 
the MTT reduction assay. This method depends on the cellular activity of viable cells by 
producing a colored solution. Cells were exposed to different amounts of PCL-THY following 
the two methodologies described in the experimental section (Appendix I). The results obtained 
from both approaches were compared with cells treated with PCL patches (control samples) and 

















Figure III.5: J774 macrophages viability after treatment with PCL-THY following two different 
approaches regarding the patch weight: A) Treatment for 24h (5 and 7 mg of PCL-THY); B) 
Treatment for 1h and incubation for other 24h (10 and 12 mg PCL-THY). The results are 
graphed in basis to untreated cells which were assigned with a 100% viability. *p<0.05; 
**p<0.01; ****p<0.0001. Mean ± SD of three replicas are represented.  
In the first approach, cells were treated with 5 and 7 mg of PCL-THY for 24h. As depicted 
in Figure III.5, a 50% cell growth inhibition was attained with 7 mg of PCL-THY, which 
corresponds to 0.09 mg/mL of THY released. However, the treatment with 5 mg of PCL-THY 
(0.06 mg/mL of THY released in 24h) displayed a 80% cell viability after 24h incubation, 
classifying the material as non-cytotoxic (according to the value established by the ISO 10993-
5).233 Considering the direct relationship among increased concentration and cell toxicity, the 
treatment with more than 7 mg of PCL-THY for 24h would reduce significantly cell viability at 
levels below 70%. Due to that fact and keeping in mind that inhibitory and bactericidal 
concentrations were achieved with 10 and 12 mg PCL-THY, cells were treated with 10 and 12 
mg PCL-THY but for a reduced incubation time (just 1h). Following this protocol, cell viability 
was quite similar for both amounts evaluated, obtaining >70% of viability required to consider 
these concentrations as non-cytotoxic, which corresponds to 0.12 mg/mL using 10 mg PCL-
THY and 0.14 mg/mL using 12 mg PCL-THY for 1h.  
The cytotoxicity caused by THY against eukaryotic cells is related to its non-selective 
antiseptic character. During the regenerative process in an infected wound after adding an 
antiseptic, pathogenic prokaryotic cells are removed but also some somatic eukaryotic ones. 
However, due to the immune response, new regenerative cells are recruited to the wound area 
 
 
 Chapter III 
72 
compensating the initial loss owing to the antiseptic effect. In addition, short contact times 
would minimize this cytotoxic effect. 
III.4.5. In vitro model of infection of J774 macrophages 
In sections III.4 and III.5 it has been studied the effect of PCL-THY on bacteria growth and 
biofilm formation. As we mentioned before, macrophages play a crucial role in wound healing, 
managing pathogens, phagocytizing dead cells and recruiting other cells which help to fight 
infection, such as neutrophils, fibroblasts, keratinocytes or endothelial cells.262,263 To investigate 
the impact of the treatment of PCL-THY on a S. aureus infected cell line, J774 macrophages 
were visualized in contact with cGFP-expressing S. aureus. Figures III.6 and III.7 represent the 
orthogonal projection using the maximum intensity projection (MIP), to visualize bacteria inside 
and outside cells, represented both in the same plane. Bacteria are shown in green while cell 
nuclei are stained with DAPI (blue) and cytoskeleton, with phalloidin 546 (red). 
Figure III.6 depicts activated macrophages with LPS and treated with 5 and 7 mg of PCL-
THY for 24h. Control samples (Figures III.6.A and III.6.B) showed cells totally filled with 
bacteria (green), indicating the successful infection of macrophages. However, the treatment 
with 5 mg of PCL-THY (Figures III.6.C and III.6.D) and 7 mg of PCL-THY (Figures III.6.E 
and III.6.F) for 24h clearly demonstrate the efficiency of the synthesized loaded antimicrobial 
patches showing a reduced number of bacteria in a dose-dependent manner. In the time span 
studied, 5 and 7 mg patches would release an amount of THY of 0.06 mg/mL and 0.09 mg/mL 

























Figure III.6: In vitro co-culture model of cGFP-expressing S. aureus and J774 macrophages. 
Cells were treated for 24h with: (A, B) 7 mg of PCL patches (control samples); (C, D) 5 mg 
PCL-THY; (E, F) 7 mg PCL-THY. Left images were acquired with a 63x oil immersion 
objective. Right images correspond with a zoomed area of left images. Bacteria are stained in 
green while cell nuclei are stained with DAPI (blue) and cytoskeleton with phalloidin 546 (red). 
Due to the results observed in the cell toxicity study, we treated infected macrophages 
also with 10 and 12 mg PCL-THY though reducing the time of incubation also to 1h (Figure 
III.7). These images demonstrate the same trend observed in the previous assay. When cells 
were treated with 12 mg of PCL (Figures III.7.A and III.7.B), bacteria were found throughout 
the plate. However, when cells were treated with 10 mg PCL-THY (0.12 mg/mL of THY 
released in 1h; Figures III.7.C and III.7.D) and 12 mg PCL-THY (0.14 mg/mL of THY released 
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in 1h; Figures III.7.E and III.7.F) for 1h, bacteria concentration was significantly reduced, even 
totally when using the highest amount, confirming the efficiency of the fabricated PCL-THY 



















Figure III.7: In vitro co-culture model of cGFP-expressing S. aureus and J774 macrophages. 
Cells were treated for 24h with: (A, B) 12 mg of THY-free PCL; (C, D) 10 mg of PCL-THY; 
(E, F) 12 mg of PCL-THY. Left images were acquired with a 63x oil immersion objective. Right 
images correspond with a zoomed area of left images. Bacteria are stained in green while cell 
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Among other functions, biofilm allows bacteria to defense itself from external threats. 
Thus, immune cells are not able to reach and eliminate bacteria, and therefore a persistent 
inflammation and wound chronification occur.280 S. aureus may survive within phagocytic cells 
including macrophages, even when host defense is activated.281 Based on that, cGFP-expressing 
S. aureus was chosen as a model of a bacterial pathogen with part of its life cycle occurring 
intracellularly to study and visualize the effect of PCL-THY on J774 macrophages in a co-
culture infection model. We observed that the treatment for 24h with a sub-inhibitory 
concentration (7 mg of PCL-THY, 0.09 mg/mL THY released) for cGFP-expressing S. aureus, 
was cytotoxic to macrophages. It is not the first time that a high toxicity of THY is reported in 
eukaryotic cell cultures. For example, Belato et al.282 analyzed the cytotoxicity of free THY on 
murine macrophages (RAW 264.7) and showed that cell viability dropped from 75% to 5% at 
concentrations higher than 0.005 mg/mL. The toxicity mechanism of this compound is poorly 
understood. There are different hypothesis about this issue; Gutierrez et al.283 reported that THY 
can affect the integrity of membranes in both prokaryotic and eukaryotic cells. However, 
Satooka et al.284 proposed that THY is intracellular transformed to a toxic radical and quinone, 
relating its toxicity to the oxidative-stress generated.  
Compared with bactericidal planktonic studies, when J774 macrophages were infected 
with cGFP-expressing S. aureus, it has been shown that a lower dose of PCL-THY patches is 
able to fight cell infection. That is probably because THY may help macrophages in the control 
of the progression of the infection in vitro.285 In summary, PCL-THY patches have demonstrated 
to induce a significant reduction of cGFP-expressing S. aureus into infected J774 macrophages, 
diminishing their intracellular colonization. In addition, the ability of THY to reduce biofilm 
formation, opens the possibility to fight bacterial infections and make the recovery of wound 
healing more efficient when using this locally delivery system of thymol. 
III.5. Conclusions 
By comparing THY-free PCL electrospun patches as a model of a conventional wound 
dressing and THY-eluting PCL electrospun patches, the later outstand as efficient antimicrobial 
materials against a pathogenic Gram-positive bacteria sensitive to conventional antibiotics used 
as a model (methicillin-sensitive S. aureus Newman strain) expressing cGFP. The fluorescent 
bacteria were used to demonstrate the successful infective action of the pathogen in eukaryotic 
cells as a model of intracellular pathogen. Finally, it has been also demonstrated that the PCL-
 
 
 Chapter III 
76 
THY patches are able to hinder biofilm formation by inhibiting the first stages of bacterial 
adhesion. The developed patches showed cytotoxicity against eukaryotic cells in a dose 
dependent manner, but at reduced doses and during short contact times, cell viability was similar 
to untreated controls. In this comparative study, research based on evidence demonstrates that 
THY-loaded electrospun PCL patches are more efficient that their THY-free counterparts 





























ELECTROSPUN ANTI-INFLAMMATORY PATCH LOADED 





This chapter summarizes the wound healing process to highlight the importance of a bacterial 
infection as one of the main reasons to increase inflammation and delay the process. Thus, the 
possibility to find a strategy that combines antimicrobial and anti-inflammatory properties is 
particularly appealing for wound healing. The ability of essential oils reducing inflammation 
was studied as free compounds and loaded into electrospun-PCL nanofibers. Thus, the 
expression of Il1b, iNos and Il6 cytokines in J774 macrophages was analyzed by RT-PCR. 
Overall, results indicate that THY-loaded patches could serve as promising candidates for the 
fabrication of dressings that incorporate bactericidal and anti-inflammatory properties while 
simultaneously avoiding the limitations of traditional antibiotic-loaded devices. 
 
 
The content of this chapter has been adapted from the following published work: 
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Electrospun Anti-Inflammatory Patch Loaded with Essential Oils for Wound Healing. 
Int. J. Pharm. 2020, 577 (January), 119067. https://doi.org/10.1016/j.ijpharm.2020.119067. 
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Previous chapters in this thesis focused on the search of therapeutic or combinatory plant-
derived natural compounds to fight infections. Recently, considerable interest has been shown 
in the use of strategies that combine antimicrobials with anti-inflammatory drugs.199 
Specifically, extracts derived from plants and animals were shown to effectively modulate 
inflammatory pathways.286,287 The inflammatory response, led by macrophages, is the first line 
of defense against pathogens.288 Toll-like receptors (TLRs), present on macrophages and 
dendritic cells, can be activated by lipopolysaccharide (LPS), an endotoxin from gram-negative 
bacteria which acts as a stimulator of inflammatory cytokines.289 The stimulation of TLRs leads 
to the activation and nuclear translocation of nuclear factor kappa-light-chain-enhancer of 
activated B cells (NF-κB) and mitogen-activate protein kinase. Both signaling pathways involve 
stimulation of activating protein-1 (AP-1) and, consequently, the down-stream transcription of 
pro-inflammatory genes, such as interleukin (Il) 1b. This cytokine is synthesized in the early 
stages of inflammation, triggering subsequent signals which activate Il10, iNos, COX-2, Il6, 
and others.289,290 When the inflammatory response is initiated, these paracrine signals recruit 
other effector cells to the wound area to advance the inflammation to tissue reparation and 
regeneration.286  
Natural compounds may be used as anti-inflammatory substances because they could 
interfere in the NF-κB signaling pathway.291 For example, squalene, a natural triterpene 
consumed as an integral part of the human diet, was found to reduce mRNA levels of NF-κB 
downstream genes such as Tnf-a or Il1b in LPS-treated murine peritoneal macrophages.139 
Curcumin modulates the inactivation of this signaling pathway, decreasing expression of pro-
inflammatory genes.289 THY and CAR, dietary monoterpenes found in certain plants, control 
the phosphorylation of multiple signaling molecules, inhibiting key mediators of inflammation 
in LPS-stimulated murine mammary epithelial cells.292 However, natural compounds have 
shown several limitations in solubility and pharmaceutical formulations. 
To overcome these pitfalls, various delivery systems have been developed to achieve 
increased solubility and efficacy while maintaining effective control and release.286 More 
recently, electrospun patches loaded with antimicrobial and anti-inflammatory drugs have been 
explored as a promising platform to develop surgical dressings with enhanced wound repair. 
Additionally, with alternative antimicrobial therapeutics being sought to minimize AMR such 
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as natural compounds, electrospun patches have garnered significant support. As Chapter III 
shows, THY encapsulated in electrospun polycaprolactone (PCL) nanofibers keeps the efficient 
bactericidal properties against pathogenic S. aureus. PCL is a biocompatible and bioresorbable 
polymer that has been FDA-approved for use in several medical and drug delivery devices.99 
IV.2. Objective 
Herein, PCL electrospun nanofibrous patches loaded with natural bactericidal compounds 
were prepared with the aim of reducing inflammation during wound healing. After the 
fabrication and characterization of the electrospun patches, the main goal was to study the ability 
of essential oils reducing inflammation by measuring the expression of Il1b, iNos and Il6 
cytokines in J774 macrophages analyzed by RT-PCR. Genetical results were corroborated by 
carrying out an immunofluorescence assay. Furthermore, it was studied if PCL-loaded patches 
show affinity for cell attachment with the aim of understanding the feasibility of the fabricated 
patches as potential dressings for wound healing. 
IV.3. Experimental 
With the aim of studying the effect of free essential oils (EOs) in an in vitro inflammatory 
model, J774 murine macrophages were used. EOs cytotoxicity was studied using the MTT 
viability assay, optical microscopy and flow cytometry. To develop the inflammatory model, 
J774 macrophages were activated using LPS and treated with optimal concentrations of free 
compounds following two procedures indicated in Scheme IV.1. The expression of pro- and 
anti-inflammatory cytokines was analyzed by RT-PCR. For this, RNA was obtained, and reverse 
transcribed to cDNA. 





The compounds displaying the best anti-inflammatory results were encapsulated into 
electrospun PCL nanofibers. Morphology was studied by Scanning Electron Microscopy 
(SEM), meanwhile drug loading and release were determined by GC-MS and UPLC liquid 
chromatography, respectively. Viscosity and conductivity of the polymer solution were studied 
both with and without natural compounds.  
MTT viability assay was carried out with J774 macrophages in contact with different EOs-
loaded PCL patches. The post-treatment approach (Scheme IV.1) was followed to determine the 
anti-inflammatory activity of these dressings analyzing Il1b, Nos2 and Il10 expression. 
Moreover, cells were stained with DAPI and Alexa Fluor 546™ and studied by confocal 
immunofluorescence. Finally, a cell colonization model was developed to study the cell 
migration and colonization of the patches by means of the MTT assay and SEM.    
The characterization techniques, the inflammatory model and analysis are described in 
Appendix I.  
IV.4. Results and discussion 
IV.4.1. Cell viability, morphology and flow cytometry of free EOs 
Macrophages play a key role during the inflammatory phase in wound healing.286 As such, 
J774 murine macrophages were used to test the anti-inflammatory ability of our selected 
compounds. To assess the cytotoxicity of our EOs in macrophages, these were exposed to EO 
groups for 24 h and evaluated for metabolic activity (Figure IV.1.A). To ensure non-lethal 
treatment, cell viability of 70% or greater was considered acceptable as previously 
established.233  Interestingly, β-caryophyllene (B-CAR) and curcumin (CUR) displayed the 
highest cytotoxicity, even at the lowest tested concentration (0.008 mg/mL). Similarly, CIN was 
also found to be cytotoxic, however, only at concentrations above 0.04 mg/mL. CAR and THY, 
which demonstrated strong bactericidal action (Chapter II), did not show differences in 
cytotoxicity; however, detrimental effects were observed at concentrations equal or > 0.12 
mg/mL. Conversely, SQU and TYR displayed no indication of cytotoxicity at any of the tested 
doses. 
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Figure IV.1: Cell viability of J774 macrophages in the presence of free EOs at concentrations 
ranging from 0.008 to 0.24 mg/mL after 24 h incubation. A) MTT cell viability assay; B) Optical 
microscope images showcasing cell morphology after 24 h of treatment. *p < 0.05; **p < 0.01; 
***p < 0.001; ****p < 0.0001. Error bars represent mean ± SD of three replicas. Gray boxes 
highlight the EO compounds removed from additional testing during this chapter due to 
cytotoxicity. 
These results were further confirmed using optical microscopy (Figure IV.1.B) and flow 
cytometry (Figure IV.2) following a 24 h treatment with the various EOs. B-CAR, CUR, and 
CIN showed the highest percentages of apoptotic/dead cells compared to untreated control cells. 
In addition, cell morphology and shape appeared round with heterogeneity in size, typical of 




highest percentages of live cells compared to control samples. Both SQU and TYR-treated 
samples displayed an elongated cell morphology, while CAR demonstrated increased damage 
as depicted by Figure IV.1.B and IV.2. As such, despite their previously reported anti-
inflammatory effects,142,294 these compounds were eliminated from further evaluation due to the 
high toxicity exerted in our in vitro model. 
 
Figure IV.2: Flow cytometry histograms of phospholipid redistribution in the apoptosis assay: 
Annexin V/Propidium iodide assay. X-axis corresponds with FITC fluorochrome and Y-axis 
shows the emission of PerCP-Cy5.5. 
IV.4.2. Anti-inflammatory effects of the different free natural compounds  
To maintain non-lethal working concentrations of EOs, CAR and THY were used at a 
concentration of 0.06 mg/mL while 0.12 mg/mL was used for SQU and TYR (results obtained 
in Section IV.4.1). Dexamethasone (DEX), a commercially available corticosteroid anti-
inflammatory drug, was used as a negative control while untreated cells served as a positive 
control. The inflammatory effects of LPS and the effect of the natural compounds were studied 
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through the expression of the pro-inflammatory genes Il1b and iNos by RT-PCR (Figure IV.3). 
Results were statistically compared to a positive control.  
Two experimental settings were performed (Scheme IV.1): pre-treatment289,295 and post-
treatment.199,290,296 Interestingly, following pre-treatment, CAR and THY displayed a substantial 
decrease in pro-inflammatory gene expression following 24 h exposure, reaching levels similar 
to DEX-treated cells (Figure IV.3.A). On the other hand, mRNA expression levels of Il1b and 
iNos diminished in the presence of TYR (91.0 ± 6.6 and 475.2 ± 36.5, respectively), resulting 
in higher values when compared to CAR (34.1 ± 5.3 for Il1b and 34.1 ± 4.6 for iNos) and THY, 
with expression levels of 20.9 ± 3.2 for Il1b and 49.8 ± 9.8 for iNos. Similarly, TYR expression 
showed lower values when compared to SQU (189.3 ± 35.1 for Il1b and 1824.2 ± 137.9 for 
iNos). Furthermore, SQU was found to be the least effective in reducing pro-inflammatory gene 
expression, demonstrating comparable levels to LPS-treated cells whose expression levels were 
256.2 ± 18.2 for Il1b and 2429.2 ± 144.4 for iNos. 
Evaluation of post-treatment cells (Figure IV.3.B) revealed THY significantly reduced 
Il1b expression (51.4 ± 8.4) to levels comparable to DEX control samples (162.4 ± 18.2), 
whereas iNos levels displayed no difference. Similarly, iNos expression levels for THY were 
62.2 ± 11.2 and 43.4 ± 13.6 for DEX samples. Furthermore, although TYR demonstrated a 
downregulation of Il1b and iNos (326.1 ± 15.4 and 93.3 ± 12.2, respectively), values were still 
higher when compared to THY-treated cells. This trend closely matched the pre-treatment 
observations (Figure IV.3.A). On the other hand, SQU did not reduce Il1b and iNos expression 
compared to the LPS-treated control cells, which was in accordance with the results obtained 
from the pre-treatment approach. Considering treatment concentrations for both CAR and THY 
were half of what was used for TYR and SQU (i.e., 0.06 vs 0.12 mg/mL), it can be concluded 
that the anti-inflammatory effect of CAR and THY was much higher than the other EOs. The 
differences between both compounds were highlighted in the post-treatment approach (Figure 
IV.3.B) in which CAR displayed lower inhibitory effects than THY in regulation of Il1b and 
iNos. These changes between both approaches may be related to increased levels of inducible 
p-NF-κB p65, which plays an inhibitory role and remained unchanged by THY.297 Furthermore, 
of all tested EOs, THY consistently exhibited the highest anti-inflammatory effect. When 




showcased a similar ability to modulate the expression of Il1b and iNos, demonstrating its 
potential as a natural origin anti-inflammatory compound. 
Figure IV.3: Comparison of pro-inflammatory markers (Il1b and iNos) in LPS -activated 
macrophages following A) pre-treatment and B) post-treatment with EOs. ***p < 0.001; ****p 
< 0.0001. Mean ± SD of three replicas are represented. Fold change relative to housekeeping 
gene (β-actin) and untreated cells. 
IV.4.3. Characterization of electrospun nanofibers 
The synthesis and characterization of electrospun nanofibers developed in this chapter 
were carried out by Enrique Gamez in a thesis collaboration.  
The average diameters of the nanofibers were as follows: PCL nanofibers, 480 ± 109 nm; 
PCL-THY, 293 ± 59 nm; PCL-TYR, 380 ± 67 nm; PCL-THY-TYR, 948 ± 277 nm; PCL-CAR, 
258 ± 47 nm; PCL-SQU, 493 ± 106 nm; and PCL-THY-SQU, 752 ± 257 nm. Figure IV.4 shows 

































Figure IV.4: Characterization of electrospun PCL patches by SEM.   
 
The drug loading and encapsulation efficiency of the PCL-patches are summarized in 




reported values.190,247 PCL fibrous patches were found to possess a porosity of 78.8% with a 
pore diameter of 1.8 μm and a density of 0.22 g/mL. Water uptake was in the range 52–66 %. 
Evaluation of drug release kinetics demonstrated a burst release effect from the patch 
(Table IV.1). Specifically, PCL-THY showcased a 7.33% burst release of THY in the first 60 
min while PCL-TYR resulted in release of 61.74% after 8 h. When co-loaded, PCL-THY-TYR 
displayed a release of 5.36% of THY and 41.38% of TYR. The difference observed between 
THY and TYR release may be explained by THY’s lower solubility in water (0.9 mg/mL) 
compared to TYR (25.3 mg/mL), despite the use of a solubilizing agent. 
Table IV.1: EOs compounds loading, encapsulation efficiency and release. 
Sample Drug loading (% w/w) 
Encapsulation 
efficiency (%) 
Drug release after 
24 h (%) 
PCL-THY 17.13 ± 1.61 85.65 ± 8.05 7.33 ± 0.85 
PCL-TYR 17.72 ± 1.80 88.62 ± 8.99 61.74 ± 2.99 
PCL-CAR 15.40 ± 1.44 77.00 ± 7.18 5.78 ± 0.93 
PCL-SQU 16.32 ± 1.40 81.61 ± 7.01 0 
PCL-THY-TYR THY – 7.46 ± 1.35 74.62 ± 7.98 5.36 ± 0.12 TYR – 7.17 ± 1.12 71.71 ± 11.19 41.38 ± 1.39 
PCL-THY-SQU THY – 7.75 ± 0.17 77.52 ± 7.16 8.92 ± 1.18 TYR – 7.27 ± 0.73 72.73 ± 7.88 0 
IV.4.4. Cell viability of natural compound loaded PCL patches  
It is known that nanofibrous materials have several advantages as delivery systems due to 
their high surface to volume ratio and high favorable for wound dressing applications. Many 
bioactive substances can be loaded into polymeric nanofibers and maintain their function.294,299 
Although these compounds demonstrate effective anti-inflammatory effects, their low solubility 
makes them challenging to administer. As such, we investigated the use electrospun PCL as a 
delivery strategy for wound healing due to the large area per volume ratio of the nanofibers 
To elucidate possible cytotoxic effects of the PCL patch, cell viability in macrophages 
was observed using an MTT assay. Instead, we evaluated the potential benefit associated with 
PCL patches developed in combination with CAR, THY, TYR, and SQU. In this case, all 
patches with the exception of PCL-CAR displayed cell viability > 70% (Figure IV.5). 
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Interestingly, macrophages treated with PCL-CAR exhibited cell viability below 50% with a 
dramatic reduction in viability observed at higher concentrations (i.e., 1.0 and 1.5 mg). 
Conversely, PCL-SQU was found to be the most biocompatible with cell viability consistently 
over 80%. As such, all subsequent studies maintained a patch mass of 0.75 mg while PCL-CAR 
was entirely removed from additional testing in this chapter. Moreover, in an effort to evaluate 
combinatory EO release from patches, PCL-THY-TYR and PCLTHY- SQU were tested and 
found to maintain viability >70% only at 0.75 mg. THY was specifically included in the 
combination patches due to its bactericidal properties demonstrated in Chapter II and Chapter 












Figure IV.5: Cell viability of J774 macrophages after 24 h incubation in the presence of 0.75, 
1.0, and 1.5 mg of patches loaded with various natural compounds. *p < 0.05; ***p < 0.001; 
****p < 0.0001. Error bars represent the SD of three replicas. Gray boxes highlight the treatment 
group removed from additional testing due to cytotoxicity. 
IV.4.5. Anti-inflammatory effects of the loaded patches 
To evaluate anti-inflammatory properties, macrophages were exposed to loaded PCL 
patches using the post-treatment strategy above and evaluated for pro- and anti-inflammatory 
genes. Specifically, the expression of Il1b, iNos (i.e., pro-inflammatory) and Il10 (i.e, anti-
inflammatory) were analyzed (Figure IV.6). When compared to an LPS treated control, PCL-




expression). Conversely, TYR demonstrated higher levels of downregulation for Il1b when 
compared to SQU, although SQU displayed higher inhibition of Il10 and iNos. More so, when 
a combinatory treatment strategy was employed, THY-TYR loaded patches demonstrated a 
greater reduction in Il1b and Il10 cytokine levels when compared to THY-SQU although no 
difference was observed in iNos levels. 
Figure IV.6: Expression of mRNA levels for pro-inflammatory (Il1b, iNos) and anti-
inflammatory (Il10) genes following treatment with PCL-THY, PCL-TYR, PCL-SQU, 
PCLTHY- TYR and PCL-THY-SQU. Measurements were collected 24 h post-LPS activation. 
Post-treatment approach was followed to carry out this assay. *p < 0.05; **p < 0.01; ***p < 
0.001; ****p < 0.0001. Error bars represent the SD of three replicas. Fold change is relative to 
housekeeping gene and untreated control cells. Gray boxes highlight the treatment group 
removed from additional testing due to the low anti-inflammatory effect. 
As THY and TYR displayed the highest levels of reduction in inflammatory markers, 
further analysis was performed to evaluate their therapeutic potential over 48 h (Figure. IV.7). 
Kinetic evaluation of mRNA levels revealed highest peaks of Il1b and iNos occurring at 24 h 
across all patch groups while Il10 expression remained consistently low for all time points. 
Furthermore, when compared with the LPS-treated cells, THY-loaded patches exhibited more 
efficient downregulation of anti-inflammatory genes than TYR- and THY-TYR-loaded patches. 
This data revealed a combinatory loading strategy does not offer increased anti-inflammatory 






Figure IV.7: Expression of mRNA level for pro-inflammatory (Il1b, iNos) and anti-
inflammatory (Il10) genes in J774 macrophages following treatment with patches loaded with 
PCL-THY, PCL-TYR and PCL-THY-TYR. Stimulation with LPS was carried out for 3 h and 
subsequently treated with patches for 12, 24, and 48 h. This assay followed the post-treatment 
approach. **p < 0.01; ****p < 0.0001. Error bars represent the SD of three replicas. 
Among the most sensitive cytokines to LPS and the earliest to show gene expression in 
inflammation is Il1b.300 As it is shown, Il1b was the only cytokine studied having the highest 
expression after 24 h. At two different time points, THY, TYR, and their combination were able 
to reduce Il1b expression. THY patches present superior reduction in inflammation compared 
to TYR, although slight differences were found regarding PCL-THY-TYR. This demonstrates 
that THY is the compound that may exert the anti-inflammatory effect in combination patches. 
Several studies have established THY as anti-inflammatory compound through different 
models, i.e. by the inhibition of the expression of pro-inflammatory cytokines, such as Il1b or 




potential than free THY, suggesting the anti-inflammatory effect of THY was retained even 
when encapsulated within a nanoparticle.  
IV.4.6. Cell migration towards PCL-loaded nanofibers and colonization of the patches 
The role of a wound dressing is to provide the optimum conditions for wound healing 
while simultaneously protecting the wound from further trauma and invasion by pathogenic 
microorganisms. It is also important that the dressings can be removed atraumatically avoiding 
cell adherence and colonization so as to prevent further damage to the wound surface during 
dressing changes. To evaluate the patches potential as a wound dressing, we assessed their 
response in cell colonization. To this end, PCL-THY, PCL-TYR and PCL-THY-TYR patches 
were placed atop a monolayer of macrophage cells and allowed direct contact with the cells for 
24 h. Following this incubation, patches were analyzed for cytotoxicity using the MTT assay 
and by SEM to visualize cell migration towards the patches and their colonization. 
In this assessment, cells were primarily found to remain intact on the bottom wells as 
observed by viability testing (Figures IV.8 A and B). Similarly, this was further showcased by 
evaluating cell viability on the patch itself which revealed negligible values for all groups. To 
further validate our hypothesis, SEM was carried out on the patch to check both the fibers 
morphology and the potential presence of cells. SEM micrographs for all patch groups reveal 
no observable signs of cell colonization (Figure IV.8). These results support the feasibility of 




Figure IV.8: J774 migration to patch and colonization. A) Cell viability assessment using MTT 
was performed on seeded cells and B) Cells remaining on patch. C) SEM images of patches 
following 24 h exposure to cells. 1: PCL-THY; 2: PCL-TYR; 3: PCL-THY-TYR. *p < 0.05; 
***p < 0.001; ****p < 0.0001. Error bars represent the SD of three replicas. 
IV.4.7. Immunofluorescence assay 
As PCL-THY was the most effective in anti-inflammation, it was evaluated its effect on 
cell morphology. To this end, both activated or non-activated macrophages were treated with 
PCL-THY (0.75 mg) and evaluated using confocal microscopy (Figure IV.9). 
Immunofluorescent images were obtained following treatment and used to assess cell size after 
removal of the patch. As expected, LPS-activated macrophages displayed the highest cell area 
when compared to untreated cells. Conversely, when cells were treated with PCL-THY, average 
cell area was significantly less than LPS-treated cells and only slightly higher than non-treated 




treated cells showcased similar sizes as DEX-treated cells, indicating a comparable inhibition 
in inflammation. 
Figure IV.9: Confocal microscope images of J774 murine macrophages stained for cell 
membrane (green) and nucleus (blue). A) Non treated cells (negative control); B) LPS-treated 
cells (positive control); C) Cells treated with LPS- and DEX; D) Cells treated with PCL-THY; 
E) Cells treated with LPS- and PCL-THY; F) Average area per cell calculated from the total 
area obtained in cell membrane and dividing it by the total number of events counted (nuclei). 
NT, no treatment; DEX, dexamethasone; THY, Thymol. Error bars represent the SD of 4–8 
representative field of views. 
LPS can bind to many receptors on the macrophage surface resulting in activation of the NF-κB 
pathway and changes in cell morphology. For example, in these experiments, cells displayed an 
increase in size when activated with LPS (Figure IV.8). However, when they were treated with 
PCL THY or free DEX, the size decreased to levels comparable to untreated cells, which is in 
agreement with previous studies.300 Specifically, LPS-stimulation of macrophage cells result in 






PCL-based electrospun patches incorporating compounds commonly present in EOs, such 
as THY, TYR, and SQU, and their combinations THY-TYR and THY-SQU, were able to 
significantly reduce inflammation in an in vitro model based on LPS-activated J774 murine 
macrophages. When encapsulated within PCL, THY demonstrated the most successful in terms 
of efficiency against inflammation and in inhibiting the expression of the pro-inflammatory 
mediators Il1b and iNos. In addition, loaded patches were successful in reducing the size of 
inflamed cells, indicating an alleviation of the inflammatory response, with colonization assays 
highlighting the potential use of synthesized patches for wound healing. The work presented 
here demonstrates that natural compounds loaded within nanofibers hold great promise for 
wound healing, stemming from their unique ability to resolve two essential mechanisms in 
wound repair: fighting infections and mitigating inflammation. Thus, THY is proposed to be a 





















EFFICIENCY OF ANTIMICROBIAL ELECTROSPUN THYMOL-




In this chapter, electrospun thymol (THY)-loaded polycaprolactone (PCL) nanofibers 
were synthesized to be potentially used as wound dressing materials. In vivo studies were 
performed using eight to ten-week-old male SKH1 hairless mice which were subjected to an 
excisional wound splinting model in order to evaluate wound infection prevention. The infection 
progression in wounds was evaluated through a semi-quantitative method and quantitative 
polymerase chain reaction (qPCR). Post-mortem wounds were analyzed by histopathological 
and immunohistochemical studies. Results indicated that PCL-THY patches act as inhibitors of 
Staphylococcus aureus ATCC 25923 strain growth and reduce the cellular inflammatory 
response. Therefore, wound dressings containing natural compounds can prevent infection, 
promote wound healing and prompt regeneration. 
 
 
The content of this chapter has been adapted from the following accepted work:  
Garcia-Salinas, S.; Gamez-Herrera, E.; Asin, J.; de Miguel, R.; Andreu, V.; Sancho-Albero, M.; 
Mendoza, G.; Irusta, S.; Arruebo, M. 
Efficiency of Antimicrobial Electrospun Thymol-Loaded Polycaprolactone Mats in vivo  
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V.1. Introduction 
Injuries caused by burns, trauma or surgery are significant economic and social burden to 
healthcare providers.303 Wound dressings play an important role during the healing process and 
they have received growing attention in recent years.304–306 In general, wound dressings are 
required to have good biocompatibility, provide a barrier against dust and bacteria, absorb 
exudates and debris and facilitate blood clogging while promoting transpiration avoiding wound 
maceration.307 It is also important for a wound dressing material to be as strong at least as human 
skin (tensile strength in the range 2-16 MPa) to withstand mechanical stress to support the 
patient daily activities.307 Another expected characteristic is having adequate porosity to allow 
gas exchange but avoiding bacterial penetration acting as a physical barrier.303 
Polymer nanofibers provide the possibility to immobilize antimicrobial compounds and 
their structure, similar to the extracellular matrix, has high interconnected porosity, and allows 
gas permeability.248 Among the different fibers fabrication techniques, electrospinning is the 
most commonly used method because of its versatility, cost-efficiency and straightforward 
setup.308 Synthetic (e.g., PCL, poly (L-lactic acid) (PLLA), poly(lactic-co-glycolic acid), etc.) 
and natural polymers (e.g., polysaccharides, proteins, polyesters, etc.) have been used to produce 
electrospun nanofiber patches. Among the natural polymers, collagen nanofibrous matrices have 
been prepared and used in preclinical models demonstrating their superior improvement of the 
healing process.309 Microscopic examination revealed that early-stage healing in the group 
treated with these fibers was faster than these obtained for the control group. Also silk fibroin 
nanomatrices have demonstrated to accelerate re-epithelialization and wound closure in burns310 
and collagen/chitosan composite membranes have promoted wound healing and induced cell 
migration and proliferation.311 In this sense, amoxicillin grafted onto regenerated bacterial 
cellulose sponges312 and hyaluronan/silver nanocomposites313 were also able to stimulate wound 
healing and reduce inflammation in different murine in vivo wound models. 
However, the biodegradation rate and the relatively low mechanical strength displayed by 
natural polymers restrict their application as wound dressings despite of their reduced immune 
response and associated toxicity.314 For example, edible films developed from fruit and 
vegetable residue flour were reported to have a maximum tensile strength as low as 0.084 
MPa.315 Polyvinil acetate/chitosan/starch patches degradation in the first 7 days is reported to 
be in the range 15-30%.316 Among the synthetic polymers, fibrous polyurethane membranes 
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were evaluated as wound dressings and found to show oxygen permeability, controlled water 
evaporation while promoting fluid drainage.317 Other synthetic polymers have been used to 
produce electrospun wound dressings, among them poly(lactic acid-co-glycolic acid) was found 
to produce patches with appropriate mechanical strength (tensile modulus from 39.23 ± 8.15 to 
79.21 ± 13.71 MPa) and porosity (38 to 60 %).318  PCL, a hydrophobic polyester polymer, has 
been widely used to prepare electrospun wound dressings because of its biodegradability, 
biocompatibility, chemical and thermal stability and good mechanical properties.319 
Furthermore, multicoated electrospun PCL/gelatin/nanosilver membranes have been recently 
shown as efficient antibacterial dressings in vivo by protecting wounds and promoting 
healing.320 Since bacterial infection is the most serious complication which might affect the 
wound healing process and can lead to impaired wound healing and increased morbidity and 
mortality,321 it is necessary to add antimicrobial agents to the wound dressing materials. 
However, it is also necessary to demonstrate that those advanced dressings are more effective 
than simple conventional dressings in clinical settings for the treatment of infected wounds. The 
electrospinning process allows the production in one step of drug loaded patches with the ability 
of providing a sustained release in the management of wound-associated infections. 
The evolution of antimicrobial resistant pathogens that are refractory to the antibiotics of 
last resort represents a global public health challenge.322 Wound dressings containing natural 
products with long-term antimicrobial activity are considered as potential alternatives as cost-
effective materials in combating antimicrobial resistance.323 In the last years, an increased 
number of publications on electrospun patches loaded with essential oils has been reported.324 
A considerable number of these studies used pure bioactive compounds obtained from essential 
oils such as carvacrol and thymol (THY).325–329  
Wound in mice infected with S. aureus, were also treated with poly(lactic-co-glycolic 
acid)/chitosan nanofiber wound dressings.330 Dressings containing hydroxypropyltrimethyl 
ammonium chloride were able to reduce the wound sizes by 21.8 % after 3 days and by 100 % 
after 15 days. Electrospun curcumin-loaded PCL-polyethylene glycol fibers have shown an 
efficiency on S. aureus inhibition of 95 % after 12 h treatment having also anti-inflammatory 
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V.2. Objective 
Previous chapters demonstrated the antimicrobial and anti-inflammatory potential of THY 
loaded into electrospun PCL nanofibers using in vitro models. This chapter analyzes the in vivo 
efficacy of the THY loaded PCL nanostructured fibrous patches in a full-thickness excision 
wound model in eight to ten-week-old male SKH1 hairless mice. Wounds were infected using 
a S. aureus (ATCC 25923) strain and the infection progression was measured at 1,2,3 and 7 
days post-infection (dpi). In addition, histopathological and immunohistochemical studies were 
carried out in post-mortem wounds. Herein it was evaluated the bactericidal efficiency of the 
prepared patches (PCL-THY group) in an in vivo model of infected wounds and compared to 
unloaded fibers (PCL group), free thymol (THY group) and free chlorhexidine (CLXD group) 
as disinfectant and antiseptic model widely used on the skin. Also, fibers morphology was 
analyzed by SEM, whereas THY loading and release from fibers were also studied to determine 
the appropriate amount of patches to be applied on wounds. Mechanical properties of THY 
loaded PCL nanofibers were studied in order to confirm the potential applicability of the 
material as wound dressing.  
V.3. Experimental  
PCL-THY patches were synthetized by electrospinning technique and characterized by 
morphology, THY loading and release. Empty and THY-loaded PCL nanofibers were visualized 
by SEM, meanwhile drug loading and release were determined by GC-MS and UPLC liquid 
chromatography, respectively. To better compare with skin properties, it was studied the 
strength and elasticity of PCL and PCL-THY dressings.  
To study the effect of PCL-THY dressings in an in vivo model of infected wounds, eight 
to ten-week-old male SKH1 hairless mice were used. The schematic procedure of the in vivo 

















Scheme V.I: Schematic representation of the in vivo wound model: 1) Splinting wounds were 
surgically performed with a 8-mm-diameter biopsy punch and the splinting ring sutured around 
the wound; 2) Induction of the infection was achieved by the inoculation of Staphylococcus 
aureus (107 colony forming units (CFU)); 3) Wound treatment was carried out by adding the 
different synthesized patches and covering the wounds. 
The infection progression was analyzed in wounds at 1, 2, 3 and 7 dpi through a semi-
quantitative analysis of microbiological cultures and quantitative polymerase chain reaction 
(qPCR). Euthanasia was carried out by CO2 inhalation after 3 and 7 dpi. At these time points, 
histological samples were collected and Gram stain was carried out for bacteria determination 
in the tissues. Moreover, tissue sections were stained with hematoxylin and eosin (HE) for 
histopathological analysis and an immunohistochemical evaluation was performed by using 
rabbit polyclonal CD31 antibody to further assess wound angiogenesis.  
The characterization techniques, and the analyses of infection, inflammation and 
regeneration are described in Appendix I.  
V.4. Results and discussion 
V.4.1. Electrospun PCL nanofibers characterization  
The morphology of PCL and PCL-THY nanofibers was characterized by SEM (Figure 
V.1). The mean diameter of unloaded fibers (266 ± 73 nm) showed no significant changes when 
THY was incorporated to the spinning solution (299 ± 71 nm).  
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Figure V.1: SEM images of A) PCL nanofibers and B) PCL-THY nanofibers used for 
mice wound treatment. 
Electrospun nanofibers can act as drug delivery systems that exhibit sustained drug release 
profiles, leading to a potential reduction in the frequency of the treatments when topical 
applications are envisaged. Besides, it is known that the electrospinning technique allows high 
loading capacities.331 A THY load of 14.92 ± 1.31 % w/w was achieved by incorporation of the 
THY to the electrospinning solution, which corresponds to an encapsulation efficiency of 
74.62%, similar to previously reported papers with EOs encapsulated in PCL electrospun 
fibers.190,247  
The in vitro release of THY from the PCL nanofibers shows an initial burst release 
observed in the first minutes. It may be related to the EO compound present on the external 
surface of the fibers.332 This initial release was followed by a controlled release over 8 h and 
only 8.81 % of the loaded THY was released during this time.333 Drug release from nanofibers 
could be caused by its desorption from the fibers surface, diffusion from the pores or matrix 
degradation.334 The observed burst release would be attributed to the desorption from the 
surface.  
V.4.2. Mechanical properties of PCL-THY patches 
Since the wound dressing materials being wrapped on the wound area are likely to be 
subjected to pulling forces in order to adhere the patch smoothly and effectively to the skin, they 
are expected to have similar mechanical strength and elasticity than normal human skin. Tensile 
strength of human skin is in the range 2-16 MPa and its elongation-at-break in the 70-77 % 
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range.335 One of the significant features of PCL for biomedical application is its high elongation-
at-break,336 in our case, the measured value of 108.6 ± 11.3 % is much higher than the one of 
the human skin. The tensile strength retrieved of 5.1 ± 0.5 MPa would be also in the required 
range for wound dressing applications. This value decreased to 3.0 ± 0.5 MPa with the addition 
of THY, but it is still in the appropriate applicability range. Similar results were obtained from 
the elongation-at-break of THY loaded PCL fibers, the value was reduced to 74.4 ± 9.5 %. It is 
known that the mechanical properties of pure polymers can be varied by incorporating bioactive 
compounds. PCL molecular chains are likely to be more uneven and disordered due to the 
presence of THY, resulting in reduced mechanical properties.337 However, the mechanical 
properties of the THY loaded PCL mats here reported are mechanically appropriate for wound 
dressing applications. 
V.4.3. In vivo bactericidal activity 
Both, acute and chronic infections are severe complications worldwide that delay and 
complicate wound healing. If the host defense is no capable of overcoming the bacterial burden, 
an infection takes place, causing delayed wound healing, inflammation and tissue damage.338 
Since extensive abuse of antibiotics in wound care has led to new pathogens occurrence and the 
prevalence of multi-resistant bacteria, the use of natural components as antimicrobial and 
antiseptic agents is steadily growing.  
In vivo wound infection model in SKH1 mice and treatment with the electrospun patches 
(PCL and PCL-THY groups), free THY and an antiseptic model CLXD was developed as 
Scheme V.1 indicates. Twelve mm-diameter disks were evaluated with the necessary weight to 
reach the minimum bactericidal concentration (MBC) value found previously by the group in in 
vitro assays on S. aureus (ATCC 25923) (30 mg of patch containing 4.48 mg of THY).247  
None of the animals presented changes in bahavior or showed any signs of physical 
disconfort, but a purulent secretion was observed in the PCL group as can be seen in the visual 
evolution photographically recorded at 7 dpi (Figure V.2.A). Microbiological swab analysis 
results are shown as insets in Figure V.1.A. Animals treated with unloaded fibers (PCL group) 
presented massive bacterial growth at any time analyzed. After one day post-surgery and 
infection, the application of a single dose of CLXD seemed to be the most effective treatment 
since no growth was observed from the collected swabs while mild bacterial growth was 
detected in wounds treated in PCL-THY group. On the other hand, free THY was less effective 
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and a moderate bacterial growth was observed. After 2 days, results were similar except for the 
CLXD group that showed the presence of a mild bacterial growth. In the third day a decrease in 
the media of colonies counted was observed for the THY group. After this time, no treatment 
was applied to the wounds and, as a consequence, massive bacterial growth was observed in the 
THY group. PCL-THY and CLXD groups showed a moderate bacterial growth; however, no 
massive growth was found. These high loadings, even observed for the commonly used 
commercially available CLXD used at the clinical concentration available, may be attributed to 
the enormous bacterial challenge that was used (4 x 108 CFU/mL). 
Quantitative PCR analyses of post-mortem skin samples (Figure V.2.b) indicated that, 
after three days of treatment, PCL-THY and CLXD groups showed at least two log-reduction 
in the number of S. aureus (ATCC 25923) strain copies. These results would indicate that THY 
loaded PCL fibers act as inhibitors of this bacterial strain growth being as efficient as the model 
antiseptic used CLXD. However, our previous studies showed the in vitro detrimental effects of 
CLXD treatment in different human cell cultures, resulting in cell viability percentages lower 
than 70 % at the lowest concentration tested (4 µg/mL) which were dramatically decreased to 
20 % from 15 µg/mL. On the other hand, THY treatment did not show cytotoxic effects 
(viability ≥ 70 %) in these cell lines up to concentrations higher than 60 µg/mL. These results 





























Figure V.2: In vivo wound infection model in SKH1 mice and treatment with the electrospun 
patches (PCL and PCL-THY groups), free THY and the model antiseptic CLXD: A) Wounds 
evolution at 1, 2, 3 and 7 dpi with S. aureus (ATCC 25923). Microbiological results in 
experimental and control groups are showed as insets. NG No growth; (+) Mild bacterial growth; 
(++) Moderate bacterial growth; (+++) Massive bacterial growth. Scale bar is the same for all 
wounds in the figure. B) Microbiological qPCR results in experimental and control groups. 
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V.4.4. Histopathological and immunohistochemical studies 
Histopathological and immunohistochemical studies of treated wounds were carried out 
to evaluate the effects of PCL-THY patches related to infection, angiogenesis, and tissue 
regeneration (Figures V.3-5). The most important lesions were observed for the PCL group 
(Figure V.3.A), consisted on severe diffuse necrotizing dermatitis in the wound area that was 
characterized by massive infiltrations of inflammatory cells (lymphocytes and macrophages) 
together with severe tissue necrosis around muscle fibers. Inflammatory reaction affected all 
layers of the skin, reaching the adipose tissue (panniculitis). Throughout the skin layers but 
mostly on the surface, abundant colonies of coccoid bacteria were observed, pointed with arrows 
in Figure V.3.A. The PCL-THY group showed wounds that were almost free of inflammation 
reaction, with only a few layers of coagulative necrosis on the surface of the exposed area of the 
wounds (Figure V.3.B). The THY group showed a less intense, multifocal inflammatory 
reaction in the panniculus when compared to the inflammation caused in the PCL group (Figure 
V.3.C). Finally, the CLXD group also showed absence of inflammatory reaction but a much 
thicker layer of coagulative necrosis on the exposed surface of the wound (Figure V.3.D), which 
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Figure V.3: Histological analysis of skin wounds, representative images at 3 dpi. A) PCL group. 
Clusters of coccoid bacteria are observed in the superficial layers (arrows). Inset: Detail of the 
inflammatory reaction, with numerous lymphocytes and macrophages around muscle fibers; B) 
PCL-THY group. Sagittal section of the wound and wound edges (arrowhead). Exposed dermis 
is pointed with asterisk. Inset: Absence of inflammation in another area of the dermis in the 
same animal; C) THY group. Focal, less severe inflammatory reaction in the panniculus. Inset: 
Detail of the deep inflammatory reaction; D) CLXD group. Absence of inflammation in the 
dermis. Exposed dermal surface presents an important superficial layer of coagulative necrosis 
(square bracket). Inset: Detail of another area of the same animal, showing lack of inflammation. 
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Regarding bacteria presence, samples were analyzed using Gram stain. Coccoid bacteria 
were only observed in sections of the PCL and THY groups (Figure V.4). Figure V.4.A shows 
a massive growth of coccoid bacteria in clusters in superficial layers of the skin together with 
severe tissue necrosis in PCL samples. Figure V.4.B shows growth of coccoid bacteria within a 
hair follicle in THY samples.  PCL-THY and CLXD groups are not represented due to the lack 













Figure V.4: Detection of bacteria in skin wounds. Representative images of PCL and THY 
groups after 3 dpi. PCL-THY and CLXD groups are not represented due to the lack of bacteria. 
A) PCL group. Massive growth of coccoid bacteria in clusters in superficial layers of the skin 
together with severe tissue necrosis. Inset: Detail of the bacteria in the same animal. B) THY 
group. Growth of coccoid bacteria within a hair follicle. Inset: Detail of the bacteria. Gram 
staining, 20x, insets at 60x. 
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Finally, the semi-quantitative analysis of angiogenesis performed with rabbit polyclonal 
CD31 antibody showed a homogeneous increase in the number of blood vessels at 7 dpi 
compared with samples at 3 dpi, similar for all infected groups (Figure V.5). 
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Figure V.5: Location of blood vessels in skin wound samples, representative images at 3 and 7 
dpi. All groups showed an increased number of blood vessels at 7 dpi compared with samples 
at 3 dpi. Immunohistochemitry for CD31, 20x. 
A large amount of reports and experimental evidence sustain the beneficial properties of 
essential oil compounds on promoting wound healing.339 For example, electrospun patches 
based on PCL, PLA, and 50/50 hybrid composites were loaded with THY and their effects 
evaluated in an in vivo rat wound model by Karami et al.340 Their findings pointed to a 
significant better performance of the PLA/PCL hybrid membranes loading THY at the end of 
the experiments (14 days of treatment) regarding granulation tissue formation and re-
epithelialization compared to commercial dressings and gauze bandages. In this sense, THY 
enriched collagen hydrogels341 and bacterial cellulose hydrogels102 were previously reported as 
novel and efficient composite dressing mats in the in vivo healing of different rat models. 
Collagen-based films loading THY (1.2 mg of THY per dressing) clearly reduced inflammation 
and enhanced regeneration in surgical 8-mm wounds in a rat model after 7 days of treatment, 
highlighting the presence of mature granulation tissue due to the presence of well-formed and 
dilated vessels.341 On the other hand, the in vivo effects of THY loaded bacterial cellulose 
hydrogels as dressings in a burn wound model also showed a decreased inflammatory reaction 
in the groups treated with the hydrogels loading THY compared to control groups after treatment 
for 15 days.102 Both studies pointed to the potential stimulation of skin regeneration through the 
formation of granulation tissue due to the proliferative effects of THY in fibroblast and enhanced 
collagen deposition.   
Adicionally, some studies confirm the benefits of nanostructured materials compared with 
commercially available wound dressings. For example, the antimicrobial peptide Tet213 
immobilized onto a substrate of alginate, hyaluronic acid and collagen nanostructured composite 
presents a better wound closure rate when compared with commercial Aquacel Ag wound 
dressing after 7 days since wound infection. Also, bacterial presence in wound was lower when 
treated with this composite material when compared with Aquacel Ag-treated wounds after 3 
days.342 Another study shows the potential use of electrospun nanofibers based on honey, 
polyvinyl alcohol and chitosan, enriched with the aqueous extracts of Cleome droserifolia and 
Allium sativum as antimicrobial wound dressings. Results show a superior in vitro antibacterial 
activity against S. aureus of the synthetized nanofibers compared with commercial Aquacel Ag. 
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This study also shows a faster wound closure when using the synthetized nanofibers compared 
to the timing needed to reach closure with Aquacel Ag treated on infected wounds.343 
V.5. Conclusion 
Tensile strength and elongation at break of PCL-THY patches make them appropriate for 
wound dressing applications. In vivo tests to evaluate the antimicrobial action of the patches 
showed that animals treated with unloaded fibers presented massive growth at any time 
analyzed. On the contrary, one day post-surgery and infection, few colonies were detected in 
wounds treated with THY loaded patches while a high number of colonies appeared in wounds 
treated with free THY, showing the importance of drug encapsulation and the need of contact 
between bacteria and the patch to generate a superior antimicrobial action. After treatment 
discontinuation, massive bacterial growth was observed in the THY group while for PCL-THY 
and CLXD treated wound no massive growths were found.  
Histopathological and immunohistochemical studies of wounds showed severe diffuse 
necrotizing dermatitis in the wound area that was characterized by massive infiltrations of 
inflammatory cells and severe tissue necrosis in the PCL treated wounds. In addition, massive 
growths of coccoid bacteria were observed in these tissues. The PCL-THY treated wounds were 
almost free of inflammatory reaction, with only a few layers of coagulative necrosis on the 
surface of the exposed area of the wounds. In comparison, CLXD treated wounds showed a 
much thicker layer of coagulative necrosis in the exposed surface of the wound. These results 
show that PCL-THY mats are able to control bacterial infection as efficiently as the model 
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VI. General conclusions 
The main goal of the thesis was to design a bioactive dressing loading natural compounds 
with anti-inflammatory and antimicrobial properties for wound healing treatment. Considering 
this scenario, the most relevant conclusions obtained during this thesis are summarized:  
• Among the natural compounds studied, CAR, CIN and THY showed the highest in vitro 
bactericidal properties against a Gram-positive model, S. aureus and a Gram-negative 
model, E. coli. According to SEM images, flow cytometry and confocal microscopy, 
plant-derived natural compounds exhibited antimicrobial activities associated with 
membrane disruption. In addition, THY demonstrated to be one of the most efficient 
compounds by the elimination of bacterial growth using low concentrations. CAR, CIN 
and THY also demonstrated their antimicrobial activity by inhibiting bacterial growth in 
preformed biofilms and during biofilm formation. When these compounds are combined, 
only CAR and THY showed an additive effect, while CIN had no interaction with the 
other compounds. Likewise, no antagonism between compounds has been found. 
• Thymol and carvacrol, not only showed antimicrobial activity, but also demonstrated 
lower cytotoxicity (0.06 mg/mL) than chlorhexidine (< 0.004 mg/mL) in an in vitro 
metabolic assay in cell lines related to wound healing (fibroblasts, keratinocytes and 
macrophages). That fact provides an advantage to EOs in comparison with a compound 
used in the clinical practice.   
• THY-loaded PCL patches demonstrated to reduce cGFP-expressing S. aureus growth in 
an in vitro counting assay. Moreover, confocal images demonstrated that the higher 
concentration of THY, the lower bacterial adhesion to surfaces and thus, the lower biofilm 
formation observed. PCL-THY patches showed cytotoxicity against J774 macrophages in 
a dose dependent manner, but at reduced doses and during short contact times, cell 
viability was similar to untreated controls. The antimicrobial activity of designed 
dressings was also observed inhibiting bacterial growth in an in vitro infective model of 
J774 macrophages with cGFP-expressing S. aureus. Thus, the developed patches were 
efficient reducing bacteria levels comparing to non-loaded PCL patches. 
• Among the studied free natural compounds, CIN, B-CAR and CUR showed high 
cytotoxicity against J774 murine macrophages in vitro, meanwhile CAR, THY, SQU and 
TYR demonstrated higher cell viability. Among them, CAR, THY and TYR reduced the 
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expression of pro-inflammatory cytokines (Il-1b and iNos) to DEX control levels in an in 
vitro inflammatory model based on LPS-activated J774 murine macrophages. When these 
compounds were encapsulated into PCL patches, PCL-CAR demonstrated a high 
cytotoxicity against J774 macrophages. However, PCL-THY pointed to be the most 
successful inhibiting the expression of the pro-inflammatory molecules, and the 
combination between THY and TYR or THY and SQU did not reduce the expression of 
Il1b and iNos in an efficient way. By an immunofluorescence assay, PCL-THY reduced 
cell size to levels similar to DEX treated cells, a clinical anti-inflammatory drug, 
demonstrating its anti-inflammatory potential. Moreover, J774 macrophages remained 
attached to the well and do not migrate into PCL-patches, highlighting their potential as 
wound dressings.  
•  PCL-THY patches demonstrated to reduce bacterial growth in vivo in infected wounds in 
SKH1 mice. The results obtained in the evaluation of infection in wounds treated with 
PCL-THY are comparable to those obtained after chlorhexidine treatment, highlighting 
the antimicrobial potential of the designed patches. In addition, when PCL-THY treated 
wounds are compared with those treated with free THY, a lower bacteria concentration 
was obtained when patches are used, which demonstrates the advantage in the 
encapsulation of THY. When tissue samples are stained with Gram stain, bacteria can be 
only observed in PCL and free THY treated samples.  
• Regarding histopathological studies, free chlorhexidine treated wounds showed an 
important superficial layer of coagulative necrosis, which it is not observed when wounds 
are treated with PCL-THY. Immunohistochemical analysis of tissue sections with CD31 
polyclonal antibody showed an increase in the number of blood vessels at 7 dpi, that was 
similar for all infected groups.  
The present thesis demonstrates that THY loaded PCL nanofibers hold great promise for 
wound healing, due to the ability to control two essential mechanisms in wound repair: fighting 
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VI. Conclusiones generales 
El objetivo principal de la tesis doctoral se centra en el diseño de un apósito bioactivo con 
capacidad de liberar compuestos naturales que poseen propiedades anti-inflamatorias y 
antimicrobianas esenciales para el tratamiento de heridas. Con este objetivo, se han obtenido 
unos resultados que nos permiten exponer las siguientes conclusiones:   
• Los compuestos naturales derivados de plantas contienen propiedades antimicrobianas 
relacionadas con daño en la membrana celular. Entre los estudiados, CAR, CIN y THY, 
muestraron mayor capacidad bactericida cuando se ponen en contacto con una cepa 
Gram-positiva como S. aureus y una Gram-negativa como E. coli. Además, el timol 
demostró controlar el crecimiento bacteriano a menores concentraciones que el resto de 
los compuestos. CAR, CIN y THY demostraron su poder antimicrobiano inhibiendo el 
crecimiento bacteriano tanto en biofilms formados, como en el propio proceso de 
formación. Cuando estos compuestos se combinaron entre sí, solamente CAR y THY 
mostraron un efecto aditivo, mientras que el CIN no mostró interacción con ningún otro 
compuesto. Del mismo modo, no se ha encontrado antagonismo entre los diferentes 
compuestos. 
• El THY y CAR además de mostrar actividad antimicrobiana, demostraron ser menos 
citotóxicos (0.06 mg/mL) que la clorhexidina (<0.004 mg/mL) en un modelo de 
viabilidad in vitro en fibroblastos, queratinocitos y macrófagos. Este hecho proporciona 
cierta ventaja a los aceites naturales en comparación con un producto utilizado 
actualmente para desinfectar heridas.  
• Los apósitos de PCL-THY inhibieron el crecimiento de la cepa S. aureus con expresión 
de cGFP en un ensayo cuantitativo in vitro. Además, las imágenes de microscopía 
confocal demostraron que cuanto mayor es la concentración de THY, menor es la 
adhesión bacteriana a superficies y con ello, menor es la formación de biofilm. Los 
apósitos de PCL-THY mostraron cierta citotoxicidad en macrófagos J774 de forma 
dosis-dependiente. En cambio, concentraciones menores de THY en contacto con las 
células durante tiempos cortos, aumentaron la viabilidad celular hasta niveles del 
control. La actividad antimicrobiana de los apósitos diseñados fue demostrada 
inhibiendo el crecimiento bacteriano en un modelo de infección in vitro de macrófagos 
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de PCL-THY reducen de forma eficiente la carga bacteriana en comparación con los 
apósitos de PCL.  
• Entre los compuestos estudiados, el CIN, B-CAR and CUR mostraron una alta 
citotoxicidad en macrófagos murinos J774, mientras que el CAR, THY, SQU y TYR 
mostraron una viabilidad celular mayor. Entre estos, CAR, THY y TYR tienen la 
capacidad de reducir la expresión de citoquinas pro-inflamatorias (Il1b y iNos) hasta 
niveles del control de DEX en un modelo inflamatorio in vitro basado en macrófagos 
J774 activados con LPS. Cuando estos compuestos son encapsulados en membranas de 
PCL, el apósito de PCL-CAR demostró una alta citotoxicidad en J774. En cambio, el 
PCL-THY fue el apósito que mejor inhibió la expresión de moléculas pro-inflamatorias, 
y la combinación entre el THY con SQU o TYR no redujeron la expresión de Il1b o iNos 
de forma eficiente. A través de un ensayo de inmunofluorescencia, el PCL-THY redujo 
el tamaño celular a niveles de las células tratadas con DEX, un compuesto anti-
inflamatorio utilizado en la clínica. Esto demostró el potencial anti-inflamatorio de los 
apósitos diseñados. En un ensayo de migración los apósitos de PCL o PCL-THY no 
favorecen la migración celular hacia los mismos, destacando su posible aplicación como 
apósitos de heridas.   
• Los apósitos de PCL-THY reducen el crecimiento bacteriano en un modelo in vivo de 
herida infectada en ratones SKH1 de una forma similar a la que lo hacen las heridas 
tratadas con clorhexidina. Además, cuando el tratamiento de PCL-THY se compara con 
el tratamiento con THY libre, se observa una disminución de la carga bacteriana cuando 
se utilizan los apósitos, remarcando la ventaja de encapsular el compuesto para conseguir 
una liberación sostenida en el tiempo. Cuando las muestras histológicas se tiñen con la 
tinción Gram, solamente se observaron bacterias en las muestras tratadas con PCL y con 
THY libre. 
• Con relación a los estudios histopatológicos, las heridas tratadas con clorhexidina 
mostraron una necrosis coagulativa en capas superficiales de la herida en muestras 
histológicas, hecho que no se observó en las heridas tratadas con PCL-THY. Las 
muestras analizadas con un anticuerpo policlonal CD31 demostraron un aumento del 
número de vasos a los 7 dpi en comparación con 3dpi. En cambio, no hubo diferencias 
entre los grupos de tratamiento. 
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La tesis doctoral demuestra que los apósitos de PCL-THY son prometedores para el tratamiento 
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AI.1. Materials 
Carvacrol (CAR; food grade, ≥ 98%), cinnamaldehyde (CIN; > 98%), thymol (THY; 
99%), squalene (SQU; ≥ 98%), tyrosol (TYR; 98%), rosmarinic acid, β-caryophyllene (B-CAR; 
> 98%), curcumin (CUR), Tween® 80, polycaprolactone (PCL; Mn = 80,000 Da), (S)- (-)-
limonene (food grade, ≥ 95%), naproxen sodium salt (98–102%) and phosphate buffered saline 
(PBS) were purchased from Sigma-Aldrich (MO, USA). Eugenol (EUG) was supplied by Acros 
Organics (Geel, Belgium). Dichloromethane (DCM, > 99%) and N,N-dimethilformamide 
(DMF, >99%) were purchased from Fisher Scientific (Hampton, USA). Acetonitrile (≥ 99.9%), 
acetone (HPLC grade) and formic acid (98–100%) were purchased from VWR (Oud-Heverlee, 
Belgium). Dimethyl sulfoxide (DMSO) was purchased from Merck Millipore (Darmstadt, 
Germany).  
Escherichia coli (E. coli) S17 was kindly gifted by Dr. J. A. Aínsa (Department of 
Microbiology, Preventive Medicine, and Public Health, University of Zaragoza, Spain). 
Staphylococcus aureus (S. aureus; ATCC 25923) was purchased from Ielab (Alicante, Spain), 
the methicillin sensitive S. aureus Newman strain expressing the coral green fluorescent protein 
(cGFP) from the vector pCN47 was kindly donated by Dr. Cristina Prat (Institut d'Investigació 
en Ciències de la Salut Germans Trias i Pujol, Badalona, Spain). Calcofluor White Stain, 
CellCrown™ inserts (24-well plate inserts), erytromycin and propidium iodide were purchased 
from Sigma-Aldrich (St. Louis, MO, USA), Tryptone soy broth (TSB) and agar (TSA) were 
obtained from Conda-Pronadisa (Madrid, Spain). Chlorhexidine gluconate 1% was purchased 
from Salvat (Barcelona, Spain). The Live/Dead®BacLight™ bacterial viability kit was 
purchased from Fisher Scientific (Hampton, USA).  
Regarding cell lines, human dermal fibroblasts were purchased from Lonza (Bornem, 
Belgium), and THP1 human monocytes (ATCC TIB-202) from LGC Standards (Barcelona, 
Spain), while human keratinocytes (HaCaT) were kindly gifted by Dr Pilar Martín-Duque. 
J774A.1 macrophage cells (ATCC® TIB-67™) were purchased from LGC (Barcelona, Spain). 
Phorbol 12-myristate 13-acetate (PMA), Bovine Serum Albumin (BSA) and lipopolysaccharide 
(LPS) were purchased from Sigma-Aldrich (St. Louis, MO, USA). High-glucose Dulbecco’s 
Modified Eagle’s Medium (DMEM) was purchased from HyClone (South Logon, USA) and 
Biowest (Cedex, France), RPMI 1640 w/stable glutamine, and antibiotic-antimycotic (60 g/mL 
penicillin, 100 g/mL streptomycin and 0.25 g/mL amphotericin B) were supplied by Biowest 
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(Cedex, France). Cell culture reagents, such as fetal bovine serum (FBS), HEPES, non-essential 
amino acids, 2-mercaptoethanol 50 mM and sodium pyruvate 100 mM, were obtained from 
Gibco (Manchester, UK) and Biowest (Cedex, France), and the Blue Cell Viability assay from 
Abnova (Aachen, Germany). MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium 
bromide), Alexa Fluor™ 488 Conjugate and TRIzol were purchased from Invitrogen (Madson, 
USA).  
Concerning the molecular biology experiments, RNeasy mini kit was purchased from 
Qiagen (Cologne, Germany). iScript retrotranscription kit was purchased from BioRad 
Laboratories (Irvine, USA). TaqMan® Fast Advanced Master Mix and target probes were 
purchased from Applied Biosystems (Beverly, USA). Paraformaldehyde 3% with 0.1 M 
cacodylate buffer was purchased from Electron Microscopy Sciences (Hatfield, USA) and 
hexamethyldisilizane was supplied by Fluka Analytical (USA). Paraformaldehyde (PFA) 4% in 
PBS was purchased from Alfa Aesar (Karlsruhe, Germany). Saponin from Quillaja Bark pure 
and SDS for molecular biology were purchased from AppliChem (Darmstadt, Germany). DAPI-
Mowiol and phalloidin 546 were obtained from ThermoFisher Scientific (Massachusetts, USA). 
Regarding the in vivo experiments, eight to ten-week-old male SKH1 hairless mice were 
purchased from Charles River Laboratories (Barcelona, Spain). Sterile 8-mm biopsy punch was 
purchased from Eickemeyer Vererinary Equipment (Tuttlingen, Germany), meanwhile silicone 
wound splints were supplied by Grace Bio-Labs (Bend, USA). 4/0 sutures were purchased from 
Braun (Barcelona, Spain). Adhesive plasters and bandages were obtained from Hartman 
(Mataro, Spain) while the microbiological swabs were purchased from Deltalab (Barcelona, 
Spain).  
AI.2. Synthesis of loaded PCL nanofibers 
AI.2.1. Solutions preparation and characterization  
A solution of PCL (10 w/w %) was prepared in DCM and DMF at 1:1 volume ratio. For 
the preparation of loaded-PCL nanofibers, THY, TYR, SQU, CAR was added to the polymeric 
solution at 20 w/w % (referred to PCL mass). The mixture was stirred for 30 min before the 
electrospinning process. 
Viscosity and conductivity of PCL solutions with and without natural compounds were 
measured. The relative viscosity of solutions was measured at 25 °C using a Visco Basic Plus 
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viscometer (Visco Basic, Spain). On the other hand, the conductivity was measured with a 
multimeter MM41-Criston (Hach Lange, Spain). 
AI.2.2. Electrospinning process 
Chapter III develops the antimicrobial activity of PCL-THY patches, which were 
synthetized following this methodology: An Yflow 2.2 D500 electrospinner equipped with a 
rotating drum collector (100 rpm) was used to obtain bare and PCL-THY patches. The collection 
drum was covered with aluminum foil to facilitate the recovery of the electrospun nanofibers. 
PCL and PCL-THY solutions were electrospun through a 22-gauge needle with a syringe pump 
working at 1.0 mL/h flow rate. The distance from the tip of the needle to the collector was 18 
cm. The voltage applied to the collector plate was -7 kV and the voltage applied to the needle 
was +10 kV with the aim of obtaining a stable Taylor cone. Homogeneous patches of bare and 
THY-loaded PCL nanofibers were obtained after 8h of electrospinning. 
To develop Chapter IV, different types of PCL synthesis were carried out loading anti-
inflammatory EOs. Patches fabrication was carried out by Mr. Enrique Gámez-Herrera and the 
protocol has been recently published.134 Synthesis of one compound- loaded PCL patches (PCL-
THY; TYR; CAR; SQU) was carried out following synthesis described in Chapter III. However, 
for two compounds-loaded PCL patches (PCL-THY-TYR and PCL-THY-SQU), two parallel 
syringes were used containing 20% w/w EO/PCL solution and a rotating drum collector to 
assure a homogeneous distribution. Flow rate was set at 1.0 mL/h and the distance between tips 
of the needles and the collector was 18 cm. Voltage applied to the collector was – 4.00 kV and 
needles were fixed from + 6.62 to + 10.22 with the aim of obtaining a stable Taylor cone.  
In Chapter V, in vivo experiments were carried out using PCL-THY patches synthetized 
by Mr. Enrique Gámez-Herrera and the procedure was already published.247 Synthesis follows 
the same methodology that those described in Chapter III and Chapter IV for PCL-THY with 
one difference; instead using a rotating drum collector, it was used a flat collector to achieve a 
higher thickness.  
AI.3. Characterization of electrospun nanofibers 
AI.3.1. Morphology  
To perform a morphological characterization of synthetized nanofibers, samples were 
coated with a 5 nm Au/Pd layer. Following sputter coating, images were acquired with an 
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Inspect F50 SEM microscope instrument equipped with an ETD (SE) detector and operating at 
an accelerating voltage of 10-15 keV. ImageJ software (Version 1.48f, NIG, USA) was used to 
measure nanofiber diameters (N=100).  
AI.3.2. Water uptake  
The water uptake ability of the prepared patches was measured after immersing the 
samples in purified water at room temperature for 24 h. The excess of liquid was then drained 
from the surface to get the final weight (wt). The water absorption (S) was calculated with the 
following equation, where wi is the mat initial weight:  
𝑆𝑆 (%) =  
𝑊𝑊𝑡𝑡 −  𝑊𝑊𝑖𝑖
𝑊𝑊𝑖𝑖
 𝑥𝑥 100 
AI.3.3. Patches porosity  
The porosity of the synthesized patches was determined by mercury intrusion porosimetry 
(Micromeritics' AutoPore IV 9500 Series, USA).  
AI.3.4. Mechanical properties  
The mechanical properties of the mats were tested using an Instron Microtester 5548 and 
a video extensometer laser without contact (Instron 2663-281). Stress-strain curves were 
recorded at a stretching speed of 1 mm/min. The dimensions of the tested probes were in 
agreement with the ISO  527-1:2012 norm (Plastics — Determination of tensile properties). 
AI.3.5. Essential oils loading and encapsulation efficiency 
Loaded compounds masses were evaluated by gas chromatography coupled with mass 
spectrometry (GC–MS) in a Shimadzu 2010SE GC–MS chromatograph equipped with an AOC 
20i injector by using a Zebron ZB-50 capillary column (30 m × 0.25 mm, 0.25 μm thickness; 
Phenomenex, US).247 An initial oven temperature of 50 ºC was kept for 1 min and then it was 
raised at 10 ºC/ min until reaching 160 ºC, and then a second heating rate of 20 ºC/min was used 
until reaching 200 ºC. Helium was used as carrier gas at 1mL/min. The detector temperature 
was 250 ºC and the transfer line and ion source, were set at 200 ºC. One µL of each sample was 
injected for the chromatographic analysis. 
The calibration curves were prepared using 2.5 to 30 ppm and 5 ppm of (S)-(-)-limonene 
as internal standard. For sample preparation, 10 mg of nanofiber patches were dissolved in 
DCM:acetonitrile (1:1; 10 mL). The sample was diluted, and 5 ppm of the internal standard was 
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added. The EO compounds’ encapsulation efficiency (EE) and drug loading (DL) were 
calculated considering the theoretical load (wt), the measured load (we), and the weight of the 
nanofibers (wn) using the following equations: 
EE (%) = 𝑊𝑊𝑒𝑒
𝑊𝑊𝑡𝑡
 𝑥𝑥 100   DL (%) = 𝑊𝑊𝑒𝑒
𝑊𝑊𝑛𝑛
 𝑥𝑥 100 
 
AI.3.6. Release of natural compounds  
To study THY release of PCL-THY patches in Chapter III, an IKA® KS 130 orbital 
shaker was used. Ten mg of PCL-THY patches were immersed in 4 mL of PBS and kept at 37ºC 
under stirring (150 rpm). At different time points up to 24h, the supernatant was analyzed with 
in an Acquity UPLC® Waters liquid chromatography system and Waters® Empower™ 
chromatographic software (Waters, US). An Acquity UPLC® Waters BEH C18 column (2.1 x 
50 mm, 1.7 µm particle diameter) was employed for the analysis of THY. In the determination, 
25 ppm of naproxen was included as internal standard. 
For Chapters IV and V, EOs release was evaluated by Mr. Enrique Gámez-Herrera and 
previously described.134 It was used a Shimadzu LC-10AT VP syringe pump. Here, samples 
were put into the syringe and rinsed with PBS (2% w/v Tween 80) at 37 °C with a flow rate of 
1 mL/ min. Samples were collected at different time intervals up to 8 h and analyzed in an 
Acquity UPLC® Waters liquid chromatography system and Waters® EmpowerTM 
chromatographic software.247 An Acquity UPLC® Waters BEH C18 column (2.1 × 50 mm, 1.7 
μm particle diameter) was employed for the analysis of CAR and THY, whereas SQU, TYR, 
THY-SQU and THY-TYR were analyzed by a Phenomenex Kinetex EVO C18 column (2.1 × 
100 mm, 1.7 μm particle diameter; Phenomenex, USA).247  
AI.4. Antimicrobial activity 
AI.4.1. Bacteria culture  
A Gram-negative model E. coli S17 strain exerting resistance to streptomycin344, a Gram-
positive model as S. aureus ATCC 25923, well-known as not a resistant strain and used in 
susceptibility tests345,346, and a methicillin sensitive S. aureus Newman strain expressing the 
coral green fluorescent protein (cGFP) from the vector pCN47, exerting resistance to 
erythromycin, were evaluated. These strains were initially grown overnight in TSB 
supplemented with the corresponding selective antibiotic (streptomycin 100 µg/mL for E. coli 
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and erythromycin 10 µg/mL) for cGFP-expressing S. aureus) at 37 ºC under shaking (150 rpm) 
obtaining, in the stationary growth phase, 108–109 colony forming units (CFU)/mL for the three 
strains used.  
AI.4.2. Preparation of free EOs 
The reduced solubility of plant-derived natural compounds makes necessary the 
introduction of an emulsifier or solvent to favour the contact between bacteria and natural oil 
compounds. In Chapter II, EO compounds were solubilized in culture medium by adding 
Tween® 80 (1.5–2% v/v) and mixing with vortex for 1 min prior to their dilution before the 
bactericidal tests. However, in Chapter III and Chapter V, THY was solubilized in DMSO by 
preparing a stock THY solution of 50 mg/mL and dissolving up to the studied concentration in 
culture medium.  
AI.4.3. MIC and MBC determination  
Inhibitory (MIC) and bactericidal (MBC) concentrations of active EO molecules were 
tested in Chapter II, in two bacteria strains, E. coli and S. aureus, following the broth 
microdilution method.216 Liquid growth medium (TSB) containing an inoculum of 105 CFU/mL 
and concentrations of the EO compounds (0.1–4 mg/mL) were used. EOs were previously 
dissolved in Tween® 80 as Section AI.4.2 explains. Once bacteria suspension reached the 
stationary growth (108–109 CFU/mL), it was further diluted to ~105 CFU/mL and added to 
solutions with different concentrations (0.1–4 mg/mL) of the antimicrobial agents. Then, 
samples were incubated for 24 h at 37 ºC under shaking (150 rpm). After incubation, the treated 
bacterial suspensions were diluted in PBS and spot-plated on TSA plates to count colonies after 
incubation at 37 ºC for 24 h. Positive control (untreated bacteria) and negative control 
(chlorhexidine treated bacteria) samples were also tested. Chlorhexidine was used as model 
antiseptic used in the clinical practice. 
The same broth microdilution methodology was carried out in Chapter III to study the 
antibacterial activity of free thymol (THY; 0.01-0.15 mg/mL added to cGFP-expressing S. 
aureus cultures). However, PCL-THY patches were assayed in agar broth (TSA) according to 
the ASTM E-2180-18 standard test method.268 A positive control (untreated bacteria) was also 
included in both methods. 
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PCL-THY patches were cut, weighted and sterilized using UV light (254 nm wavelength; 
30 min each side). Warm TSA (47 ºC) was inoculated with 105 CFU/mL of cGFP-expressing S. 
aureus. Nanofiber-based patches were placed in 12-well plates and 3 mL of inoculated TSA 
were added to each well. Samples were incubated at 37 ºC for 24 h in a closed box with water 
to keep an adequate humidity. After incubation, each sample was collected with 7 mL of TSB, 
sonicated and vortexed for 1 min. Bacterial suspensions were diluted in PBS and plated on TSA 
to count colonies after 24 h of incubation at 37 ºC. 
AI.4.4. Bacteria morphology 
In Chapter II, bacteria morphology before and after treatment with EO molecules was 
analyzed by SEM as it was previously reported.267 Briefly, logarithmic growth phase E. coli and 
S. aureus bacteria cultures (~105 CFU/mL) were treated with the selected EO compounds at 
MIC and MBC values and incubated overnight at 37 ºC. Following incubation, samples were 
spin-dried at 600 g and washed twice in PBS (0.1 M). Bacteria were fixed in 2.5% 
glutaraldehyde for 90 min and subsequently filtered and dehydrated in ethanol solutions series 
(30, 50, 70, 80, 90, and 100%; twice for 15 min). Finally, samples were air-dried at room 
temperature and covered with a 5 nm Pt layer. SEM micrographs were acquired in a SEM 
Inspect F50 equipment (FEI Co., LMA-INA, Zaragoza, Spain). 
AI.4.5. Bactericidal mechanism  
In order to study the bactericidal mechanism of the different EOs, E. coli and S. aureus 
bacteria samples (107 CFU/mL) were centrifuged at 4400 g for 10 min and resuspended in the 
different compound solutions at MIC and MBC concentrations following the protocols 
previously described.227,267 Control groups (not treated and chlorhexidine treated bacteria) were 
also analyzed. All samples were incubated overnight at 37 ºC. After 25 µg/mL of propidium 
iodide was added, samples were analyzed by flow cytometry in Gallios equipment (Beckman 
Coulter Company, Cell Separation and Cytometry Unit, CIBA, IIS Aragon, Zaragoza, Spain). 
AI.4.6. Confocal microscopy:  
The Live/Dead®BacLight™ bacterial viability kit was used to detect bacteria membrane 
damage. The methodology is based on the double-staining by SYTO9 and propidium iodide as 
indicated by the manufacturer. Bacteria samples incubated at 24 h (107 CFU/mL) and treated 
with the selected EO compounds at MIC, were washed in sterile saline solution and further put 
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in contact with the dye mixture for 15min in the dark at room temperature. Samples were then 
mounted on slides and visualized by confocal microscopy (Leica TCS SP2 Laser Scanning 
Confocal Microscope, Microscopy Unit, CIBA, IIS Aragon, Zaragoza, Spain). Control samples 
were also tested as described above. 
AI.4.7. Synergy studies  
The Broth Dilution Checkerboard test was used to evaluate the interaction among the three 
most promising bactericidal EO molecules determined by the MIC and MBC studies against S. 
aureus. In brief, a solution containing four times the MBC of each compound was prepared. By 
using a MW96 plate and fresh medium, compound A was diluted two-fold in vertical orientation 
and compound B was diluted two-fold in horizontal direction. Then, a bacterial suspension (106 
CFU/mL, 100 µL) was added and the plate was incubated overnight at 37 ºC. After incubation, 
bacteria growth was determined by the resazurin assay. The Fractional Inhibitory Concentration 
Index (FICI) of the combination of compounds A and B was calculated according to the 
following equation: 
𝐹𝐹𝐹𝐹𝐹𝐹𝐹𝐹 = 𝐹𝐹𝐹𝐹𝐹𝐹𝐴𝐴 +  𝐹𝐹𝐹𝐹𝐹𝐹𝐵𝐵 
 
𝐹𝐹𝐹𝐹𝐹𝐹𝐴𝐴 =
𝑀𝑀𝑀𝑀𝑀𝑀𝐴𝐴 𝑖𝑖𝑖𝑖 𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑖𝑖𝑝𝑝𝑝𝑝 𝑜𝑜𝑜𝑜 𝐵𝐵
𝑀𝑀𝑀𝑀𝑀𝑀 𝑜𝑜𝑜𝑜 𝐴𝐴
   and   𝐹𝐹𝐹𝐹𝐹𝐹𝐵𝐵 =




FICI results were classified as synergy (FICI < 0.5), addition (0.5 ≤ FICI ≤ 1), 
indifference (1 < FICI ≤ 4) or antagonism (FICI > 4), as previously described.347 
AI.4.8. Biofilm formation and characterization 
S. aureus was grown overnight in TSB until stationary growth phase was reached. At this 
point, bacteria were adjusted to 107 CFU/mL and added to a MW96 microplate and incubated 
at 37 ºC for 16 h without shaking. After incubation, culture medium was discarded, and biofilms 
were washed twice with PBS. In order to study the biofilm formation two methods were used: 
4.8.1. Calcofluor White Stain (50 mL) was added to each well and incubated 1 min in the 
dark at room temperature. After incubation, the stain was removed and biofilms were 
washed twice with PBS. Samples were air-dried in the dark to be further visualized in an 
inverted fluorescence microscope (Olympus IX81).  
4.8.2. To be analyzed by scanning electron microscopy (SEM): biofilms were grown on 
sterile glass slides by adding a S. aureus (ATCC 25923) planktonic suspension (107 
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CFU/mL) and further incubation at 37 ºC for 16 h without shaking. Then, biofilms were 
washed twice with PBS (0.1 M) and fixed in 2.5% glutaraldehyde for 3 h. Samples were 
dehydrated through a series of ethanol solutions (30, 50, 70, 80, 90 and 100%; 15 min, 
twice). Finally, samples were air-dried at room temperature and coated with 5nm Pt. SEM 
images were acquired in the energy range of 10–15 keV in a SEM Inspect™ F50 (FEI Co., 
Hillsboro, OR, USA).  
 
AI.4.9. Antibiofilm activity measurement 
In Chapter II, the effects of free EOs (0.25–1 mg/mL) were studied in biofilm formation 
and in the disruption of an already formed S. aureus (ATCC 25923) biofilm.  
• The effects of EO molecules eradicating preformed biofilms (section AI.4.8). With a 
formed biofilm, EOs were added and samples were incubated for 24 h at 37 ºC without 
shaking. After incubation, culture medium containing the EO compounds was removed 
and biofilms were disrupted by sonication (15 min, 200 W). Samples were then diluted 
and seeded onto agar plates to count the viable colonies grown after 24 h of incubation 
at 37 ºC. 
• To study the effects of the EOs on biofilm formation, compounds were added to bacterial 
suspensions (107 CFU/mL) in a MW96 microplate and incubated for 16 h at 37 ºC 
without shaking. After incubation, planktonic cells were removed by washing them 
twice with PBS. Biofilm samples were then sonicated as described above and serially 
diluted to be further plated on agar. Viable bacteria (CFU/mL) were counted after 24 h 
of incubation at 37 ºC. 
 
In Chapter III, the effects of PCL-THY patches in biofilm formation are studied using 
µ-dish 35 mm ibiTreat plates and following two different methodologies:  
• In the first methodology, 104 CFU/mL of bacteria were put in contact with 5 and 7 mg 
of PCL-THY patches and incubated for 24 h at 37 ºC.  
• In the second approach, bacteria in exponential phase (104 CFU/mL) were put in contact 
with 10 and 12 mg of PCL-THY patches and incubated for 1 h. Later, patches were 
removed, and culture media was kept at 37 ºC for 24 h.  
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After 24h incubation, both approaches were processed simultaneously; planktonic cells 
were removed, and wells were washed twice with PBS. Biofilm formation was analyzed by 
following two different methods: 
- For confocal microscopy, the biofilm matrix was stained for 1 min with calcofluor white 
and washed with PBS. Next, 2 mL of PFA 4% in PBS were added to each plate for 30 
min. After this incubation time, samples were mounted in Mowiol mounting medium and 
prepared for microscopical visualization. Samples were analyzed under confocal 
microscopy (Confocal Zeiss LSM 880 with airyscan; Microscopy Unit, CIBA, IIS 
Aragon, Zaragoza, Spain).  
- For bacteria quantification, biofilm in PBS was sonicated for 15 min in an ultrasonic water 
bath to ensure its detachment from the bottom of the wells. Later, detached bacteria 
concentrations were tested following the conventional agar microdilution method.216  
In both techniques, THY-free patches (PCL patches) were tested as control samples (not 
treated bacteria). 
AI.5. Cell assays 
AI.5.1 Cytotoxicity metabolism assays  
In Chapter II, human dermal fibroblasts, human epidermal keratinocytes (HaCaT), and 
THP1 human monocytes were used to evaluate the cytotoxic effects of free EOs. Fibroblasts 
and HaCaT were routinely grown in high-glucose DMEM supplemented with 10% FBS and 
antibiotic-antimycotic in a humidified atmosphere at 37 ºC and 5% CO2. Monocytes were 
cultured in RPMI 1640 supplemented with 10% FBS, 1% HEPES, 1% non-essential amino 
acids, 0.1% 2-mercaptoethanol 50 mM, 1% sodium pyruvate 100 mM, and antibiotic-
antimycotic. Macrophages were obtained by the in vitro differentiation of monocytes by adding 
1 µM PMA to the cell culture. For fibroblasts, macrophages and HaCaT cells, cytotoxicity was 
determined by measuring cell metabolism through the Blue Cell Viability assay. Cells were 
seeded on MW96 microplates and incubated with the tested molecules (0.004–0.125 mg/mL) 
for 24 h. Control samples (not treated and chlorhexidine treated) were also analyzed. Then, the 
reagent was added (10%) and cells were incubated for 4 h at 37 ºC. The reduction of the dye by 
metabolically active cells was monitored in a microplate reader at 535/590 nm ex/em 
(Multimode Synergy HT Microplate Reader; Biotek, USA) Cell viability was determined by 
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interpolation of the emission data obtained from the treated samples and the control samples 
(not treated cells, 100% viability). 
Cytotoxicity experiments in Chapter III were carried out using J774 macrophage cells 
(ATCC®TIB-67™). This cell type was cultured following specifications provided by the 
manufacturer using high-glucose DMEM supplemented with 10% fetal bovine serum (FBS, v/v) 
and antibiotic-antymicotic at 37 °C in a humidified atmosphere with 5% CO2. Different weights 
of PCL-THY patches were tested at different time points. First, cells were seeded in 6-well 
plates (48,000 cells/cm2), and 5 and 7 mg of PCL-THY were added to 2 mL of culture medium 
and incubated at 37 ºC, 5% CO2 for 24 h. Concurrently, 10 and 12 mg of PCL-THY were added 
to 2 mL of culture medium and incubated for 1 h. After incubation time, these patches were 
removed, and cells were further incubated at 37 ºC, 5% CO2 for 24h. After incubation, cells 
were washed twice with PBS.  
After cell treatment with the loaded patches following both approaches, the MTT 
cytotoxicity assay for assessing cell metabolic activity was used by preparing a stock solution 
of the tetrazolium dye at 5 mg/mL in PBS. Cells were then incubated with 0.5 mg/ mL of the 
MTT dye for 3 h at 37 ºC. Following the incubation period, medium was removed, and the dye 
was solubilized with a solution containing DMSO (99.4% v/v), SDS (0.1% w/v) and acetic acid 
(0.6% v/v) for 15 min. The dye is reduced forming an insoluble formazan salt when the 
metabolism of cells is active. This salt was dissolved to obtain a purple solution which was 
quantified at OD of 540 nm (Multimode Synergy HT Microplate Reader; Biotek, USA). 
Viability percentages are calculated dividing the calculated OD of treatment samples by the 
calculated OD of positive control samples.  
Cytotoxicity experiments in Chapter IV were carried out using J774A.1 macrophage cells 
seeded into 96-well plates and treated with free natural compounds (0.008; 0.02; 0.04; 0.06; and 
0.12 mg/mL) for 24 h (37 °C and 5% CO2). Using 24-well plates, cells were treated with PCL-
patches (0.75, 1 and 1.5 mg of THY, CAR, TYR, SQU patches and mixed membranes with 
THY-TYR and THY-SQU) in a volume of 1 mL. After treatment, MTT solution was added to 
the cells following the methodology used in Chapter III. Eight samples were analyzed per 
concentration and compound. Results were expressed as viability percentage normalized over 
the positive control (100% viability) and negative control (no cells) samples. Not loaded PCL 
patches were assigned with 100% viability.   
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AI.5.2. Flow cytometry for apoptosis detection  
In Chapter IV flow cytometry was carried out for cells treated with free compounds. J774 
cells were seeded at densities of 9 × 104 cells/well in 24-well plates and maintained at 37 °C and 
5% CO2 overnight. Cells were then treated with free EOs at non-lethal concentrations as 
determined by the MTT assay described above: 0.06 mg/mL for CAR, CIN, THY, B-CAR, and 
0.12 mg/mL for TYR, CUR, SQU. After a 24 h incubation period, cells were collected and 
resuspended in annexin V-binding buffer (10 mM HEPES/NaOH, 140 M NaCl, 25 mM CaCl2) 
and treated with a solution composed of annexin V-FITC and propidium iodide. Cells were then 
incubated at room temperature for 15 min in the dark. Analyses were carried out using a BD 
FACSAria BD flow cytometer equipped with BD FACSDiva software (Cell Separation and 
Cytometry Unit, CIBA, IIS Aragon, Spain). Untreated control cells were used as a negative 
control to determine the basal status of the cells and the effect of EOs on J774 macrophages. 
AI.5.3 In vitro model infection of J774 macrophages  
J774 macrophages were seeded in µ-dish 35mm ibiTreat plates (130,000 cells/cm2) 
overnight. Prior to the infection assays, supplemented DMEM containing antibiotics was 
removed, cells were washed twice with PBS and DMEM renewed without adding antibiotics in 
order to not hamper infection. Not infected and infected cells without treatment were also run 
as control samples (data not shown). Equally, THY-free patches (PCL) were tested in the 
cultures to evaluate the treatment effect. Both methodologies described in cell cytotoxicity 
section were followed according to the corresponding patches weight and the results obtained 
in the cytotoxicity assays to elucidate the efficiency of the patches related to their weight and 
thus, their THY loading. Patches were added to culture cells and then infected with 105 CFU/mL 
of cGFP-expressing S. aureus in DMEM without antibiotics previously prepared. Treated 
cultures were incubated for 1 h (10 and 12 mg PCL-THY) or 24h (5-7 mg PCL-THY) at 37 ºC 
and 5% CO2. After those time periods, patches were removed, cells were washed twice with 
PBS and fixed in PFA 4% during 30 min at room temperature.  
Confocal microscopy was then used to monitor the effect of PCL-THY in the infection 
model of J774 macrophages mediated by cGFP-expressing S. aureus. After fixation, cells were 
first washed with PBS-BSA 1% and secondly, with saponin 0.1% in PBS-BSA solution. 
Straightaway, the plates were incubated in the dark with 500 µL of phalloidin 546, (1:200 in 
PBS-BSA-saponin prepared solution) for 1 h at room temperature. After incubation, cells were 
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rinsed with PBS-BSA 1% and then with distilled water. Finally, coverslips were mounted on 
glass slides in DAPI-Mowiol mounting medium. Samples were analyzed under confocal 
microscopy (Confocal Zeiss LSM 880 with airyscan; Microscopy Unit, CIBA, IIS Aragon, 
Zaragoza, Spain).). Z-stack orthogonal projections were used to visualize the presence of 
bacteria inside the cells.  
AI.6. Anti-inflammatory studies 
These experiments were carried out in the Methodist Hospital Research Institute in Houston 
(Texas, US) in the group of Biomimetic Medicine headed by Professor Ennio Tasciotti. 
AI.6.1. In vitro inflammation  
In vitro inflammation and treatment with EOs were developed following two different 
approaches, the pre-treatment approach and the post-treatment approach, which are depicted in 
Scheme described in Chapter IV (Scheme IV.1) 
• Pre-treatment approach: In the pre-treatment approach, cells were seeded in a 12-well 
plate and cultured at 37 °C and 5% CO2. After 24 h, EOs were added to the cells at the 
subcytotoxic concentration as determined by the MTT assay. Without removing EOs, cells 
were activated by using 100 ng/mL of LPS for 24 h at 37 °C and 5% CO2. 
• Post-treatment approach: In the post-treatment approach, cells were seeded and treated 
with LPS 100 ng/mL for 3 h at 37 °C and 5% CO2. Then, EOs were added to the plate 
without removing LPS.  
This approach was also followed to study the release of the compounds present in the EOs from 
loaded PCL nanofibers by adding the patches to activated cells. 
 
AI.6.2. Gene expression analysis  
J774 macrophages were treated with free EO or loaded patches for 24 h. Next, cells were 
collected to evaluate their gene expression by RT-PCR. For this, cells were washed with PBS 
and lysed with TRIzol. RNeasy mini kit was used to obtain RNA while NanoDrop ND1000 
spectrophotometer (NanoDrop Technologies, USA) was used to obtain concentration. cDNA 
was reverse transcribed with the iScript retrotranscription kit. The amplification was carried out 
using TaqMan® Fast Advanced Master Mix on a StepOne Plus realtime PCR system. Gene 
expression was evaluated using the following target probes: 
o Pro-inflammatory genes: Il1b (Mm00434228_m1) and Nos2 (Mm00440502_m1) 
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o Anti-inflammatory genes: Il10 (Mm00439614_m1) 
Gene expression was normalized to the level of actin beta (Actb, Mm00607939_s1). The 
values obtained from tested genes were normalized to those obtained from control groups (non-
stimulated cells).  
AI.6.3. Cell colonization model 
To study cell migration and colonization of the patches, J774 macrophages were seeded 
in 24-well plates (50,000 cells/well). PCL patches loaded with THY, TYR, SQU, THY-TYR or 
THY-SQU were added and incubated at 37 °C and 5% CO2 for 24 h. Then, cell colonization 
was evaluated from two points of view:  
6.3.1. Cell viability in the wells compared to that obtained from the patches: MTT assay was 
performed as described above to quantify cell viability and to compare viability exerted 
by treated cells (wells at which membranes were added) with that obtained from untreated 
cells (wells at which membranes were not added). At the same time, the viability assay 
was also carried out in the patches to evaluate cell colonization. 
6.3.2. SEM was used to observe the patches morphology and to verify the absence of cell 
colonization in patches. After incubation with loaded nanofibers, cells were washed in 
cacodylate buffer and fixed with paraformaldehyde 3% with 0.1 M cacodylate buffer at 4 
°C overnight. Then, samples were washed with cacodylate buffer and subsequently 
dehydrated in ethanol solutions series (50, 70, 80, 90, 100% for 5 min per concentration). 
Finally, samples were washed with hexamethyldisilizane, air-dried in a hood and coated 
with a thin 5 nm Pt layer. 
AI. 6.4. Immunofluorescence assay 
Cells were seeded at a concentration of 62,000 cells/cm2 and inflamed following the post-
treatment approach described above. Then, a THY patch (0.75 mg) was added to the well and 
maintained at 37 °C and 5% CO2 for 24 h. Next, cells were washed twice in PBS and fixed in 
4% paraformaldehyde for 10 min at room temperature. Following fixation, cells were stained 
with wheat germ agglutinin, Alexa Fluor™ 488 Conjugate for 10 min at room temperature in 
order to stain cell membrane. Finally, nuclei were stained with DAPI for 1 min and mounted by 
using SlowFade™ Diamond Antifade Mountant. Images were collected using a Nikon A1 
confocal microscope with post-processing performed using NIS Elements software (Nikon 
Instruments Corporation, Japan). 
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AI.7. In vivo experiments 
AI.7.1. Mouse excisional wound splinting model and infection 
In vivo studies were performed under Project License 51/14 approved by the Ethic 
Committee for Animal Experiments of the University of Zaragoza (Spain). In these studies, 
eight to ten-week-old male SKH1 hairless mice were used. Mice were fed ad libitum and 
maintained under specific pathogen-free conditions accordingly with the Spanish Policy for 
Animal Protection RD53/2013, which meets the European Union Directive 2010/63 on the 
protection of animals destined to scientific purposes. 
Thirty mice were experimentally divided in five groups (N = 6): a) Control group: Wounds 
without infection or treatment; b) PCL group: Wounds infected and treated with PCL dressings; 
c) PCL-THY group: Wounds infected and treated with thymol-loaded PCL dressings; d) THY 
group: Wounds infected and treated with free THY; e) CLXD group: Wounds infected and 
treated with chlorhexidine. In each group, three mice were euthanized at 3 days post-surgery 
and infection (dpi) and other three mice at 7 dpi.  
The mouse excisional wound splinting model348 with some modifications was developed 
to evaluate wound infection and healing while avoiding the natural murine wound closure 
through skin contraction with the purpose to mimic the granulation and reepithelization 
processes that take place during human wound healing.349  
In order to evaluate potential weight loss during the experiments, the animals were daily 
weighted. For the surgical procedure, SKH1 hairless mice were initially anesthetized with 5 % 
isoflurane, and maintained with 1-2 % isoflurane (1 L/min oxygen flow). The mice were 
rinsed with a 70 % ethanol (v/v) swab to be sterilely prepped. Meloxicam (2.5 mg/kg body 
weight) was then subcutaneously administered for pain relief (daily until 48 h post-surgery). 
Scheme in Chapter V (Scheme V.I) shows the procedure of wound infection model, in which a 
sterile 8-mm punch biopsy tool was employed to pattern two full-thickness wounds in the skin 
of the dorsum at each side of the median line of the animal. After that, two donut-shaped 
silicone wound splints were sutured with six interrupted 4/0 sutures to avoid the natural 
murine wound closure through skin contraction. Wounds were subsequently infected by 
inoculation of 107 CFU (25 µL in PBS) of S. aureus ATCC 25923. As mentioned before, 
different treatments were then applied: PCL dressing patches (as control of infection), THY 
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loaded PCL dressing patches, free THY or free CLXD (as model antiseptic in clinical use). 
The dressing patches diameter was 12 mm whereas free compounds were added in a volume 
of 25 µL. Free THY was also assessed to compare the effect in wound infection and healing 
with the encapsulated THY. Finally, wounds and dressings were covered with sterile adhesive 
plasters and bandages. Dressing patches were replaced every day for 3 days, then all wounds 
were uncovered, as recommended in the clinical practice.350,351 The progression of infection as 
well as weight loss and potential pain were monitored daily until the end of the studies. 
AI.7.2. Evaluation of infection in wounds 
The infection progression in wounds was evaluated through a semi-quantitative analysis 
of microbiological cultures and quantitative polymerase chain reaction (qPCR). The 
microbiological results were obtained from three independent experiments run in triplicate. 
Microbiological samples were harvested from wounds by means of microbiological swabs 
with Amies media at 1, 2, 3 and 7 dpi. The microbiological samples were cultured on blood agar 
and McConkey No. 3 media (Oxoid). After incubation (37 °C, 24 h), bacteria concentration in 
the samples was semiquantified and the microorganism identified by reseeding samples and 
analyzing by a MALDI-TOF system (Bruker). Concurrently, qPCR evaluation of S. aureus 
ATCC 25923 was carried out in the samples. Briefly, DNA was obtained (DNeasy Blood & 
Tissue Kit, Qiagen) and amplified through the EXOone Staphylococcus aureus one MIX qPCR 
kit (Exopol) and a 7500 FAST Real Time PCR System. The pre-incubation step (1 cycle, 5 min, 
95 °C) was followed by an amplification stage of 42 cycles of 15 s at 95 °C and 1 min at 60 °C, 
to read then the plate.  
AI.7.3. Histological studies 
Euthanasia was carried out by CO2 inhalation after 3 and 7 dpi. Then, wounds were totally 
exposed by removing splints, sutures, dressings and gauzes, and harvested together with ~ 5 mm 
in diameter of surrounding tissue. Samples were then fixed for 24 h in paraformaldehyde and 
embedded in paraffin. Five µm sections were stained with hematoxylin and eosin (HE), and 
Gram staining for histopathological and bacteria determination, respectively. In order to assess 
wound angiogenesis, an immunohistochemical evaluation was performed by using rabbit 
polyclonal CD31 antibody (ab28364, Abcam) thanks to the Histopathology Unit from CNIO 
(Madrid, Spain). In brief, the automated immunostaining platform Autostainer Link (Dako) was 
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used. The slides were dewaxed in xylene and re-hydrated in an ethanol series. Antigen retrieval 
was carried out by high pH buffer treatment (CC1m, Roche) and 3 % H2O2 was added to block 
the endogenous peroxidase. Subsequently, the slides were incubated with the primary antibody 
(1:50 for 60 min) followed by the corresponding visualization system conjugated with 
horseradish peroxidase (EnVision FLEX+, Dako). The chromogen 3, 30-diaminobenzidine 
tetrahydrochloride (DAB) was used for the detection of the immunohistochemical reaction. 
Nuclei staining were carried out using Carazzi's hematoxylin. Finally, the slides were 
dehydrated and permanent mounted to be visualized by microscopy. The interpretation of the 
histological results were performed in collaboration with Dr. Lluís Luján, Dr. Marta Pérez, Dr. 
Javier Asín and Mr. Ricardo de Miguel (Department of Animal Pathology, University of 
Zaragoza, Spain). 
AI.8. Statistical analyses  
All results were statistically analyzed using Prism 7 software (Version 7.04, GraphPad 
Software Inc., USA). All values are reported as mean ± SD. At least, three replicas for each 
experiment were performed. A one-way (Chapters III and IV) and two-way (Chapter II and 
V) analysis of variance (ANOVA) set for multiple comparisons with a Dunnett’s post-test was 
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